{
  "ids": {
    "Scan": 31,
    "ScanLog": 1344
  },
  "models": {
    "Scan": {
      "1": "{\"org\":\"ohsdi-studies\",\"id\":1}",
      "2": "{\"org\":\"ohsdi-studies\",\"id\":2}",
      "3": "{\"org\":\"ohdsi-studies\",\"id\":3}",
      "4": "{\"org\":\"ohdsi-studies\",\"id\":4}",
      "5": "{\"org\":\"ohdsi-studies\",\"id\":5}",
      "6": "{\"org\":\"ohdsi-studies\",\"id\":6}",
      "7": "{\"org\":\"ohdsi-studies\",\"id\":7}",
      "8": "{\"org\":\"ohdsi-studies\",\"id\":8}",
      "9": "{\"org\":\"ohdsi-studies\",\"id\":9}",
      "10": "{\"org\":\"ohdsi-studies\",\"id\":10}",
      "11": "{\"org\":\"ohdsi-studies\",\"id\":11}",
      "12": "{\"org\":\"ohdsi-studies\",\"id\":12}",
      "13": "{\"org\":\"ohdsi-studies\",\"id\":13}",
      "14": "{\"org\":\"ohdsi-studies\",\"id\":14}",
      "15": "{\"org\":\"ohdsi-studies\",\"id\":15}",
      "16": "{\"org\":\"ohdsi-studies\",\"id\":16}",
      "17": "{\"org\":\"ohdsi-studies\",\"id\":17}",
      "18": "{\"org\":\"ohdsi-studies\",\"id\":18}",
      "19": "{\"org\":\"ohdsi-studies\",\"id\":19}",
      "20": "{\"org\":\"ohdsi-studies\",\"id\":20}",
      "21": "{\"org\":\"ohdsi-studies\",\"id\":21}",
      "22": "{\"org\":\"ohdsi-studies\",\"id\":22}",
      "23": "{\"org\":\"ohdsi-studies\",\"id\":23}",
      "24": "{\"org\":\"ohdsi-studies\",\"id\":24}",
      "25": "{\"org\":\"ohdsi-studies\",\"id\":25}",
      "26": "{\"org\":\"ohdsi-studies\",\"id\":26}",
      "27": "{\"org\":\"ohdsi-studies\",\"id\":27}",
      "28": "{\"org\":\"ohdsi-studies\",\"id\":28}",
      "29": "{\"org\":\"ohdsi-studies\",\"id\":29}",
      "30": "{\"org\":\"ohdsi-studies\",\"id\":30}"
    },
    "ScanLog": {
      "1": "{\"status\":\"error\",\"scanId\":2,\"id\":1}",
      "2": "{\"status\":\"error\",\"scanId\":3,\"id\":2}",
      "3": "{\"status\":\"error\",\"scanId\":4,\"id\":3}",
      "4": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"readme\":{\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Complete-orange.svg\\\" alt=\\\"Study Status: Complete\\\">\"}}},\"scanId\":5,\"id\":4}",
      "5": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"summary\":{\"readme\":{\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Results%20Available-yellow.svg\\\" alt=\\\"Study Status: Results Available\\\">\"}}},\"scanId\":5,\"id\":5}",
      "6": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"summary\":{\"readme\":{\"title\":\"Cause-specific mortality prediction\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Design%20Finalized-brightgreen.svg\\\" alt=\\\"Study Status: Design Finalized\\\">\"}}},\"scanId\":5,\"id\":6}",
      "7": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"summary\":{\"readme\":{\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Design%20Finalized-brightgreen.svg\\\" alt=\\\"Study Status: Design Finalized\\\">\"}}},\"scanId\":5,\"id\":7}",
      "8": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"summary\":{\"readme\":{\"title\":\"StudyRepoTemplate\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Repo%20Created-lightgray.svg\\\" alt=\\\"Study Status: Repo Created\\\">\"}}},\"scanId\":5,\"id\":8}",
      "9": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"summary\":{\"readme\":{\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Design%20Finalized-brightgreen.svg\\\" alt=\\\"Study Status: Design Finalized\\\">\"}}},\"scanId\":5,\"id\":9}",
      "10": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"summary\":{\"readme\":{\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Results%20Available-yellow.svg\\\" alt=\\\"Study Status: Results Available\\\">\"}}},\"scanId\":5,\"id\":10}",
      "11": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"summary\":{\"readme\":{\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Results%20Available-yellow.svg\\\" alt=\\\"Study Status: Results Available\\\">\"}}},\"scanId\":5,\"id\":11}",
      "12": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"summary\":{\"readme\":{\"title\":\"Complication of intravitreous injection\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Started-blue.svg\\\" alt=\\\"Study Status: Started\\\">\"}}},\"scanId\":5,\"id\":12}",
      "13": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"summary\":{\"readme\":{\"title\":\"[Study title]\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Repo%20Created-lightgray.svg\\\" alt=\\\"Study Status: Repo Created\\\">\"}}},\"scanId\":5,\"id\":13}",
      "14": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"summary\":{\"readme\":{\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Design%20Finalized-brightgreen.svg\\\" alt=\\\"Study Status: Design Finalized\\\">\"}}},\"scanId\":5,\"id\":14}",
      "15": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2020-12-09T20:12:10Z\",\"watcbersCount\":6,\"summary\":{\"readme\":{\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Complete-orange.svg\\\" alt=\\\"Study Status: Complete\\\">\",\"useCases\":\"- Analytics use case(s): **Population-Level Estimation**\",\"studyType\":\"- Study type: **Methods Research**\",\"tags\":\"- Tags: **-**\",\"studyLead\":null,\"startDate\":\"- Study start date: **November 1, 2018**\",\"endDate\":\"- Study end date: **August 1, 2019**\",\"protocol\":\"- Protocol: [**Word file**](https://github.com/ohdsi-studies/MethodsLibraryPleEvaluation/blob/master/extras/OHDSI%20Protocol%20Method%20Evaluation.docx)\",\"publications\":\"- Publications: **[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)**\",\"results\":\"- Results explorer: **[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)**\"}}},\"scanId\":6,\"id\":15}",
      "16": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Results%20Available-yellow.svg\\\" alt=\\\"Study Status: Results Available\\\">\",\"useCases\":\"- Analytics use case(s): **Population-Level Estimation**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **-**\",\"studyLead\":null,\"startDate\":\"- Study start date: **December 11, 2018**\",\"endDate\":null,\"protocol\":\"- Protocol: [**Word file**](https://github.com/ohdsi-studies/TicagrelorVsClopidogrel/blob/master/documents/SAP_TicagrelorVsClopidogrelVer1.3.docx)\",\"publications\":null,\"results\":\"- Results explorer: **[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)**\"}}},\"scanId\":6,\"id\":16}",
      "17": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Cause-specific mortality prediction\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Design%20Finalized-brightgreen.svg\\\" alt=\\\"Study Status: Design Finalized\\\">\",\"useCases\":\"- Analytics use case(s): **Patient-Level Prediction**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **-**\",\"studyLead\":null,\"startDate\":\"- Study start date: **June 1, 2019**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: **-**\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **-**\"}}},\"scanId\":6,\"id\":17}",
      "18": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watcbersCount\":5,\"summary\":{\"readme\":{\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Design%20Finalized-brightgreen.svg\\\" alt=\\\"Study Status: Design Finalized\\\">\",\"useCases\":\"- Analytics use case(s): **Population-Level Estimation**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **OHDSI-Korea, FEEDER-NET**\",\"studyLead\":null,\"startDate\":\"- Study start date: **January 31, 2020**\",\"endDate\":null,\"protocol\":\"- Protocol: [Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":null,\"results\":null}}},\"scanId\":6,\"id\":18}",
      "19": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watcbersCount\":4,\"summary\":{\"readme\":{\"title\":\"StudyRepoTemplate\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Repo%20Created-lightgray.svg\\\" alt=\\\"Study Status: Repo Created\\\">\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":6,\"id\":19}",
      "20": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Design%20Finalized-brightgreen.svg\\\" alt=\\\"Study Status: Design Finalized\\\">\",\"useCases\":\"- Analytics use case(s): **Population-Level Estimation**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira**\",\"studyLead\":null,\"startDate\":\"- Study start date: **May 2, 2018**\",\"endDate\":\"- Study end date: **June 30, 2020**\",\"protocol\":\"- Protocol: **[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)** \",\"publications\":\"- Publications: **TBD**\",\"results\":\"- Results explorer: **In progress**\"}}},\"scanId\":6,\"id\":20}",
      "21": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Results%20Available-yellow.svg\\\" alt=\\\"Study Status: Results Available\\\">\",\"useCases\":\"- Analytics use case(s): **Characterization**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **Rheumatoid arthritis, Drug Utilization, EHDEN**\",\"studyLead\":null,\"startDate\":\"- Study start date: **January 12, 2020**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: [**Word file**](https://github.com/ohdsi-studies/EhdenRaDrugUtilization/blob/master/extras/Barcelona%20studyathon%20protocol.docx)\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":6,\"id\":21}",
      "22": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Results%20Available-yellow.svg\\\" alt=\\\"Study Status: Results Available\\\">\",\"useCases\":\"- Analytics use case(s): **Population-Level Estimation**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **EHDEN**\",\"studyLead\":null,\"startDate\":\"- Study start date: **January 13, 2020**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: [**Word file**](https://github.com/ohdsi-studies/EhdenRaDmardsEstimation/blob/master/documents/20200117_RAPLE_EUPAS_final.docx)\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)**\"}}},\"scanId\":6,\"id\":22}",
      "23": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Complication of intravitreous injection\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Started-blue.svg\\\" alt=\\\"Study Status: Started\\\">\",\"useCases\":\"- Analytics use case(s): **Characterization**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **OHDSI-Korea, FEEDER-NET**\",\"studyLead\":null,\"startDate\":\"- Study start date: **January 13, 2020**\",\"endDate\":\"- Study end date: \",\"protocol\":\"- Protocol: \",\"publications\":\"- Publications: \",\"results\":\"- Results explorer: \"}}},\"scanId\":6,\"id\":23}",
      "24": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"[Study title]\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Repo%20Created-lightgray.svg\\\" alt=\\\"Study Status: Repo Created\\\">\",\"useCases\":\"- Analytics use case(s): **-**\",\"studyType\":\"- Study type: **-**\",\"tags\":\"- Tags: **-**\",\"studyLead\":null,\"startDate\":\"- Study start date: **-**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: **-**\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **-**\"}}},\"scanId\":6,\"id\":24}",
      "25": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Design%20Finalized-brightgreen.svg\\\" alt=\\\"Study Status: Design Finalized\\\">\",\"useCases\":\"- Analytics use case(s): **Characterization** and **Population-Level Estimation**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **iud**\",\"studyLead\":null,\"startDate\":\"- Study start date: **September 23, 2019**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: **[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)**\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **-**\"}}},\"scanId\":6,\"id\":25}",
      "26": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watcbersCount\":3,\"summary\":{\"readme\":{\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Design%20Finalized-brightgreen.svg\\\" alt=\\\"Study Status: Design Finalized\\\">\",\"useCases\":\"- Analytics use case(s): **Patient-Level Prediction**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **-**\",\"studyLead\":null,\"startDate\":\"- Study start date: **Jan 1, 2020**\",\"endDate\":\"- Study end date: **April 30, 2020**\",\"protocol\":\"- Protocol: **[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)**\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **-**\"}}},\"scanId\":6,\"id\":26}",
      "27": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Started-blue.svg\\\" alt=\\\"Study Status: Started\\\">\",\"useCases\":\"- Analytics use case(s): **Patient Level Prediction**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **EHDEN**\",\"studyLead\":null,\"startDate\":\"- Study start date: **January 16, 2020**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: [**Word file**](https://github.com/ohdsi-studies/EhdenRaPrediction/blob/master/documents/RA_PLP_protocol_09042021.docx)\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: [**Shiny app**](https://data.ohdsi.org/EhdenRaPrediction/)\"}}},\"scanId\":6,\"id\":27}",
      "28": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"exists\":false}}},\"scanId\":6,\"id\":28}",
      "29": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Started-blue.svg\\\" alt=\\\"Study Status: Started\\\">\",\"useCases\":\"- Analytics use case(s): **Characterization & Population Level Estimation**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **OHDSI**\",\"studyLead\":null,\"startDate\":\"- Study start date: **1st December 2020**\",\"endDate\":\"- Study end date: **1st May 2021**\",\"protocol\":\"- Protocol: **[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)**\",\"publications\":\"- Publications: ** **\",\"results\":\"- Results explorer: \"}}},\"scanId\":6,\"id\":29}",
      "30": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Design%20Finalized-brightgreen.svg\\\" alt=\\\"Study Status: Design Finalized\\\">\",\"useCases\":\"- Analytics use case(s): **Characterization**\",\"studyType\":\"- Study type: **Methods Research**\",\"tags\":\"- Tags: **-**\",\"studyLead\":null,\"startDate\":\"- Study start date: **March 15, 2019**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: **[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)**\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **-**\"}}},\"scanId\":6,\"id\":30}",
      "31": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Complete-orange.svg\\\" alt=\\\"Study Status: Complete\\\">\",\"useCases\":\"- Analytics use case(s): **Patient-Level Prediction**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **-**\",\"studyLead\":null,\"startDate\":\"- Study start date: **Aug 9, 2019**\",\"endDate\":\"- Study end date: **Sep 16, 2019**\",\"protocol\":\"- Protocol: **[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)**\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **[Shiny App](https://data.ohdsi.org/WoO2019/)**\"}}},\"scanId\":6,\"id\":31}",
      "32": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Repo%20Created-lightgray.svg\\\" alt=\\\"Study Status: Repo Created\\\">\",\"useCases\":\"- Analytics use case(s): **Characterization**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **OHDSI-AP**\",\"studyLead\":null,\"startDate\":\"- Study start date: **-**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: **-**\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **-**\"}}},\"scanId\":6,\"id\":32}",
      "33": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Complete-orange.svg\\\" alt=\\\"Study Status: Complete\\\">\",\"useCases\":\"- Analytics use case(s): **Population-Level Estimation**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **-**\",\"studyLead\":null,\"startDate\":\"- Study start date: **December 29, 2018**\",\"endDate\":\"- Study end date: **July 31, 2019**\",\"protocol\":\"- Protocol: **[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)**\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)**\"}}},\"scanId\":6,\"id\":33}",
      "34": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Repo%20Created-lightgray.svg\\\" alt=\\\"Study Status: Repo Created\\\">\",\"useCases\":\"- Analytics use case(s): **Characterization**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **OHDSI-Korea, FEEDER-NET, Oncology WG**\",\"studyLead\":null,\"startDate\":\"- Study start date: **Februrary 25, 2020**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: **-**\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **-**\"}}},\"scanId\":6,\"id\":34}",
      "35": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watcbersCount\":9,\"summary\":{\"readme\":{\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Results%20Available-yellow.svg\\\" alt=\\\"Study Status: Results Available\\\">\",\"useCases\":\"- Analytics use case(s): **Characterization**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **OHDSI, Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"- Study start date: **March 16, 2020**\",\"endDate\":\"- Study end date: **April 9, 2020**\",\"protocol\":\"- Protocol: **[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)**\",\"publications\":\"- Publications: **[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)**\",\"results\":\"- Results explorer: **[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)**\"}}},\"scanId\":6,\"id\":35}",
      "36": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Started-blue.svg\\\" alt=\\\"Study Status: Started\\\">\",\"useCases\":\"- Analytics use case(s): **Population-Level Estimation**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"- Study start date: **March 19, 2020**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: **-**\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **-**\"}}},\"scanId\":6,\"id\":36}",
      "37": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Started-blue.svg\\\" alt=\\\"Study Status: Started\\\">\",\"useCases\":\"- Analytics use case(s): **Patient-Level Prediction**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"- Study start date: **March 9, 2020**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: **-**\",\"publications\":\"- Publications: **-**\",\"results\":\"- Results explorer: **-**\"}}},\"scanId\":6,\"id\":37}",
      "38": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Covid19CohortEvaluation\",\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":6,\"id\":38}",
      "39": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watcbersCount\":10,\"summary\":{\"readme\":{\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"<img src=\\\"https://img.shields.io/badge/Study%20Status-Results%20Available-yellow.svg\\\" alt=\\\"Study Status: Results Available\\\">\",\"useCases\":\"- Analytics use case(s): **Patient-Level Prediction**\",\"studyType\":\"- Study type: **Clinical Application**\",\"tags\":\"- Tags: **Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"- Study start date: **Mar 26, 2020**\",\"endDate\":\"- Study end date: **-**\",\"protocol\":\"- Protocol: **[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)**\",\"publications\":\"- Publications: **[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)**\",\"results\":\"- Results explorer: **[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)**\"}}},\"scanId\":6,\"id\":39}",
      "40": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2020-12-09T20:12:10Z\",\"watcbersCount\":6,\"summary\":{\"readme\":{\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation**\",\"studyType\":\"Methods Research**\",\"tags\":\"-**\",\"studyLead\":null,\"startDate\":\"November 1, 2018**\",\"endDate\":\"August 1, 2019**\",\"protocol\":\"[**Word file**](https://github.com/ohdsi-studies/MethodsLibraryPleEvaluation/blob/master/extras/OHDSI%20Protocol%20Method%20Evaluation.docx)\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)**\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)**\"}}},\"scanId\":7,\"id\":40}",
      "41": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation**\",\"studyType\":\"Clinical Application**\",\"tags\":\"-**\",\"studyLead\":null,\"startDate\":\"December 11, 2018**\",\"endDate\":null,\"protocol\":\"[**Word file**](https://github.com/ohdsi-studies/TicagrelorVsClopidogrel/blob/master/documents/SAP_TicagrelorVsClopidogrelVer1.3.docx)\",\"publications\":null,\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)**\"}}},\"scanId\":7,\"id\":41}",
      "42": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction**\",\"studyType\":\"Clinical Application**\",\"tags\":\"-**\",\"studyLead\":null,\"startDate\":\"June 1, 2019**\",\"endDate\":\"-**\",\"protocol\":\"-**\",\"publications\":\"-**\",\"results\":\"-**\"}}},\"scanId\":7,\"id\":42}",
      "43": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watcbersCount\":5,\"summary\":{\"readme\":{\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation**\",\"studyType\":\"Clinical Application**\",\"tags\":\"OHDSI-Korea, FEEDER-NET**\",\"studyLead\":null,\"startDate\":\"January 31, 2020**\",\"endDate\":null,\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":null,\"results\":null}}},\"scanId\":7,\"id\":43}",
      "44": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watcbersCount\":4,\"summary\":{\"readme\":{\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":7,\"id\":44}",
      "45": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation**\",\"studyType\":\"Clinical Application**\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira**\",\"studyLead\":null,\"startDate\":\"May 2, 2018**\",\"endDate\":\"June 30, 2020**\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)** \",\"publications\":\"TBD**\",\"results\":\"In progress**\"}}},\"scanId\":7,\"id\":45}",
      "46": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization**\",\"studyType\":\"Clinical Application**\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN**\",\"studyLead\":null,\"startDate\":\"January 12, 2020**\",\"endDate\":\"-**\",\"protocol\":\"[**Word file**](https://github.com/ohdsi-studies/EhdenRaDrugUtilization/blob/master/extras/Barcelona%20studyathon%20protocol.docx)\",\"publications\":\"-**\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":7,\"id\":46}",
      "47": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation**\",\"studyType\":\"Clinical Application**\",\"tags\":\"EHDEN**\",\"studyLead\":null,\"startDate\":\"January 13, 2020**\",\"endDate\":\"-**\",\"protocol\":\"[**Word file**](https://github.com/ohdsi-studies/EhdenRaDmardsEstimation/blob/master/documents/20200117_RAPLE_EUPAS_final.docx)\",\"publications\":\"-**\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)**\"}}},\"scanId\":7,\"id\":47}",
      "48": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization**\",\"studyType\":\"Clinical Application**\",\"tags\":\"OHDSI-Korea, FEEDER-NET**\",\"studyLead\":null,\"startDate\":\"January 13, 2020**\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":7,\"id\":48}",
      "49": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-**\",\"studyType\":\"-**\",\"tags\":\"-**\",\"studyLead\":null,\"startDate\":\"-**\",\"endDate\":\"-**\",\"protocol\":\"-**\",\"publications\":\"-**\",\"results\":\"-**\"}}},\"scanId\":7,\"id\":49}",
      "50": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization** and **Population-Level Estimation**\",\"studyType\":\"Clinical Application**\",\"tags\":\"iud**\",\"studyLead\":null,\"startDate\":\"September 23, 2019**\",\"endDate\":\"-**\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)**\",\"publications\":\"-**\",\"results\":\"-**\"}}},\"scanId\":7,\"id\":50}",
      "51": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watcbersCount\":3,\"summary\":{\"readme\":{\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction**\",\"studyType\":\"Clinical Application**\",\"tags\":\"-**\",\"studyLead\":null,\"startDate\":\"Jan 1, 2020**\",\"endDate\":\"April 30, 2020**\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)**\",\"publications\":\"-**\",\"results\":\"-**\"}}},\"scanId\":7,\"id\":51}",
      "52": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction**\",\"studyType\":\"Clinical Application**\",\"tags\":\"EHDEN**\",\"studyLead\":null,\"startDate\":\"January 16, 2020**\",\"endDate\":\"-**\",\"protocol\":\"[**Word file**](https://github.com/ohdsi-studies/EhdenRaPrediction/blob/master/documents/RA_PLP_protocol_09042021.docx)\",\"publications\":\"-**\",\"results\":\"[**Shiny app**](https://data.ohdsi.org/EhdenRaPrediction/)\"}}},\"scanId\":7,\"id\":52}",
      "53": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"exists\":false}}},\"scanId\":7,\"id\":53}",
      "54": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation**\",\"studyType\":\"Clinical Application**\",\"tags\":\"OHDSI**\",\"studyLead\":null,\"startDate\":\"1st December 2020**\",\"endDate\":\"1st May 2021**\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)**\",\"publications\":\" **\",\"results\":\"\"}}},\"scanId\":7,\"id\":54}",
      "55": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization**\",\"studyType\":\"Methods Research**\",\"tags\":\"-**\",\"studyLead\":null,\"startDate\":\"March 15, 2019**\",\"endDate\":\"-**\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)**\",\"publications\":\"-**\",\"results\":\"-**\"}}},\"scanId\":7,\"id\":55}",
      "56": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction**\",\"studyType\":\"Clinical Application**\",\"tags\":\"-**\",\"studyLead\":null,\"startDate\":\"Aug 9, 2019**\",\"endDate\":\"Sep 16, 2019**\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)**\",\"publications\":\"-**\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)**\"}}},\"scanId\":7,\"id\":56}",
      "57": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization**\",\"studyType\":\"Clinical Application**\",\"tags\":\"OHDSI-AP**\",\"studyLead\":null,\"startDate\":\"-**\",\"endDate\":\"-**\",\"protocol\":\"-**\",\"publications\":\"-**\",\"results\":\"-**\"}}},\"scanId\":7,\"id\":57}",
      "58": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation**\",\"studyType\":\"Clinical Application**\",\"tags\":\"-**\",\"studyLead\":null,\"startDate\":\"December 29, 2018**\",\"endDate\":\"July 31, 2019**\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)**\",\"publications\":\"-**\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)**\"}}},\"scanId\":7,\"id\":58}",
      "59": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization**\",\"studyType\":\"Clinical Application**\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG**\",\"studyLead\":null,\"startDate\":\"Februrary 25, 2020**\",\"endDate\":\"-**\",\"protocol\":\"-**\",\"publications\":\"-**\",\"results\":\"-**\"}}},\"scanId\":7,\"id\":59}",
      "60": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watcbersCount\":9,\"summary\":{\"readme\":{\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization**\",\"studyType\":\"Clinical Application**\",\"tags\":\"OHDSI, Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"March 16, 2020**\",\"endDate\":\"April 9, 2020**\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)**\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)**\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)**\"}}},\"scanId\":7,\"id\":60}",
      "61": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation**\",\"studyType\":\"Clinical Application**\",\"tags\":\"Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"March 19, 2020**\",\"endDate\":\"-**\",\"protocol\":\"-**\",\"publications\":\"-**\",\"results\":\"-**\"}}},\"scanId\":7,\"id\":61}",
      "62": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction**\",\"studyType\":\"Clinical Application**\",\"tags\":\"Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"March 9, 2020**\",\"endDate\":\"-**\",\"protocol\":\"-**\",\"publications\":\"-**\",\"results\":\"-**\"}}},\"scanId\":7,\"id\":62}",
      "63": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Covid19CohortEvaluation\",\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":7,\"id\":63}",
      "64": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watcbersCount\":10,\"summary\":{\"readme\":{\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction**\",\"studyType\":\"Clinical Application**\",\"tags\":\"Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"Mar 26, 2020**\",\"endDate\":\"-**\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)**\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)**\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)**\"}}},\"scanId\":7,\"id\":64}",
      "65": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation**\",\"studyType\":\"Clinical Application**\",\"tags\":\"Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"March 26, 2020**\",\"endDate\":\"-**\",\"protocol\":\"-**\",\"publications\":\"-**\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)**\"}}},\"scanId\":7,\"id\":65}",
      "66": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watcbersCount\":7,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation**\",\"studyType\":\"Clinical Application**\",\"tags\":\"Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"March 26, 2020**\",\"endDate\":\"-**\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)**\",\"publications\":\"-**\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)**\"}}},\"scanId\":7,\"id\":66}",
      "67": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watcbersCount\":3,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation**\",\"studyType\":\"Clinical Application**\",\"tags\":\"Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"March 26, 2020**\",\"endDate\":\"-**\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)**\",\"publications\":\"-**\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)**\"}}},\"scanId\":7,\"id\":67}",
      "68": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization**\",\"studyType\":\"Clinical Application**\",\"tags\":\"OHDSI, Study-a-thon, COVID-19**\",\"studyLead\":null,\"startDate\":\"April 4, 2020**\",\"endDate\":null,\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)**\",\"publications\":null,\"results\":null}}},\"scanId\":7,\"id\":68}",
      "69": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization**\",\"studyType\":\"Clinical application**\",\"tags\":\"COVID-19, Oncology**\",\"studyLead\":null,\"startDate\":\"April 7, 2020**\",\"endDate\":\"-**\",\"protocol\":\"-**\",\"publications\":\"-**\",\"results\":\"-**\"}}},\"scanId\":7,\"id\":69}",
      "70": "{\"status\":\"complete\",\"scanId\":7,\"id\":70}",
      "71": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2020-12-09T20:12:10Z\",\"watcbersCount\":6,\"summary\":{\"readme\":{\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\"}}},\"scanId\":8,\"id\":71}",
      "72": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 11, 2018\",\"endDate\":null,\"protocol\":\"[\",\"publications\":null,\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\"}}},\"scanId\":8,\"id\":72}",
      "73": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":8,\"id\":73}",
      "74": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watcbersCount\":5,\"summary\":{\"readme\":{\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 31, 2020\",\"endDate\":null,\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\\n- Publications:\\n- Results explorer:\\n\\nThis study aims to compare the risk of cancer between H2 blockers\\n\\nRequirements\\n============\\n\\n- A database in [Common Data Model version 5](https://github.com/OHDSI/CommonDataModel) in one of these platforms: SQL Server, Oracle, PostgreSQL, IBM Netezza, Apache Impala, Amazon RedShift, or Microsoft APS.\\n- R version 3.5.0 or newer\\n- On Windows: [RTools](http://cran.r-project.org/bin/windows/Rtools/)\\n- [Java](http://java.com)\\n- 25 GB of free disk space\\n\\nSee [this video](https://youtu.be/K9_0s2Rchbo) for instructions on how to set up the R environment on Windows.\\n\\n- Required fields of CDM include:\\n\\t- (Mandatory) CONCEPT, CONCEPT_RELATIONSHIP, CONCEPT_ANCESTOR (You can download these tables from the [ATHENA](http://athena.ohdsi.org/))\\n\\t- (Mandatory) PERSON, OBSERVATION_PERIOD, VISIT_OCCURRENCE, CONDITION_OCCURRENCE, DRUG_EXPOSURE, DRUG_ERA\\n\\t- (Optioinal) PROCEDURE_OCCURRENCE, OBSERVATION, DEATH\\n\\nHow to run\\n==========\\n1. We strongly recommend using `renv` to build project-specific R environment as guided [here](StudyPackageSetup.md).\\n \\t Otherwise, in `R`, use the following code to install the dependencies:\\n\\n\\t```r\\n\\tinstall.packages(\\\"devtools\\\")\\n\\tlibrary(devtools)\\n\\tinstall_github(\\\"ohdsi/SqlRender\\\")\\n\\tinstall_github(\\\"ohdsi/DatabaseConnector\\\")\\n\\tinstall_github(\\\"ohdsi/OhdsiSharing\\\")\\n\\tinstall_github(\\\"ohdsi/FeatureExtraction\\\")\\n\\tinstall_github(\\\"ohdsi/CohortMethod\\\")\\n\\tinstall_github(\\\"ohdsi/EmpiricalCalibration\\\")\\n\\tinstall_github(\\\"ohdsi/MethodEvaluation\\\")\\n\\t```\\n\\n\\tIf you experience problems on Windows where rJava can't find Java, one solution may be to add `args = \\\"--no-multiarch\\\"` to each `install_github` call, for example:\\n\\n\\t```r\\n\\tinstall_github(\\\"ohdsi/SqlRender\\\", args = \\\"--no-multiarch\\\")\\n\\t```\\n\\n\\tAlternatively, ensure that you have installed both 32-bit and 64-bit JDK versions, as mentioned in the [video tutorial](https://youtu.be/K9_0s2Rchbo).\\n\\n2. In 'R', use the following code to install the RanitidineCancerRisk package:\\n\\n  ```r\\n\\tinstall_github(\\\"ohdsi-studies/RanitidineCancerRisk\\\", args = \\\"--no-multiarch\\\")\\n  ```\\n\\n3. Once installed, please execute the following code. Then Send the file ```./export/Results_<DatabaseId>.zip``` in the output folder to the study coordinator (SCYou, applegna@gmail.com)\\n\\n\\t```r\\n\\tlibrary(RanitidineCancerRisk)\\n\\n\\t# Optional: specify where the temporary files (used by the ff package) will be created:\\n\\toptions(fftempdir = \\\"c:/FFtemp\\\")\\n\\n\\t# Maximum number of cores to be used:\\n\\tmaxCores <- parallel::detectCores()\\n\\n\\t# Minimum cell count when exporting data:\\n\\tminCellCount <- 5\\n\\n\\t# The folder where the study intermediate and result files will be written:\\n\\toutputFolder <- \\\"c:/RanitidineCancerRisk\\\"\\n\\n\\t# Details for connecting to the server:\\n\\t# See ?DatabaseConnector::createConnectionDetails for help\\n\\tconnectionDetails <- DatabaseConnector::createConnectionDetails(dbms = \\\"postgresql\\\",\\n\\t\\t\\t\\t\\t\\t\\t\\t\\tserver = \\\"some.server.com/ohdsi\\\",\\n\\t\\t\\t\\t\\t\\t\\t\\t\\tuser = \\\"joe\\\",\\n\\t\\t\\t\\t\\t\\t\\t\\t\\tpassword = \\\"secret\\\")\\n\\n\\t# The name of the database schema where the CDM data can be found:\\n\\tcdmDatabaseSchema <- \\\"cdm_synpuf\\\"\\n\\n\\t# The name of the database schema and table where the study-specific cohorts will be instantiated:\\n\\tcohortDatabaseSchema <- \\\"scratch.dbo\\\"\\n\\tcohortTable <- \\\"my_study_cohorts\\\"\\n\\n\\t# Some meta-information that will be used by the export function:\\n\\tdatabaseId <- \\\"Synpuf\\\"\\n\\tdatabaseName <- \\\"Medicare Claims Synthetic Public Use Files (SynPUFs)\\\"\\n\\tdatabaseDescription <- \\\"Medicare Claims Synthetic Public Use Files (SynPUFs) were created to allow interested parties to gain familiarity using Medicare claims data while protecting beneficiary privacy. These files are intended to promote development of software and applications that utilize files in this format, train researchers on the use and complexities of Centers for Medicare and Medicaid Services (CMS) claims, and support safe data mining innovations. The SynPUFs were created by combining randomized information from multiple unique beneficiaries and changing variable values. This randomization and combining of beneficiary information ensures privacy of health information.\\\"\\n\\n\\t# For Oracle: define a schema that can be used to emulate temp tables:\\n\\toracleTempSchema <- NULL\\n\\n\\texecute(connectionDetails = connectionDetails,\\n\\t        cdmDatabaseSchema = cdmDatabaseSchema,\\n\\t        cohortDatabaseSchema = cohortDatabaseSchema,\\n\\t        cohortTable = cohortTable,\\n\\t        oracleTempSchema = oracleTempSchema,\\n\\t        outputFolder = outputFolder,\\n\\t        databaseId = databaseId,\\n\\t        databaseName = databaseName,\\n\\t        databaseDescription = databaseDescription,\\n\\t        createCohorts = TRUE,\\n\\t        synthesizePositiveControls = TRUE,\\n\\t        runAnalyses = TRUE,\\n\\t        packageResults = TRUE,\\n\\t        maxCores = maxCores)\\n\\t```\\n\\n4. To upload the result file to the AWS S3 study repository, please contact to the study coordinator to get the key and secret code (SCYou, seng.chan.you@ohdsi.org or applegna@gmail.com). The execute the code below to send the result file named as ```export/Results<DatabaseId>.zip```:\\n\\n\\t```r\\n\\tinstall.packages(\\\"aws.s3\\\")\\n\\n\\tfile <- \\\"your file name\\\"\\n\\tobject <- basename(file)\\n\\taws.s3::put_object(file = file,\\n\\t\\t\\t   object = object,\\n\\t\\t\\t   bucket = \\\"ohdsiranitidinecancerrisk\\\",\\n\\t\\t\\t   key= \\\"\\\",\\n\\t\\t\\t   secret = \\\"\\\",\\n\\t\\t\\t   region = \\\"ap-northeast-2\\\",\\n\\t\\t\\t   check_region = F\\n\\t\\t\\t   )\\n\\t```\\n\\n6. To view the results, use the Shiny app:\\n\\n\\t```r\\n\\tprepareForEvidenceExplorer(\\\"Result<databaseId>.zip\\\", \\\"/shinyData\\\")\\n\\tlaunchEvidenceExplorer(\\\"/shinyData\\\", blind = TRUE)\\n\\t```\\n\\n  Note that you can save plots from within the Shiny app. It is possible to view results from more than one database by applying `prepareForEvidenceExplorer` to the Results file from each database, and using the same data folder. Set `blind = FALSE` if you wish to be unblinded to the final results.\\n\\n\\nLicense\\n=======\\nThe RanitidineCancerRisk package is licensed under Apache License 2.0\\n\\n\\nDevelopment\\n===========\\nRanitidineCancerRisk was developed in ATLAS and R Studio.\\n\\n### Development status\\n\\nUnder development\\n\",\"publications\":null,\"results\":null}}},\"scanId\":8,\"id\":74}",
      "75": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watcbersCount\":4,\"summary\":{\"readme\":{\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":8,\"id\":75}",
      "76": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLead\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\"}}},\"scanId\":8,\"id\":76}",
      "77": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLead\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\\n\\nWe aim to characterize the treatment pathways of newly diagnosed RA patients from 2000-2018 across the OHDSI Network. The instructions below aim to provide a guide for running the different analyses in the study.\\n\\nATLAS Pathways Characterizations\\n================================\\n\\nThis study includes a pathways analysis designed using [ATLAS](https://github.com/OHDSI/Atlas). At the time of this study, the design was done using Atlas 2.7.4. \\n\\nThe pathway design specification for the study is located in `\\\\inst\\\\characterization\\\\Pathways-Analysis.json`. Copy this JSON into your ATLAS environment to run against your CDM data. When complete, use the code in `extras\\\\ExportPathwaysResults.R` to export the 2 JSON files for your analysis. ZIP the output folder and send to the study coordinator.\\n\\nRunning Cohort Stability Diagnostics\\n====================================\\n\\n\"}}},\"scanId\":8,\"id\":77}",
      "78": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\"}}},\"scanId\":8,\"id\":78}",
      "79": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\\n- Protocol: \\n- Publications: \\n- Results explorer: \\n\\nA study to describe the baseline characteristics of patients used intravitreous injection and their complications\\n\\nLicense\\n=======\\n\\nThe Complication of intravitreous injection study package is licensed under Apache License 2.0\\n\",\"protocol\":\"\\n- Publications: \\n- Results explorer: \\n\\nA study to describe the baseline characteristics of patients used intravitreous injection and their complications\\n\\nLicense\\n=======\\n\\nThe Complication of intravitreous injection study package is licensed under Apache License 2.0\\n\",\"publications\":\"\\n- Results explorer: \\n\\nA study to describe the baseline characteristics of patients used intravitreous injection and their complications\\n\\nLicense\\n=======\\n\\nThe Complication of intravitreous injection study package is licensed under Apache License 2.0\\n\",\"results\":\"\\n\\nA study to describe the baseline characteristics of patients used intravitreous injection and their complications\\n\\nLicense\\n=======\\n\\nThe Complication of intravitreous injection study package is licensed under Apache License 2.0\\n\"}}},\"scanId\":8,\"id\":79}",
      "80": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":8,\"id\":80}",
      "81": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLead\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":8,\"id\":81}",
      "82": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watcbersCount\":3,\"summary\":{\"readme\":{\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":8,\"id\":82}",
      "83": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\"}}},\"scanId\":8,\"id\":83}",
      "84": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"exists\":false}}},\"scanId\":8,\"id\":84}",
      "85": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLead\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\" \",\"results\":\"\\n    - \"}}},\"scanId\":8,\"id\":85}",
      "86": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":8,\"id\":86}",
      "87": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\"}}},\"scanId\":8,\"id\":87}",
      "88": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":8,\"id\":88}",
      "89": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\"}}},\"scanId\":8,\"id\":89}",
      "90": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLead\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":8,\"id\":90}",
      "91": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watcbersCount\":9,\"summary\":{\"readme\":{\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\"}}},\"scanId\":8,\"id\":91}",
      "92": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":8,\"id\":92}",
      "93": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":8,\"id\":93}",
      "94": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Covid19CohortEvaluation\",\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":8,\"id\":94}",
      "95": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watcbersCount\":10,\"summary\":{\"readme\":{\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\"}}},\"scanId\":8,\"id\":95}",
      "96": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\"}}},\"scanId\":8,\"id\":96}",
      "97": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watcbersCount\":7,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\"}}},\"scanId\":8,\"id\":97}",
      "98": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watcbersCount\":3,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\"}}},\"scanId\":8,\"id\":98}",
      "99": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"April 4, 2020\",\"endDate\":null,\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":null,\"results\":null}}},\"scanId\":8,\"id\":99}",
      "100": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical application\",\"tags\":\"COVID-19, Oncology\",\"studyLead\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":8,\"id\":100}",
      "101": "{\"status\":\"complete\",\"scanId\":8,\"id\":101}",
      "102": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2020-12-09T20:12:10Z\",\"watcbersCount\":6,\"summary\":{\"readme\":{\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\"}}},\"scanId\":9,\"id\":102}",
      "103": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\"}}},\"scanId\":9,\"id\":103}",
      "104": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":9,\"id\":104}",
      "105": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watcbersCount\":5,\"summary\":{\"readme\":{\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":9,\"id\":105}",
      "106": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watcbersCount\":4,\"summary\":{\"readme\":{\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":9,\"id\":106}",
      "107": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLead\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\"}}},\"scanId\":9,\"id\":107}",
      "108": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLead\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":9,\"id\":108}",
      "109": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\"}}},\"scanId\":9,\"id\":109}",
      "110": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":9,\"id\":110}",
      "111": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":9,\"id\":111}",
      "112": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLead\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":9,\"id\":112}",
      "113": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watcbersCount\":3,\"summary\":{\"readme\":{\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":9,\"id\":113}",
      "114": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\"}}},\"scanId\":9,\"id\":114}",
      "115": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"exists\":false}}},\"scanId\":9,\"id\":115}",
      "116": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLead\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\" \",\"results\":\"\"}}},\"scanId\":9,\"id\":116}",
      "117": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":9,\"id\":117}",
      "118": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\"}}},\"scanId\":9,\"id\":118}",
      "119": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":9,\"id\":119}",
      "120": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\"}}},\"scanId\":9,\"id\":120}",
      "121": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLead\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":9,\"id\":121}",
      "122": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watcbersCount\":9,\"summary\":{\"readme\":{\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\"}}},\"scanId\":9,\"id\":122}",
      "123": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":9,\"id\":123}",
      "124": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":9,\"id\":124}",
      "125": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Covid19CohortEvaluation\",\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":9,\"id\":125}",
      "126": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watcbersCount\":10,\"summary\":{\"readme\":{\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\"}}},\"scanId\":9,\"id\":126}",
      "127": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\"}}},\"scanId\":9,\"id\":127}",
      "128": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watcbersCount\":7,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\"}}},\"scanId\":9,\"id\":128}",
      "129": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watcbersCount\":3,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\"}}},\"scanId\":9,\"id\":129}",
      "130": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":9,\"id\":130}",
      "131": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical application\",\"tags\":\"COVID-19, Oncology\",\"studyLead\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":9,\"id\":131}",
      "132": "{\"status\":\"complete\",\"scanId\":9,\"id\":132}",
      "133": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2020-12-09T20:12:10Z\",\"watcbersCount\":6,\"summary\":{\"readme\":{\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\"}}},\"scanId\":10,\"id\":133}",
      "134": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\"}}},\"scanId\":10,\"id\":134}",
      "135": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":10,\"id\":135}",
      "136": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watcbersCount\":5,\"summary\":{\"readme\":{\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":10,\"id\":136}",
      "137": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watcbersCount\":4,\"summary\":{\"readme\":{\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":10,\"id\":137}",
      "138": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLead\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\"}}},\"scanId\":10,\"id\":138}",
      "139": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLead\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":10,\"id\":139}",
      "140": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\"}}},\"scanId\":10,\"id\":140}",
      "141": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":10,\"id\":141}",
      "142": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":10,\"id\":142}",
      "143": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLead\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":10,\"id\":143}",
      "144": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watcbersCount\":3,\"summary\":{\"readme\":{\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":10,\"id\":144}",
      "145": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\"}}},\"scanId\":10,\"id\":145}",
      "146": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"exists\":false}}},\"scanId\":10,\"id\":146}",
      "147": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLead\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\" \",\"results\":\"\"}}},\"scanId\":10,\"id\":147}",
      "148": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":10,\"id\":148}",
      "149": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watcbersCount\":2,\"summary\":{\"readme\":{\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\"}}},\"scanId\":10,\"id\":149}",
      "150": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":10,\"id\":150}",
      "151": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\"}}},\"scanId\":10,\"id\":151}",
      "152": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLead\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":10,\"id\":152}",
      "153": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watcbersCount\":9,\"summary\":{\"readme\":{\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\"}}},\"scanId\":10,\"id\":153}",
      "154": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":10,\"id\":154}",
      "155": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":10,\"id\":155}",
      "156": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Covid19CohortEvaluation\",\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":10,\"id\":156}",
      "157": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watcbersCount\":10,\"summary\":{\"readme\":{\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\"}}},\"scanId\":10,\"id\":157}",
      "158": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\"}}},\"scanId\":10,\"id\":158}",
      "159": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watcbersCount\":7,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\"}}},\"scanId\":10,\"id\":159}",
      "160": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watcbersCount\":3,\"summary\":{\"readme\":{\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\"}}},\"scanId\":10,\"id\":160}",
      "161": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watcbersCount\":0,\"summary\":{\"readme\":{\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":10,\"id\":161}",
      "162": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watcbersCount\":1,\"summary\":{\"readme\":{\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical application\",\"tags\":\"COVID-19, Oncology\",\"studyLead\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":10,\"id\":162}",
      "163": "{\"status\":\"complete\",\"scanId\":10,\"id\":163}",
      "164": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2020-12-09T20:12:10Z\",\"watchersCount\":6,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\"}}},\"scanId\":11,\"id\":164}",
      "165": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\"}}},\"scanId\":11,\"id\":165}",
      "166": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":11,\"id\":166}",
      "167": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watchersCount\":5,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":11,\"id\":167}",
      "168": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watchersCount\":4,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":11,\"id\":168}",
      "169": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLead\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\"}}},\"scanId\":11,\"id\":169}",
      "170": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLead\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":11,\"id\":170}",
      "171": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\"}}},\"scanId\":11,\"id\":171}",
      "172": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":11,\"id\":172}",
      "173": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":11,\"id\":173}",
      "174": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLead\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":11,\"id\":174}",
      "175": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":11,\"id\":175}",
      "176": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\"}}},\"scanId\":11,\"id\":176}",
      "177": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":11,\"id\":177}",
      "178": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLead\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\" \",\"results\":\"\"}}},\"scanId\":11,\"id\":178}",
      "179": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":11,\"id\":179}",
      "180": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\"}}},\"scanId\":11,\"id\":180}",
      "181": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":11,\"id\":181}",
      "182": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\"}}},\"scanId\":11,\"id\":182}",
      "183": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLead\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":11,\"id\":183}",
      "184": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watchersCount\":9,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\"}}},\"scanId\":11,\"id\":184}",
      "185": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":11,\"id\":185}",
      "186": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":11,\"id\":186}",
      "187": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":11,\"id\":187}",
      "188": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watchersCount\":10,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\"}}},\"scanId\":11,\"id\":188}",
      "189": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\"}}},\"scanId\":11,\"id\":189}",
      "190": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\"}}},\"scanId\":11,\"id\":190}",
      "191": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\"}}},\"scanId\":11,\"id\":191}",
      "192": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":11,\"id\":192}",
      "193": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical application\",\"tags\":\"COVID-19, Oncology\",\"studyLead\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":11,\"id\":193}",
      "194": "{\"status\":\"complete\",\"scanId\":11,\"id\":194}",
      "195": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2020-12-09T20:12:10Z\",\"watchersCount\":6,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\"}}},\"scanId\":12,\"id\":195}",
      "196": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\"}}},\"scanId\":12,\"id\":196}",
      "197": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":12,\"id\":197}",
      "198": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watchersCount\":5,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":12,\"id\":198}",
      "199": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watchersCount\":4,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":12,\"id\":199}",
      "200": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLead\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\"}}},\"scanId\":12,\"id\":200}",
      "201": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLead\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":12,\"id\":201}",
      "202": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\"}}},\"scanId\":12,\"id\":202}",
      "203": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":12,\"id\":203}",
      "204": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":12,\"id\":204}",
      "205": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLead\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":12,\"id\":205}",
      "206": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":12,\"id\":206}",
      "207": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\"}}},\"scanId\":12,\"id\":207}",
      "208": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":12,\"id\":208}",
      "209": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLead\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\" \",\"results\":\"\"}}},\"scanId\":12,\"id\":209}",
      "210": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":12,\"id\":210}",
      "211": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\"}}},\"scanId\":12,\"id\":211}",
      "212": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":12,\"id\":212}",
      "213": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\"}}},\"scanId\":12,\"id\":213}",
      "214": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLead\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":12,\"id\":214}",
      "215": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watchersCount\":9,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\"}}},\"scanId\":12,\"id\":215}",
      "216": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":12,\"id\":216}",
      "217": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":12,\"id\":217}",
      "218": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":12,\"id\":218}",
      "219": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watchersCount\":10,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\"}}},\"scanId\":12,\"id\":219}",
      "220": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\"}}},\"scanId\":12,\"id\":220}",
      "221": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\"}}},\"scanId\":12,\"id\":221}",
      "222": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\"}}},\"scanId\":12,\"id\":222}",
      "223": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":12,\"id\":223}",
      "224": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical application\",\"tags\":\"COVID-19, Oncology\",\"studyLead\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":12,\"id\":224}",
      "225": "{\"status\":\"complete\",\"scanId\":12,\"id\":225}",
      "226": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2020-12-09T20:12:10Z\",\"watchersCount\":6,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\"}}},\"scanId\":13,\"id\":226}",
      "227": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\"}}},\"scanId\":13,\"id\":227}",
      "228": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":13,\"id\":228}",
      "229": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watchersCount\":5,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":13,\"id\":229}",
      "230": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watchersCount\":4,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":13,\"id\":230}",
      "231": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLead\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\"}}},\"scanId\":13,\"id\":231}",
      "232": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLead\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":13,\"id\":232}",
      "233": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\"}}},\"scanId\":13,\"id\":233}",
      "234": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":13,\"id\":234}",
      "235": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":13,\"id\":235}",
      "236": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLead\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":13,\"id\":236}",
      "237": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":13,\"id\":237}",
      "238": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\"}}},\"scanId\":13,\"id\":238}",
      "239": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":13,\"id\":239}",
      "240": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLead\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\" \",\"results\":\"\"}}},\"scanId\":13,\"id\":240}",
      "241": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":13,\"id\":241}",
      "242": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\"}}},\"scanId\":13,\"id\":242}",
      "243": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":13,\"id\":243}",
      "244": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\"}}},\"scanId\":13,\"id\":244}",
      "245": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLead\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":13,\"id\":245}",
      "246": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watchersCount\":9,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\"}}},\"scanId\":13,\"id\":246}",
      "247": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":13,\"id\":247}",
      "248": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":13,\"id\":248}",
      "249": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":13,\"id\":249}",
      "250": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watchersCount\":10,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\"}}},\"scanId\":13,\"id\":250}",
      "251": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\"}}},\"scanId\":13,\"id\":251}",
      "252": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\"}}},\"scanId\":13,\"id\":252}",
      "253": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\"}}},\"scanId\":13,\"id\":253}",
      "254": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":13,\"id\":254}",
      "255": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical application\",\"tags\":\"COVID-19, Oncology\",\"studyLead\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":13,\"id\":255}",
      "256": "{\"status\":\"complete\",\"scanId\":13,\"id\":256}",
      "257": "{\"status\":\"error\",\"scanId\":14,\"id\":257}",
      "258": "{\"status\":\"error\",\"scanId\":15,\"id\":258}",
      "259": "{\"status\":\"error\",\"scanId\":16,\"id\":259}",
      "260": "{\"status\":\"error\",\"scanId\":17,\"id\":260}",
      "261": "{\"status\":\"error\",\"scanId\":18,\"id\":261}",
      "262": "{\"status\":\"error\",\"scanId\":19,\"id\":262}",
      "263": "{\"status\":\"error\",\"scanId\":20,\"id\":263}",
      "264": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2023-01-27T00:49:38Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\"}}},\"scanId\":21,\"id\":264}",
      "265": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\"}}},\"scanId\":21,\"id\":265}",
      "266": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":21,\"id\":266}",
      "267": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watchersCount\":5,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":21,\"id\":267}",
      "268": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watchersCount\":4,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":21,\"id\":268}",
      "269": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLead\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\"}}},\"scanId\":21,\"id\":269}",
      "270": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLead\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":21,\"id\":270}",
      "271": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\"}}},\"scanId\":21,\"id\":271}",
      "272": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":21,\"id\":272}",
      "273": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":21,\"id\":273}",
      "274": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLead\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":21,\"id\":274}",
      "275": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":21,\"id\":275}",
      "276": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\"}}},\"scanId\":21,\"id\":276}",
      "277": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":21,\"id\":277}",
      "278": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLead\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\" \",\"results\":\"\"}}},\"scanId\":21,\"id\":278}",
      "279": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":21,\"id\":279}",
      "280": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\"}}},\"scanId\":21,\"id\":280}",
      "281": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLead\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":21,\"id\":281}",
      "282": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\"}}},\"scanId\":21,\"id\":282}",
      "283": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLead\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":21,\"id\":283}",
      "284": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watchersCount\":9,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\"}}},\"scanId\":21,\"id\":284}",
      "285": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":21,\"id\":285}",
      "286": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":21,\"id\":286}",
      "287": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":21,\"id\":287}",
      "288": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watchersCount\":10,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\"}}},\"scanId\":21,\"id\":288}",
      "289": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\"}}},\"scanId\":21,\"id\":289}",
      "290": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\"}}},\"scanId\":21,\"id\":290}",
      "291": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\"}}},\"scanId\":21,\"id\":291}",
      "292": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2023-01-27T00:49:38Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":\"Martijn Schuemie\",\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\"}}},\"scanId\":23,\"id\":292}",
      "293": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":\"Seng Chan You\",\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\"}}},\"scanId\":23,\"id\":293}",
      "294": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":\"Chungsoo Kim\",\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":23,\"id\":294}",
      "295": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watchersCount\":5,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":\"Seng Chan You, Seung In Seo, Chan Hyuk Park\",\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":23,\"id\":295}",
      "296": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watchersCount\":4,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":23,\"id\":296}",
      "297": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLead\":\"Bridget Wang\",\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\"}}},\"scanId\":23,\"id\":297}",
      "298": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLead\":\"Anthony G. Sena\",\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":23,\"id\":298}",
      "299": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":\"Jamie Weaver, Ed Burn\",\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\"}}},\"scanId\":23,\"id\":299}",
      "300": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":\", \",\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":23,\"id\":300}",
      "301": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLead\":\"-\",\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":23,\"id\":301}",
      "302": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLead\":\"Matthew Spotnitz\",\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":23,\"id\":302}",
      "303": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":\"Jenna Reps, Christophe Lambert\",\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":23,\"id\":303}",
      "304": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":\"Cynthia Yang, Ross Williams\",\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\"}}},\"scanId\":23,\"id\":304}",
      "305": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":23,\"id\":305}",
      "306": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLead\":\"Jenny Lane\",\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\" \",\"results\":\"\"}}},\"scanId\":23,\"id\":306}",
      "307": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":\"Anna Ostropolets\",\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":23,\"id\":307}",
      "308": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":\"Maura Beaton, Jill Hardin, Kristin Kostka, Anna Ostropolets, Jenna Reps, Erica Voss\",\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\"}}},\"scanId\":23,\"id\":308}",
      "309": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLead\":\"OHDSI-AP\",\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":23,\"id\":309}",
      "310": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":\"Dan Fife, Clair Blacketer, Karl Knight, James Weaver\",\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\"}}},\"scanId\":23,\"id\":310}",
      "311": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLead\":\"Hokyun Jeon, Seng Chan You\",\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":23,\"id\":311}",
      "312": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watchersCount\":9,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":\"Edward Burn, Seng Chan You\",\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\"}}},\"scanId\":23,\"id\":312}",
      "313": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Martijn Schuemie, Daniel Prieto-Alhambra\",\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":23,\"id\":313}",
      "314": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Seng Chan You\",\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":23,\"id\":314}",
      "315": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":23,\"id\":315}",
      "316": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watchersCount\":10,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Jenna Reps, Ross Williams, Peter Rijnbeek\",\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\"}}},\"scanId\":23,\"id\":316}",
      "317": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Daniel Prieto-Alhambra\",\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\"}}},\"scanId\":23,\"id\":317}",
      "318": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Jennifer Lane, James Weaver\",\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\"}}},\"scanId\":23,\"id\":318}",
      "319": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Marc A. Suchard, Seng Chan You, Mitchell M. Conover\",\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\"}}},\"scanId\":23,\"id\":319}",
      "320": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":\"Asieh Golozar, Seng Chan You\",\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":23,\"id\":320}",
      "321": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical application\",\"tags\":\"COVID-19, Oncology\",\"studyLead\":\"Talita Duarte-Salles, Shilpa Ratwani\",\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":23,\"id\":321}",
      "322": "{\"status\":\"complete\",\"scanId\":23,\"id\":322}",
      "323": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2023-01-27T00:49:38Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":\"Martijn Schuemie\",\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\"}}},\"scanId\":24,\"id\":323}",
      "324": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":\"Seng Chan You\",\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\"}}},\"scanId\":24,\"id\":324}",
      "325": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":\"Chungsoo Kim\",\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":24,\"id\":325}",
      "326": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watchersCount\":5,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":\"Seng Chan You, Seung In Seo, Chan Hyuk Park\",\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":24,\"id\":326}",
      "327": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watchersCount\":4,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":24,\"id\":327}",
      "328": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLead\":\"Bridget Wang\",\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\"}}},\"scanId\":24,\"id\":328}",
      "329": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLead\":\"Anthony G. Sena\",\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":24,\"id\":329}",
      "330": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":\"Jamie Weaver, Ed Burn\",\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\"}}},\"scanId\":24,\"id\":330}",
      "331": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":\", \",\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":24,\"id\":331}",
      "332": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLead\":\"-\",\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":24,\"id\":332}",
      "333": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLead\":\"Matthew Spotnitz\",\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":24,\"id\":333}",
      "334": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":\"Jenna Reps, Christophe Lambert\",\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":24,\"id\":334}",
      "335": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":\"Cynthia Yang, Ross Williams\",\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\"}}},\"scanId\":24,\"id\":335}",
      "336": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":24,\"id\":336}",
      "337": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLead\":\"Jenny Lane\",\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\" \",\"results\":\"\"}}},\"scanId\":24,\"id\":337}",
      "338": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":\"Anna Ostropolets\",\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":24,\"id\":338}",
      "339": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":\"Maura Beaton, Jill Hardin, Kristin Kostka, Anna Ostropolets, Jenna Reps, Erica Voss\",\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\"}}},\"scanId\":24,\"id\":339}",
      "340": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLead\":\"OHDSI-AP\",\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":24,\"id\":340}",
      "341": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":\"Dan Fife, Clair Blacketer, Karl Knight, James Weaver\",\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\"}}},\"scanId\":24,\"id\":341}",
      "342": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLead\":\"Hokyun Jeon, Seng Chan You\",\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":24,\"id\":342}",
      "343": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watchersCount\":9,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":\"Edward Burn, Seng Chan You\",\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\"}}},\"scanId\":24,\"id\":343}",
      "344": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Martijn Schuemie, Daniel Prieto-Alhambra\",\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":24,\"id\":344}",
      "345": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Seng Chan You\",\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":24,\"id\":345}",
      "346": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":24,\"id\":346}",
      "347": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watchersCount\":10,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Jenna Reps, Ross Williams, Peter Rijnbeek\",\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\"}}},\"scanId\":24,\"id\":347}",
      "348": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Daniel Prieto-Alhambra\",\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\"}}},\"scanId\":24,\"id\":348}",
      "349": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Jennifer Lane, James Weaver\",\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\"}}},\"scanId\":24,\"id\":349}",
      "350": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":\"Marc A. Suchard, Seng Chan You, Mitchell M. Conover\",\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\"}}},\"scanId\":24,\"id\":350}",
      "351": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":\"Asieh Golozar, Seng Chan You\",\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":24,\"id\":351}",
      "352": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical application\",\"tags\":\"COVID-19, Oncology\",\"studyLead\":\"Talita Duarte-Salles, Shilpa Ratwani\",\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":24,\"id\":352}",
      "353": "{\"status\":\"complete\",\"scanId\":24,\"id\":353}",
      "354": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2023-01-27T00:49:38Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":[\"Martijn Schuemie\"],\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\"}}},\"scanId\":26,\"id\":354}",
      "355": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":[\"Seng Chan You\"],\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\"}}},\"scanId\":26,\"id\":355}",
      "356": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":[\"Chungsoo Kim\"],\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":26,\"id\":356}",
      "357": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watchersCount\":5,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":[\"Seng Chan You\",\" Seung In Seo\",\" Chan Hyuk Park\"],\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":26,\"id\":357}",
      "358": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watchersCount\":4,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"useCases\":null,\"studyType\":null,\"tags\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":26,\"id\":358}",
      "359": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLead\":[\"Bridget Wang\"],\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\"}}},\"scanId\":26,\"id\":359}",
      "360": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLead\":[\"Anthony G. Sena\"],\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":26,\"id\":360}",
      "361": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":[\"Jamie Weaver\",\" Ed Burn\"],\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\"}}},\"scanId\":26,\"id\":361}",
      "362": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":[\"\",\" \"],\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":26,\"id\":362}",
      "363": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLead\":[\"-\"],\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":26,\"id\":363}",
      "364": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLead\":[\"Matthew Spotnitz\"],\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":26,\"id\":364}",
      "365": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":[\"Jenna Reps\",\" Christophe Lambert\"],\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":26,\"id\":365}",
      "366": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":[\"Cynthia Yang\",\" Ross Williams\"],\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\"}}},\"scanId\":26,\"id\":366}",
      "367": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":26,\"id\":367}",
      "368": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLead\":[\"Jenny Lane\"],\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\" \",\"results\":\"\"}}},\"scanId\":26,\"id\":368}",
      "369": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":[\"Anna Ostropolets\"],\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":26,\"id\":369}",
      "370": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":[\"Maura Beaton\",\" Jill Hardin\",\" Kristin Kostka\",\" Anna Ostropolets\",\" Jenna Reps\",\" Erica Voss\"],\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\"}}},\"scanId\":26,\"id\":370}",
      "371": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLead\":[\"OHDSI-AP\"],\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":26,\"id\":371}",
      "372": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":[\"Dan Fife\",\" Clair Blacketer\",\" Karl Knight\",\" James Weaver\"],\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\"}}},\"scanId\":26,\"id\":372}",
      "373": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLead\":[\"Hokyun Jeon\",\" Seng Chan You\"],\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":26,\"id\":373}",
      "374": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2023-01-27T00:49:38Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":[\"Martijn Schuemie\"],\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\"}}},\"scanId\":27,\"id\":374}",
      "375": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":[\"Seng Chan You\"],\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\"}}},\"scanId\":27,\"id\":375}",
      "376": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":[\"Chungsoo Kim\"],\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":27,\"id\":376}",
      "377": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watchersCount\":5,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"],\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":27,\"id\":377}",
      "378": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watchersCount\":4,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\"}}},\"scanId\":27,\"id\":378}",
      "379": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLead\":[\"Bridget Wang\"],\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\"}}},\"scanId\":27,\"id\":379}",
      "380": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLead\":[\"Anthony G. Sena\"],\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\"}}},\"scanId\":27,\"id\":380}",
      "381": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":[\"Jamie Weaver\",\"Ed Burn\"],\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\"}}},\"scanId\":27,\"id\":381}",
      "382": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLead\":[\"\",\"\"],\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":27,\"id\":382}",
      "383": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLead\":[\"-\"],\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":27,\"id\":383}",
      "384": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLead\":[\"Matthew Spotnitz\"],\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":27,\"id\":384}",
      "385": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"],\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":27,\"id\":385}",
      "386": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLead\":[\"Cynthia Yang\",\"Ross Williams\"],\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\"}}},\"scanId\":27,\"id\":386}",
      "387": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLead\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}}},\"scanId\":27,\"id\":387}",
      "388": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLead\":[\"Jenny Lane\"],\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":27,\"id\":388}",
      "389": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLead\":[\"Anna Ostropolets\"],\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":27,\"id\":389}",
      "390": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watchersCount\":2,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":[\"Maura Beaton\",\"Jill Hardin\",\"Kristin Kostka\",\"Anna Ostropolets\",\"Jenna Reps\",\"Erica Voss\"],\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\"}}},\"scanId\":27,\"id\":390}",
      "391": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLead\":[\"OHDSI-AP\"],\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":27,\"id\":391}",
      "392": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"],\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\"}}},\"scanId\":27,\"id\":392}",
      "393": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"],\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":27,\"id\":393}",
      "394": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watchersCount\":9,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"],\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\"}}},\"scanId\":27,\"id\":394}",
      "395": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":[\"Martijn Schuemie\",\"Daniel Prieto-Alhambra\"],\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":27,\"id\":395}",
      "396": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":[\"Seng Chan You\"],\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":27,\"id\":396}",
      "397": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\"}}},\"scanId\":27,\"id\":397}",
      "398": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watchersCount\":10,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"],\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\"}}},\"scanId\":27,\"id\":398}",
      "399": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":[\"Daniel Prieto-Alhambra\"],\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\"}}},\"scanId\":27,\"id\":399}",
      "400": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watchersCount\":7,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"],\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\"}}},\"scanId\":27,\"id\":400}",
      "401": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watchersCount\":3,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"],\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\"}}},\"scanId\":27,\"id\":401}",
      "402": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watchersCount\":0,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"],\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\"}}},\"scanId\":27,\"id\":402}",
      "403": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watchersCount\":1,\"summary\":{\"readme\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical application\",\"tags\":\"COVID-19, Oncology\",\"studyLead\":[\"Talita Duarte-Salles\",\"Shilpa Ratwani\"],\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\"}}},\"scanId\":27,\"id\":403}",
      "404": "{\"status\":\"complete\",\"scanId\":27,\"id\":404}",
      "405": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2023-01-27T00:49:38Z\",\"watchersCount\":7},\"scanId\":28,\"id\":405}",
      "406": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watchersCount\":1},\"scanId\":28,\"id\":406}",
      "407": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watchersCount\":0},\"scanId\":28,\"id\":407}",
      "408": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watchersCount\":5},\"scanId\":28,\"id\":408}",
      "409": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watchersCount\":4},\"scanId\":28,\"id\":409}",
      "410": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watchersCount\":0},\"scanId\":28,\"id\":410}",
      "411": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watchersCount\":2},\"scanId\":28,\"id\":411}",
      "412": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watchersCount\":1},\"scanId\":28,\"id\":412}",
      "413": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watchersCount\":0},\"scanId\":28,\"id\":413}",
      "414": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watchersCount\":1},\"scanId\":28,\"id\":414}",
      "415": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watchersCount\":0},\"scanId\":28,\"id\":415}",
      "416": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watchersCount\":3},\"scanId\":28,\"id\":416}",
      "417": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watchersCount\":1},\"scanId\":28,\"id\":417}",
      "418": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watchersCount\":0},\"scanId\":28,\"id\":418}",
      "419": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watchersCount\":1},\"scanId\":28,\"id\":419}",
      "420": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watchersCount\":2},\"scanId\":28,\"id\":420}",
      "421": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watchersCount\":2},\"scanId\":28,\"id\":421}",
      "422": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watchersCount\":1},\"scanId\":28,\"id\":422}",
      "423": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watchersCount\":0},\"scanId\":28,\"id\":423}",
      "424": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watchersCount\":1},\"scanId\":28,\"id\":424}",
      "425": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watchersCount\":9},\"scanId\":28,\"id\":425}",
      "426": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watchersCount\":0},\"scanId\":28,\"id\":426}",
      "427": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watchersCount\":1},\"scanId\":28,\"id\":427}",
      "428": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watchersCount\":1},\"scanId\":28,\"id\":428}",
      "429": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watchersCount\":10},\"scanId\":28,\"id\":429}",
      "430": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watchersCount\":0},\"scanId\":28,\"id\":430}",
      "431": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watchersCount\":7},\"scanId\":28,\"id\":431}",
      "432": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watchersCount\":3},\"scanId\":28,\"id\":432}",
      "433": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watchersCount\":0},\"scanId\":28,\"id\":433}",
      "434": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watchersCount\":1},\"scanId\":28,\"id\":434}",
      "435": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"03cf7464cdaaaaa12419021b72ba98ba8a310839\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-02-04T04:51:05Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":28,\"id\":435}",
      "436": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6aecc47dc6c8bb5660435f7fa74cf925b43e6eef\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-17T05:57:21Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"Paper under review\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":28,\"id\":436}",
      "437": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f0800d6cfa76911fadad5796a0ff24caf833fb8e\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T11:41:42Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"Paper under review\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":28,\"id\":437}",
      "438": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4e3a1a661a49d6d5b408bcb07795e1d69d48c07a\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T11:37:56Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/MethodsLibraryPleEvaluation/blob/master/extras/OHDSI%20Protocol%20Method%20Evaluation.docx)\",\"publications\":\"Paper under review\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":28,\"id\":438}",
      "439": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f72806df4060174f8d4291d45bd8c9d89b8634d6\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-09-02T12:35:03Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\\\"> <img src=\\\"https://img.shields.io/badge/Study%20Type-Methods%20Research-blue.svg\\\" alt=\\\"Study Type: Methods Research\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/MethodsLibraryPleEvaluation/blob/master/extras/OHDSI%20Protocol%20Method%20Evaluation.docx)\",\"publications\":\"Paper under review\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":28,\"id\":439}",
      "440": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0cc444058def9e183922e4f33ea2c4045a2cf73d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-09-02T12:34:28Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\\\"> <img src=\\\"https://img.shields.io/badge/Study%20Type-Methods%20Research-blue.svg\\\" alt=\\\"Study Type: Methods Research\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/MethodsLibraryPleEvaluation/blob/master/extras/OHDSI%20Protocol%20Method%20Evaluation.docx)\",\"publications\":\"Paper under review\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":28,\"id\":440}",
      "441": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0bdd50b112cc2c018da3fe2a6083be99627901bc\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-04-18T07:07:50Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"studyLeads\":null}},\"scanId\":28,\"id\":441}",
      "442": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"51f4d2bcaf69c6544482701b0fc55c8a08541335\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2018-12-13T05:57:29Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"studyLeads\":null}},\"scanId\":28,\"id\":442}",
      "443": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1762d6ea91fa6bb24e1c6833dda4bc8a818263b2\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2018-11-07T07:58:18Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"studyLeads\":null}},\"scanId\":28,\"id\":443}",
      "444": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ce79787dc2370fbeb18f4e9002bf8040f1f41245\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-05-13T12:15:40Z\"},\"summary\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":28,\"id\":444}",
      "445": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"05a4d406fd21dcb8088755688a53f4b985ae74ec\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-17T05:24:05Z\"},\"summary\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":28,\"id\":445}",
      "446": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c29355c3f78caeebc1dfb67f7132367a5b3e899e\",\"author\":{\"name\":\"Kim Chungsoo\",\"email\":\"42205861+ted9219@users.noreply.github.com\",\"date\":\"2020-02-19T07:11:53Z\"},\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":28,\"id\":446}",
      "447": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d8d07ee5f30fe78273373001d482a08a582d65ac\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:06:40Z\"},\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":28,\"id\":447}",
      "448": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a341bcfdbf51a1840b24f3db8c2930b5ba66c23f\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:03:15Z\"},\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":28,\"id\":448}",
      "449": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9ec5c60f4ae4b23d4f71637cb702de24411bb331\",\"author\":{\"name\":\"Kim Chungsoo\",\"email\":\"42205861+ted9219@users.noreply.github.com\",\"date\":\"2020-01-17T07:54:49Z\"},\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"June, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":28,\"id\":449}",
      "450": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a976806e2322b2ea8523985f3ebb43635bdf4da3\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2021-04-07T02:57:33Z\"},\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":28,\"id\":450}",
      "451": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eacb6c08e26c266d9b2b10273ad547e318e1861b\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2021-01-13T23:59:34Z\"},\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":28,\"id\":451}",
      "452": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d51d8c9f0375e21f43edce1f00109962b4ec14fa\",\"author\":{\"name\":\"Seng Chan You\",\"email\":\"applegna@gmail.com\",\"date\":\"2021-01-13T23:53:00Z\"},\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":28,\"id\":452}",
      "453": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4237c7dc0d949feff2f6f36e0b8279d90de27d60\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-02T23:16:50Z\"},\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":28,\"id\":453}",
      "454": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"22588d6d57fcfcbd58987cf9307ecee9ca5da0c9\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-29T07:38:27Z\"},\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":28,\"id\":454}",
      "455": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e83369b0ed009f035c69e248e6c1a5062a004e1f\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-29T06:58:14Z\"},\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":28,\"id\":455}",
      "456": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"67e3f3fa9358efd761e4a2937aae2cd41ccaeb85\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-13T04:49:37Z\"},\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"Not avialble now\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":28,\"id\":456}",
      "457": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2df2ad9bacc60ccf3a662deea8d62b125207f1f0\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-31T11:46:43Z\"},\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"Not avialble now\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":28,\"id\":457}",
      "458": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d5613000110bbd86436388cd0a1d964292c994f9\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-31T10:48:24Z\"},\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"Not avialble now\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":28,\"id\":458}",
      "459": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d1b9cdf9aa1dcccbc78cd254d57176257bbfc03e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-06-25T13:58:19Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":459}",
      "460": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cd910db439a30cdbe24c1cc5e1d08c76323097a4\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-13T09:06:48Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":460}",
      "461": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"20a7b33ac4f03e05ef0441017de45fe1aac98c4b\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-08T06:16:58Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":461}",
      "462": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"dc33808fa3ed5243c03f6781a36a105a20c3e0f0\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-04T07:24:07Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":462}",
      "463": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d80502e286e206b63a8c78ddd368c00bb1e1bf8d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-04T07:08:33Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":463}",
      "464": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0a24c7b0b872e2ce796c8a79a16aa82c8ac0a8b6\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-17T05:49:40Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":464}",
      "465": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"92c2590daee478fc141ff40287aa1281776a4cb8\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-17T05:46:17Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":465}",
      "466": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3069500e74a6f6293deacface9697f725f656a19\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T10:34:11Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":466}",
      "467": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2a9f81688d4dcd3caab2f20bedc52ebcccfe7153\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T09:23:08Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\\\"> | The study repository has just been created. Work has not yet commenced. | <button onclick=\\\"copyToClipboard('<img src=&quot;Study%20Status-Repo%20Created-lightgray.svg&quot; alt=&quot;Study Status: Repo Created&quot;>')\",\"studyLeads\":null}},\"scanId\":28,\"id\":467}",
      "468": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f09bdbdbd798f5fa3a8e0445044054b34e478ffa\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-12-16T07:12:11Z\"},\"summary\":{\"exists\":false,\"title\":null,\"studyLeads\":null}},\"scanId\":28,\"id\":468}",
      "469": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"33cb4f3a3bc3f6469ff88cba9782d7434b169398\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-19T17:09:39Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":469}",
      "470": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"344aa13a10781f2615f897e59d2a14c1c6e082d6\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T21:11:54Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":470}",
      "471": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7d1473227d4f839d415a95d7138a039e2e181079\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T18:57:41Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":471}",
      "472": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"235f6f7969d060aeadea64e4add1500074d1d3b2\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T17:47:47Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":472}",
      "473": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"796214333e19a3255ac532a0157eb8bb0767b93d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T17:46:44Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":473}",
      "474": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6d4e21df72cef9649b0441eb91e71cf96b255dd3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-05T23:17:55Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":474}",
      "475": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ce0d728ca8ee692885a057709e895265bd088cb3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-05T23:17:07Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":475}",
      "476": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b2f2afb16cec44cc0dd338847ac71b4aa94b9159\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:11:37Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"Early Spring 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":476}",
      "477": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"432552ede0413ab22d9dadc6f9af819f5468ec38\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-16T17:59:55Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"Early Spring 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":477}",
      "478": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"707da9cf486ad088d6147ea3e0e6bf7b262abd36\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-03T14:22:32Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"Early Spring 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":478}",
      "479": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a9701894cdc904847ed088b580503d9b01ab5ef0\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T22:49:27Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":479}",
      "480": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a542ec6ab6e411c249dda319d97fc79b508469e3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T20:21:42Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":480}",
      "481": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"39e7660f8554761ef77f26a1dbd1a1a4f4a1d0bd\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T19:25:08Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":481}",
      "482": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d53b4844a8c0e26e8aacd83879a691fa16e454e4\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T19:19:55Z\"},\"summary\":{\"exists\":false,\"title\":null,\"studyLeads\":null}},\"scanId\":28,\"id\":482}",
      "483": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"24def2bc735fdcd45ff97870a56b9f231f76d9f9\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:57:37Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":483}",
      "484": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"27ac2fe2f9c3f7e33ae31359b263d498f641f0db\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:56:51Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":484}",
      "485": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b8232e42252a074a3d2e350401235059ebfcc1d6\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:56:11Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":485}",
      "486": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cf6563681641c1c4aef0d48a86d9a2d7e960d802\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:53:38Z\"},\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":486}",
      "487": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"482db713fdc786b560c733ea5dff4664724bcc2f\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:42:13Z\"},\"summary\":{\"exists\":false,\"title\":\"[Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis]\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":487}",
      "488": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5ffefd65e4c66c09eeb84d6c8dad6f5da3821f4d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:39:25Z\"},\"summary\":{\"exists\":false,\"title\":\"[Tofacitinib Safety in Rheumatoid Arthritis]\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":488}",
      "489": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7bab7baba89139768edff939f554de7bce3f2a71\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:38:35Z\"},\"summary\":{\"exists\":false,\"title\":\"[Tofacitinib Safety in Rheumatoid Arthritis]\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":28,\"id\":489}",
      "490": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b3d561948afe47655c540ac504bf787639976989\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:38:02Z\"},\"summary\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLeads\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}},\"scanId\":28,\"id\":490}",
      "491": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f428ed3c6e346ae6b34bb24a5e7bad19549ef78e\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:27:11Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":491}",
      "492": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"03c65960e7e79427bc28eeb35e34feee6cd02c8b\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2021-07-07T16:02:30Z\"},\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":28,\"id\":492}",
      "493": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f8fe2d9b1983128271260f566b3343ed47cfdf99\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:08:38Z\"},\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":28,\"id\":493}",
      "494": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2ee98f15c9043acc087cc12f8934e69ef4703524\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-17T11:09:54Z\"},\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":28,\"id\":494}",
      "495": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c41a3260fb9c333c6a8c1ceb1891dcbc064f3ab1\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:09:32Z\"},\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":28,\"id\":495}",
      "496": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"544f7bac170051aab0434fdd0d145961f86fb607\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-15T23:09:32Z\"},\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":28,\"id\":496}",
      "497": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"200ccb07ef0b97e5f8a425cd1949de6d7c865f6a\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-14T23:20:31Z\"},\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":28,\"id\":497}",
      "498": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aa7d9e64c4fa715918de2c16dbae21ed03742d14\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-12T16:40:26Z\"},\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":28,\"id\":498}",
      "499": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"95f7ad96896d107561f73cd308710f10ef15c162\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-12T16:25:32Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":499}",
      "500": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b6a3c482be29780e026329fcc351bdceb9226d7e\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-09T14:47:46Z\"},\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\",\"studyLead\":[\"Jamie Weaver\",\"Ed Burn\"]}},\"scanId\":28,\"id\":500}",
      "501": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"daf4ac2378d8ed3b964ae07154bc8546f68db3e1\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-09T14:44:45Z\"},\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":28,\"id\":501}",
      "502": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b05436fbef86476606bc3b0497a34d3e45b3ad74\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-22T20:33:56Z\"},\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":28,\"id\":502}",
      "503": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c2da6ca11e7ce9ed5c9480e5c77c53c82892b21a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T15:00:58Z\"},\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":28,\"id\":503}",
      "504": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7be0d549b90b728dccad2133105cfdbb41c6a56e\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T14:58:24Z\"},\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":28,\"id\":504}",
      "505": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"609c2abe26c1e2d0915e26918ccff47f73c32279\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T14:55:22Z\"},\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":28,\"id\":505}",
      "506": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4e25e8555ced93d5fcb2d4f9635a0c16adc43bc4\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T14:51:46Z\"},\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":28,\"id\":506}",
      "507": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"988a35ade5804cac844d7157f5e2aa47f406ca4a\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:07:09Z\"},\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":28,\"id\":507}",
      "508": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"24dc2a8da60ab9d7f4e03032cf9f12601cec3eb0\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-12T18:28:30Z\"},\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":508}",
      "509": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0325f45de87df07e8a08332b751e469796e01e9b\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2020-01-12T17:49:27Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":509}",
      "510": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5fb9f9ff028df1a60bd30c27e51574b1429a9d18\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:14:17Z\"},\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"\",\"\"]}},\"scanId\":28,\"id\":510}",
      "511": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"24b9054828289da401fc257222d5a3cf6314846d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T13:47:57Z\"},\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"\",\"\"]}},\"scanId\":28,\"id\":511}",
      "512": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4b27524a375a49e9cb80fb8994965cebd0c34c74\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T13:08:19Z\"},\"summary\":{\"exists\":false,\"title\":\"[Complication of intravitreous injection]\",\"status\":\"Started\",\"useCases\":\"`Characterization`\",\"studyType\":\"`Clinical Application`\",\"tags\":\"`OHDSI-Korea`,`FEEDER-NET`\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"\",\"\"]}},\"scanId\":28,\"id\":512}",
      "513": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"82c91839fffa3579cef3db7df80034ef6cd7b1d6\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T09:00:06Z\"},\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection \",\"status\":\"Started\",\"studyLeads\":null}},\"scanId\":28,\"id\":513}",
      "514": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"22e3fc0e1c5b4908f8b68fc8b1422e1fd0a5e281\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T02:57:13Z\"},\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection \",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":514}",
      "515": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2b35fb2d3d951384bda88e09960bb3586b429539\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T02:39:35Z\"},\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":28,\"id\":515}",
      "516": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"40a19ce3da119f536ef49e9846873ae297b37b7d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T13:08:40Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":516}",
      "517": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c04b9bc1163f8bee80ee442e3346b5ee40a888d7\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T09:14:09Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":517}",
      "518": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d1431f38249143579ef5f3447e10319b3b31701d\",\"author\":{\"name\":\"mattspotnitz\",\"email\":\"43792067+mattspotnitz@users.noreply.github.com\",\"date\":\"2022-10-10T14:29:41Z\"},\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":28,\"id\":518}",
      "519": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f760690521e215e253c66746945bd14bcc4bf20a\",\"author\":{\"name\":\"cukarthik\",\"email\":\"cukarthik@users.noreply.github.com\",\"date\":\"2022-10-05T19:33:12Z\"},\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":28,\"id\":519}",
      "520": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f3fb9ebaa76dad451e964ee36d4f492db216b153\",\"author\":{\"name\":\"cukarthik\",\"email\":\"cukarthik@users.noreply.github.com\",\"date\":\"2020-06-19T01:23:01Z\"},\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":28,\"id\":520}",
      "521": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2f3d3df095295a68e32b9236be3f616393ddc984\",\"author\":{\"name\":\"cukarthik\",\"email\":\"kn2174@cumc.columbia.edu\",\"date\":\"2020-02-21T04:06:55Z\"},\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":28,\"id\":521}",
      "522": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a5031d8ec1f3a8db12b303ded820b41fbbd0f6e7\",\"author\":{\"name\":\"cukarthik\",\"email\":\"kn2174@cumc.columbia.edu\",\"date\":\"2020-02-21T01:35:05Z\"},\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":28,\"id\":522}",
      "523": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"94ad2913189fd7095cad6ce081fe312189af9b0a\",\"author\":{\"name\":\"cukarthik\",\"email\":\"kn2174@cumc.columbia.edu\",\"date\":\"2020-02-11T04:40:41Z\"},\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: <br> Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"`Characterization` and `Population-Level Estimation`\",\"studyType\":\"`Clinical Application`\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"09/23/2019\",\"endDate\":\"-\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"[Prior single site study](https://journals.lww.com/greenjournal/fulltext/2020/02000/relative_risk_of_cervical_neoplasms_among_copper.11.aspx)\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz and Karthik Natarajan\"]}},\"scanId\":28,\"id\":523}",
      "524": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"efe6bd17883254013509a1038e9a3c4c3a623a83\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T09:16:58Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":524}",
      "525": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"441fae07fef60705584537e23ebf48f46d0f96dc\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-07-10T17:19:30Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":525}",
      "526": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a8c0900730bac59ded0c9bcfd50413be89e18e53\",\"author\":{\"name\":\"Christophe Lambert\",\"email\":\"ChristopheLambert@users.noreply.github.com\",\"date\":\"2020-03-13T16:53:06Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":526}",
      "527": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd8f998b291f1f2c883d590ea6db6294b44765c9\",\"author\":{\"name\":\"Christophe Lambert\",\"email\":\"ChristopheLambert@users.noreply.github.com\",\"date\":\"2020-03-13T15:46:25Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":527}",
      "528": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7756bdeb821f231f56f5e8da0a69069b7222df4b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-13T15:39:03Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":528}",
      "529": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"06c9c64894931504777ea9a3a411efc68b95a49b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-13T15:15:28Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":529}",
      "530": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"72daa9786d764a008739caa64cd0749ff5fbd150\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-13T15:14:59Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":530}",
      "531": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7df9f56fe912c4ca12bf3658f94f03e52df8930e\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-12T13:12:59Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":531}",
      "532": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6d083c23eb5c4459910935a5a1266a20dea237ab\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-09T19:06:05Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":532}",
      "533": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c1aebdc574bd667b50f39b03d2edbeee5b989d1b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T19:15:33Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":533}",
      "534": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8a1f25acee9934b28ed5abb4c812ee7fd6c62dfd\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T19:10:51Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":534}",
      "535": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9fe9d06eeda114121b4335fef7fe95acd12cd12e\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T19:09:29Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":535}",
      "536": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6200258dd010b289df065a6ea183fef0f248f818\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:58:22Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":536}",
      "537": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"faf3f82e283f5681c8409057f0e8ad14ec51d3be\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:53:36Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":537}",
      "538": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eda681962576b5e79eb3b55387948dc37d4736ff\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:52:00Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":538}",
      "539": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"990305fecabfbf896d7d8e038f454f617f574838\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:46:17Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":539}",
      "540": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3418566cda0d417da1ae8251828fd32575f28211\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:46:13Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":540}",
      "541": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"90ea55a7d699a27bc91bf3ea7a4280bf39a9f15a\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-25T17:05:13Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":541}",
      "542": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b533a94966ae72db7b6279ba3e0c6f207b90a6c9\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-21T16:27:36Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":542}",
      "543": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2d29262936d06a1ca734cb9ed614c56263b603a4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-21T16:26:06Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":543}",
      "544": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"26ffc65bc835a444f4e02592f73d41fcc23f7c13\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-21T15:56:23Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":544}",
      "545": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e6575280d7c4f0eb268d4ce91c3a8f29d7168870\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-17T14:21:52Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":545}",
      "546": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"067563321fcc101bdcc8ed05fe62338739fd5ab0\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-17T14:21:48Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":546}",
      "547": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8851b3453e13ccabf1fa99454d44899eadccc524\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T06:10:21Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":547}",
      "548": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"582d9f8a36ecdbfd349f7621584bf42564e63086\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T06:00:24Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":548}",
      "549": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd98870ba20c389be94032663c4b7e3c45409cae\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:10:53Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":549}",
      "550": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"bb68a01b0a8b21c3facd0abb6721a18fb061a416\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-15T18:45:10Z\"},\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":550}",
      "551": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0f3e3104d48fc69aa26abeb48d0ea6d15f28e7b6\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-15T18:41:16Z\"},\"summary\":{\"exists\":false,\"title\":\"[External Validation of Model Predicting Bipolar Misdiagnosed as MDD]\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":28,\"id\":551}",
      "552": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6154650335dbf9a8b9c08bbfaed13d01fd99a0d4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-15T16:04:18Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":552}",
      "553": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"408347f43218324176274f1601c48c79c5cd3815\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2021-09-09T12:25:07Z\"},\"summary\":{\"exists\":false,\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\",\"studyLead\":[\"Cynthia Yang\",\"Ross Williams\"]}},\"scanId\":28,\"id\":553}",
      "554": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"17b070994e9074e61d6a55165f62ae8ef2e02587\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-01-27T11:25:52Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Cynthia Yang\"]}},\"scanId\":28,\"id\":554}",
      "555": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ad59e3f12eb5a2f4fb9985035c051728a6674869\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-01-27T11:01:19Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Cynthia Yang\"]}},\"scanId\":28,\"id\":555}",
      "556": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c0dc4432a3bdff52c327761922790e7637a38848\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-01-27T10:57:23Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":28,\"id\":556}",
      "557": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"05477c3d99b5b9cd20c712a3fa28d0f20164eb36\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-21T09:29:57Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":28,\"id\":557}",
      "558": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"51c727707e8947b95d693b90af4e609c3967b367\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:10:02Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":28,\"id\":558}",
      "559": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"089c7dc11e6ce330cb12ec14e29addae97732599\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-17T09:58:40Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":28,\"id\":559}",
      "560": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5e8a80b5ccb04f02da117f3f7befd3853c487419\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-17T09:53:25Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":28,\"id\":560}",
      "561": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"be0d31cd90524262518611f11f7bb78df67c9420\",\"author\":{\"name\":\"RossDWilliams\",\"email\":\"r.williams@erasmusmc.nl\",\"date\":\"2020-01-17T09:52:16Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":28,\"id\":561}",
      "562": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9c09c671c1631d7ffb43b39fa5f2af99db474ac1\",\"author\":{\"name\":\"RossDWilliams\",\"email\":\"r.williams@erasmusmc.nl\",\"date\":\"2020-01-17T09:47:43Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":28,\"id\":562}",
      "563": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"16c8f275053262d47bab39563c0d73ab65dae1dc\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-17T09:36:19Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":28,\"id\":563}",
      "564": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4368b4f23904596b285e574d25ecdf04188114a2\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-16T16:32:09Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":28,\"id\":564}",
      "565": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b182d1b0b5f16e7a5cd304778576533959cb6908\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-16T14:40:20Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":28,\"id\":565}",
      "566": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"72d94ae63502c01064b0c36dffa41f7bc616e2cb\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-16T13:39:48Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":28,\"id\":566}",
      "567": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"388a8717daab3710c558499034a7c45aa9b25545\",\"author\":{\"name\":\"Joel Swerdel\",\"email\":\"jswerdel@its.jnj.com\",\"date\":\"2020-01-16T13:29:11Z\"},\"summary\":{\"exists\":false,\"title\":\"A Package Skeleton for Patientl-Level Prediction Studies\",\"studyLeads\":null}},\"scanId\":28,\"id\":567}",
      "568": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"92e29b70e535a6c5e0dead9f4b774bbbbdae478a\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-16T13:16:48Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":568}",
      "569": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"39e574789da2d7c231081917d49fbad39d244915\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-17T08:20:53Z\"},\"summary\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLeads\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}},\"scanId\":28,\"id\":569}",
      "570": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"93753ef640069cd3d01a7373a5875d9792c1a399\",\"author\":{\"name\":\"Joel Swerdel\",\"email\":\"jswerdel@its.jnj.com\",\"date\":\"2020-01-17T08:06:15Z\"},\"summary\":{\"exists\":false,\"title\":\"EHDENRAPredictionValidation\",\"studyLeads\":null}},\"scanId\":28,\"id\":570}",
      "571": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0bee36097132db98d0cc134a8521322828351fb0\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-17T08:00:13Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":571}",
      "572": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd660aa41a9931788f31062ff241a71e3545eae9\",\"author\":{\"name\":\"Jennifer Lane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-09-09T00:31:15Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":572}",
      "573": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cf215963c9ba30d911c7b7efe15b01ac3cdf9952\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2021-04-07T09:25:31Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":573}",
      "574": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d9f38e2d61081aa81f854bbbcdbb549ed1d029d6\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:23:24Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":574}",
      "575": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"56efde3877ec7cec3e56bb19cbbbdf7f13947928\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:07:33Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":575}",
      "576": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ceddc253d7488f10fed912f0bcdedf5b371c3244\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:03:20Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":576}",
      "577": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"87459109fba5811d910551184c8d5e188bafa553\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:01:36Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":577}",
      "578": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"adc6f3926c9dee4870f60c0b9a84273f9b4de04f\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T15:31:17Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":578}",
      "579": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"33278d67f3ecc06830271d1df7cb3621b583a97d\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T14:30:39Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":579}",
      "580": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"27fa7a2e9c293dcd50a8854c1579cfe70e083604\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T14:49:20Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":580}",
      "581": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6dc3de410a7f9c3c7db3fa8706c8daa1706e59ea\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T14:48:42Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":581}",
      "582": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b069d63fc103b02562a08a3643d0b2314e36e858\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:54:39Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":582}",
      "583": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1652dd39876b794e097879464929595f09a3d473\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:48:37Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":583}",
      "584": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cecd3e84ad7bf0321c955fc7fdab97ba415e73bf\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:42:16Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer:\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":584}",
      "585": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"287d79653e45a096f1420ae77f57d93062c5a741\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:41:05Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer:\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":585}",
      "586": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a275cdf3f041a583ae30d19738a28d3a5d0c7282\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:35:35Z\"},\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":586}",
      "587": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"71aa7961f8e0453a8bef42b072aade88b157810e\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:33:36Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics & Final Population Level Estimation Package\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":587}",
      "588": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5e0a485f1a9d771d2b4fb21de055590995cfc15c\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:30:09Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics & Final Population Level Estimation Package\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":588}",
      "589": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a5f274992ed72fc7f320b8a148571cf0bccde0ae\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:29:34Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility & Final Population Level Estimation Package\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":589}",
      "590": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8e8696cb76c44ce207e1e2454765eb5715b394b0\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:28:23Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":590}",
      "591": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c36d38c6845345bc9e5ff17e9410311352af5227\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-29T12:03:05Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[ShinyApp](https://jenniferlane.shinyapps.io/CohortDiagnosticsMSKAI_FinalDesign/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":591}",
      "592": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e1548c31de6463c985b743fedd59d5dedbb7423d\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-02-10T17:47:28Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":592}",
      "593": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"98d975fd9a0eea535a27ed55edaacffc50750155\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2021-01-12T07:55:14Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":593}",
      "594": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a4cf02600761f9a52989cacf4eb36fa076b1aa17\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-01-11T09:24:58Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":594}",
      "595": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5091190e4ab17586c443a9d788eb8521e32f247b\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-01-11T09:22:40Z\"},\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":595}",
      "596": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"50df1063b23f836f4da01b2cfd07b6c2900a64d4\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-01-11T09:20:41Z\"},\"summary\":{\"exists\":false,\"title\":\"Cohort Diagnostics to establish the feasibility of investigating musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":596}",
      "597": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"75f83b5aac7cd1a1f4519757cdef50f9b3c38ca6\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2021-01-07T09:19:33Z\"},\"summary\":{\"exists\":false,\"title\":\"A Cohort Diagnostics package to establish the feasibility of investigating musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":597}",
      "598": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8aedc25f50d96bd78baf6b2e95b3250ad455b8b0\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2020-12-18T09:05:26Z\"},\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":598}",
      "599": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1d1adc4153ecdfdb196a8081d1130dc779ce705c\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2020-12-18T08:43:07Z\"},\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Shiny app](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":599}",
      "600": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3696705fba1b1aa268df0c045132529794d03b80\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2020-12-17T10:34:13Z\"},\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Shiny app](https://jenniferlane.shinyapps.io/CohortDiagnostics_MSK_AI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":28,\"id\":600}",
      "601": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"26a204a7b1adec83521b388efc53efae5607a0fd\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-21T16:31:46Z\"},\"summary\":{\"exists\":false,\"title\":\"Musculoskeletal adverse outcomes after treatment with aromatase inhibitors for breast cancer: an OHDSI based population level estimate cohort study\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"PLE\",\"studyLeads\":null,\"startDate\":\"January 20, 2020\",\"endDate\":\"July 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Dr. Jenny Lane\"]}},\"scanId\":28,\"id\":601}",
      "602": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"01cdb142bf2da987190f2ab0f93111df727d12ac\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-02-28T21:04:16Z\"},\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":28,\"id\":602}",
      "603": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b746ff403d1453a6fa265c5af015937c65ceb46d\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-02-28T21:03:32Z\"},\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":28,\"id\":603}",
      "604": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4fe8742450616e20e3dd5c8c09588d5ed336b492\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-02-28T21:01:50Z\"},\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":28,\"id\":604}",
      "605": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b6461ccd8ee3506196ea7b3edd85c3585a5f962e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-30T08:18:41Z\"},\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":28,\"id\":605}",
      "606": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aa61ef7f52b4003bd561fa784e6f86cac5c67ef3\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-01-28T07:01:06Z\"},\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"ConceptPrevalence\",\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx\",\"publications\":\"TBD\",\"results\":\"TBD\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":28,\"id\":606}",
      "607": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"925aa0d261cb41c5665d97c7af8290f600f3c1d8\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-27T14:54:12Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":607}",
      "608": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"098c81b8171f275fe16b863e31926361e37f9281\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-12T02:15:39Z\"},\"summary\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\",\"studyLead\":[\"Maura Beaton\",\"Jill Hardin\",\"Kristin Kostka\",\"Anna Ostropolets\",\"Jenna Reps\",\"Erica Voss\"]}},\"scanId\":28,\"id\":608}",
      "609": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"360f005fd98671dd84b5e21e0e9702213a99b32e\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-11T01:44:00Z\"},\"summary\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\",\"studyLead\":[\"Maura Beaton\",\"Jill Hardin\",\"Kristin Kostka\",\"Anna Ostropolets\",\"Jenna Reps\",\"Erica Voss\"]}},\"scanId\":28,\"id\":609}",
      "610": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"080654fabe1a8b0d1e6b908ee6d7bb02b46bdad4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-11T01:41:26Z\"},\"summary\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/ProtocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\",\"studyLead\":[\"Maura Beaton\",\"Jill Hardin\",\"Kristin Kostka\",\"Anna Ostropolets\",\"Jenna Reps\",\"Erica Voss\"]}},\"scanId\":28,\"id\":610}",
      "611": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"59ce5606a50d1d6d07889d612f4f341c8ab08a26\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-11T01:27:52Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":611}",
      "612": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"11f1bbc2dba6a2dfe99b1115da729e8bdb004e47\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-02-12T08:54:26Z\"},\"summary\":{\"exists\":false,\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"OHDSI-AP\"]}},\"scanId\":28,\"id\":612}",
      "613": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"506e9aabaa9bd551be760127d9efbd33e1d3741b\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-11T04:03:53Z\"},\"summary\":{\"exists\":false,\"title\":\"[Characterization of DM in OHDSI-AP network]\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"OHDSI-AP\"]}},\"scanId\":28,\"id\":613}",
      "614": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"feea0a53c0fd316da207c5f763018f3e7703b10f\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-11T04:00:30Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":614}",
      "615": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"50e0efdb41528812fd0c36633f7f8821f813054b\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2021-04-07T20:31:25Z\"},\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":28,\"id\":615}",
      "616": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"78efc21af1986bef5828b8bfbc35e91553b38540\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2021-04-07T20:30:32Z\"},\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":28,\"id\":616}",
      "617": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"256648dce72772af1127ddbb7d0d1aae1dcad57a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2021-04-07T20:28:02Z\"},\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskElderlyApUsers/), [StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":28,\"id\":617}",
      "618": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4f5293dfd8bf546ceee976403ba7dfbbad326658\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-10-28T18:44:01Z\"},\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":28,\"id\":618}",
      "619": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"60dcd9a55d2d51dc6e93eb2fe0fd04a80c67d2cd\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-02-21T21:20:02Z\"},\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":28,\"id\":619}",
      "620": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3735eb343ca416b6be7c4d5a558228e9f73378e9\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-02-21T21:15:24Z\"},\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":28,\"id\":620}",
      "621": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c1385a3130dcb46595be0df4cb5adaab9735c2e6\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-02-19T14:54:26Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":621}",
      "622": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e72fea56d38a9cfe1acca47e05f82c1d1e0c5094\",\"author\":{\"name\":\"neal1202\",\"email\":\"47546151+neal1202@users.noreply.github.com\",\"date\":\"2020-03-09T15:09:08Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":622}",
      "623": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6f511fde5b06d5403cfd83dc0d10d12925b4f5a4\",\"author\":{\"name\":\"neal1202\",\"email\":\"47546151+neal1202@users.noreply.github.com\",\"date\":\"2020-03-09T15:08:31Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":623}",
      "624": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"03f538809c92e139e2a8fcf72481c3f37afc4153\",\"author\":{\"name\":\"neal1202\",\"email\":\"47546151+neal1202@users.noreply.github.com\",\"date\":\"2020-03-09T14:56:56Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":624}",
      "625": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"44a40ca7eb4d549b82892dc2c3548350652fc656\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-25T07:07:37Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":625}",
      "626": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cc492cfe4c0cbc26f74c657991e57ae3c1e57979\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-25T07:06:52Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":626}",
      "627": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4a14da3317f525650a370428d31583ab8860f79e\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-25T07:02:22Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":627}",
      "628": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"bb735572e0a2f0a2fe7bdd68f8c6eb6a112d0514\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-05-13T03:09:31Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":628}",
      "629": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd5f78c23c1e6a6e88e05c1bc1ff22add77a39b3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-05-13T03:09:18Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv]](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":629}",
      "630": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1dcba242e3898967ef9ff04a9c2f7e774105fc9b\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-05-13T03:07:35Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"\",\"results\":\"[Influenza Cohort Diagnostics](https://data.ohdsi.org/Covid19InfluenzaHospitalizations/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":630}",
      "631": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"21e7323ff4594c341cedc757af71d2f08983c15a\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-08T01:04:10Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"\",\"results\":\"[Influenza Cohort Diagnostics](https://data.ohdsi.org/Covid19InfluenzaHospitalizations/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":631}",
      "632": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b6b22a47dcca62e7e2556337eaef3065353fac5d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-08T01:03:51Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"\",\"results\":\"[Influenza Cohort Diagnostics](https://data.ohdsi.org/Covid19InfluenzaHospitalizations/\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":632}",
      "633": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"273671d17cad9222aa582693f1f00ba1bea3489d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-08T01:00:19Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":633}",
      "634": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1084813b756bc42efa30ae6172b47fe8664dcc54\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T23:54:22Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":634}",
      "635": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a1e9ea255f3b144d2d43228a86c6f56dc4afc8b9\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T23:51:52Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":635}",
      "636": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"abfeb9d4d164e8ac75b0c374549eb3b1a3014a5a\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T23:38:53Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":636}",
      "637": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aaf120977f92300b55a331d7589b5b138a1e774c\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-03-19T07:36:13Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of COVID-19\\r\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":28,\"id\":637}",
      "638": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7b3926453105308d8febaeb58a42c72d28dbcda3\",\"author\":{\"name\":\"Seng Chan You\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-16T06:34:17Z\"},\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of COVID-19\\r\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":28,\"id\":638}",
      "639": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"da40825f5f3831ea1603b20f56cf1e5485216422\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-19T08:18:54Z\"},\"summary\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Martijn Schuemie\",\"Daniel Prieto-Alhambra\"]}},\"scanId\":28,\"id\":639}",
      "640": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9e3607fe75078d861da809d67c91906c0db387cb\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-19T07:32:06Z\"},\"summary\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":28,\"id\":640}",
      "641": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"31a19598e52da5348a88c5b89b46ec74dfa24724\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-03-19T07:15:35Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":641}",
      "642": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7c926d4116c5ab733758ee75826c32cb4d6c5399\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-19T23:20:02Z\"},\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":28,\"id\":642}",
      "643": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"081a047766edfb7af6a243b4c4f1e159973ed3ea\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-19T23:14:57Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":643}",
      "644": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"50b3254b856a8e696794f1bcc982d3eddae914c3\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-25T07:47:08Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":28,\"id\":644}",
      "645": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7c078e4f6bf9162d36de335ab3a353bb22564cd4\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-25T05:36:05Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":28,\"id\":645}",
      "646": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a4eb253774c6c0d4899668a386f6041fa4c81af3\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-24T16:50:32Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":28,\"id\":646}",
      "647": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aca774db8c3cd87b36fe8eeea272b7e9f7252c82\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-24T16:09:08Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":28,\"id\":647}",
      "648": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7dabe0cf615f8c61c494b16b7805d721bc7a2fdd\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-24T15:38:30Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":28,\"id\":648}",
      "649": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ada984610aed1800ceec11d6202ab36457d39030\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-23T16:25:16Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":28,\"id\":649}",
      "650": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"af65b1fc84c04c14956acbbf5541e6d29e571ec5\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-08-17T01:32:30Z\"},\"summary\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":650}",
      "651": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2ecc070799db12cb811743bb3e32eb8d5b32f366\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-24T14:13:01Z\"},\"summary\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":651}",
      "652": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f90f5bf727f0f8bfd256d70bbde7ddffb45f4c8d\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-22T12:14:58Z\"},\"summary\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":652}",
      "653": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"36d56c063ad27321eb2560891af9c84d1583a4f1\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-22T09:52:31Z\"},\"summary\":{\"exists\":false,\"title\":\"Validation of simple patient-level prediction models for predicting short-term and long-term survival in patients hospitalized with pneumonia and ARDS and requiring intensive care: a rapid network study to inform the management of COVID-19\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":653}",
      "654": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"61916c5ee5b142e539cef15686a604ea8875cf4b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-20T19:43:30Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":654}",
      "655": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e8a8440a5db3bcab0b721531a0262b2cf1c03e02\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-17T16:06:29Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":655}",
      "656": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e02e1ff68ad47e31f3457a6ab78ed5966e4897e3\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-16T19:40:29Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":656}",
      "657": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a82dca17db1c37b16c0a8dfa92a52e4699f74f2c\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-16T15:47:52Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":657}",
      "658": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f02dc12a50a721f36620a6e1b34e01f99966e90e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-06T03:36:45Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":658}",
      "659": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7f1ef8141508c45daf8ef4626376c906892f0355\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-04T04:21:38Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":659}",
      "660": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"84ae56af21a897fab6ca0baa8e0a8f4147ee0d33\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-03T02:54:05Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":660}",
      "661": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eb300df831fb67b73559640b7710b80e89f3bce8\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T23:13:50Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":661}",
      "662": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0a5e54d900dd7c72593feedce7ce6289dcec42ae\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T19:37:05Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":662}",
      "663": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e7bab20bcc920e551162373e0e1c311bb76723ab\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-03-29T19:07:56Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":663}",
      "664": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"90ccfb77e692def449f0b424ea7d7c8ab8b6001d\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-03-29T19:03:07Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":664}",
      "665": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0437081bc815fdef85ca8904df07bc4e6257037d\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-03-29T18:34:04Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":665}",
      "666": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4bd9e124269c74acfa67a2dce23a6010ff33818b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T07:42:39Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":666}",
      "667": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a8fd552ca7a91f855b2667b1672310d6568927e7\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T06:18:55Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":667}",
      "668": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9798d737ef16d44c63b61fbe497e19d22882009a\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T05:52:49Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":668}",
      "669": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"baafb0d689e60baafcea2df9d276d8c6f6ec58a1\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T05:47:36Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":669}",
      "670": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eb1a110aec8e29a3ac3f2ac14148c33bcd7f0b47\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T04:19:52Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":670}",
      "671": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a88b3c6e8ec03dbbdf4f5f2d859052237fd8e64f\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T22:24:47Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":671}",
      "672": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a121b79c2ef256cd0713fe9e30296807dd0245a4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T22:24:05Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":672}",
      "673": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"17cdee6cab09f701014fb2c768010e0de4ae54d5\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T22:20:31Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":673}",
      "674": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8f1bd884d676c0fa61bad11433e8e11764905b2b\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-03-28T18:34:41Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":674}",
      "675": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5b4827be873507fb2b0bc53bd62b4ee4349dfa12\",\"author\":{\"name\":\"RossDWilliams\",\"email\":\"r.williams@erasmusmc.nl\",\"date\":\"2020-03-28T18:30:28Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":675}",
      "676": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1a468d33fb4faca0cb0c8efc80cd23dbac97474d\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T17:46:57Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":676}",
      "677": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6ceaf041f80d9cbe297af11134eccd3d26a66dd5\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-27T04:04:17Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":677}",
      "678": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"99d3a123bd7391a2375e6f46da76d559e17cffcf\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-27T02:22:49Z\"},\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":28,\"id\":678}",
      "679": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3ca0a27f5f8f83ca447260b330f83f4e438ce60b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-27T00:03:44Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":679}",
      "680": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d010dae8dce9e9530825599d24a00a0c08d6230a\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-06-22T09:43:37Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\",\"studyLead\":[\"Daniel Prieto-Alhambra\"]}},\"scanId\":28,\"id\":680}",
      "681": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7da682d025eb22eaf00b44be69acfc6e19ca1eba\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-28T16:42:10Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/\",\"studyLead\":[\"Daniel Prieto-Alhambra\"]}},\"scanId\":28,\"id\":681}",
      "682": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a27c5a799ad95f23326fdabb57533c51172cceaa\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2020-03-28T15:15:41Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":682}",
      "683": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d5ab703f48bec9aede5542f530b34a4260b67abf\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-10-28T18:40:56Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":683}",
      "684": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9ab2e646d4c7138bebb25a770fb7f3e22bbdcc8a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-11T06:20:50Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":684}",
      "685": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5a57adb42c28c1ed4300457f61733ebe9a796667\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-07T08:56:38Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":685}",
      "686": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2b3cd5a2e118a332830599adcb83f5910aecb121\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T22:41:31Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":686}",
      "687": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eabb1a91ef2b4b8117bef73168bd00f9f66a7dd8\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T17:27:51Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":687}",
      "688": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1e77318c70aefe0f37583e821642b106eee3547b\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-05T08:44:50Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":688}",
      "689": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2a1dbc82fd0535ebef3c345a8bce0f241ae677f3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-04T20:52:39Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":689}",
      "690": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"811951eb287c74bd2a6042866b553a4c98778ac9\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-03T23:20:51Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":690}",
      "691": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"584bb31e643d118125f11ca07cb987588549be5b\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-03T23:20:13Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":691}",
      "692": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3b350b61765cda0aaf7f043ec879d870d3d22731\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-03T23:19:18Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":692}",
      "693": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aab35d9876e94aa25f8f0e6ffaaabf5221d32d2d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-02T17:49:40Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":693}",
      "694": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3d78be016a56e8c2a2badbc8de64a3a54b7155a5\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-01T00:51:30Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":694}",
      "695": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"268244ae9279ecfb89953c6b00743803f71188fb\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-31T20:36:12Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":695}",
      "696": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fc719f1433da9e0bde47d5e34d94e8480db52d37\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-31T17:26:32Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":28,\"id\":696}",
      "697": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e4b02691a00a2173b3fa8000a954cdeba07f7254\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-29T19:53:55Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\"]}},\"scanId\":28,\"id\":697}",
      "698": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4f73a6f95fa27adea563023c8fab179e7df6c20a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-29T02:20:24Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\"]}},\"scanId\":28,\"id\":698}",
      "699": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"dbe2a1c4416f15ab54690f10e3fb536f9dcc7d70\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2020-03-28T17:37:26Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":699}",
      "700": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"77e8176adbfa6ba62126ba427afbad780404ff03\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-06-05T13:45:48Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":28,\"id\":700}",
      "701": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7d1a38158624f614a2ce7f0559b9071e14dd70e8\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-06-05T13:42:05Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":28,\"id\":701}",
      "702": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6808f3b0835d6ce830b702a76cec0a8fa211e0a1\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-06-04T12:54:43Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":28,\"id\":702}",
      "703": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"422de1c8ea30e32c093ada52ab7da934e3dfd3cc\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-05-19T15:37:10Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":28,\"id\":703}",
      "704": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"633758e75af5623b58a51b07cba8271299f1f7f1\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T22:42:05Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":28,\"id\":704}",
      "705": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4f925bb70675f35e560c5f604e9bd7f2e7c1a005\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T18:08:19Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":28,\"id\":705}",
      "706": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0391de3e4e15d8a18d5c1a58acd68457c7e3f5f5\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T17:59:37Z\"},\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":28,\"id\":706}",
      "707": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7f9c6e1c16c7cc188810f936f5f3d7610bf18e30\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T17:58:59Z\"},\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":28,\"id\":707}",
      "708": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f496d0bb02f7da9e88a02b0469259b4411d79dc1\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-04-02T20:20:45Z\"},\"summary\":{\"exists\":false,\"title\":null,\"studyLeads\":null}},\"scanId\":28,\"id\":708}",
      "709": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c0b95e61d0fce1d3de1a5e7ef87cc79f99784f1e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-06-22T10:01:35Z\"},\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":709}",
      "710": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9af773f78cede486f8b18632eb672df71b905d7c\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-04-17T02:34:20Z\"},\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":710}",
      "711": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6e593c1e4f1030061f0f7cd34bb0b23f29cc75b2\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-04-17T02:32:30Z\"},\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":711}",
      "712": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f8e98a4e0083ff6815274aa45e5b6743fdd7eedc\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-04-17T02:28:01Z\"},\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":28,\"id\":712}",
      "713": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0631e7d767ece6463392e383656e290c77d962f9\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-28T03:43:14Z\"},\"summary\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical application\",\"tags\":\"COVID-19, Oncology\",\"studyLeads\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Talita Duarte-Salles\",\"Shilpa Ratwani\"]}},\"scanId\":28,\"id\":713}",
      "714": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e1b08f5b3626e2adaa391089c266e03efad2ea15\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T20:58:53Z\"},\"summary\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Clinical application\",\"studyType\":\"Characterization\",\"tags\":\"COVID-19, Oncology\",\"studyLeads\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Talita Duarte-Salles\",\"Shilpa Ratwani\"]}},\"scanId\":28,\"id\":714}",
      "715": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7842ff2b717987e3f4f78be70f8ffbbb984de6dc\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T20:58:40Z\"},\"summary\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Clinical application\",\"studyType\":\"Characterization\",\"tags\":\"COVID-19, Oncology\",\"studyLeads\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Talita Duarte-Salles\",\"Shilpa Ratwani\"]}},\"scanId\":28,\"id\":715}",
      "716": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9767d71459e17a5528ffe070d501ed98b0d3845d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T20:53:49Z\"},\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":28,\"id\":716}",
      "717": "{\"status\":\"complete\",\"scanId\":28,\"id\":717}",
      "718": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2023-01-27T00:49:38Z\",\"watchersCount\":7},\"scanId\":29,\"id\":718}",
      "719": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watchersCount\":1},\"scanId\":29,\"id\":719}",
      "720": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watchersCount\":0},\"scanId\":29,\"id\":720}",
      "721": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watchersCount\":5},\"scanId\":29,\"id\":721}",
      "722": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watchersCount\":4},\"scanId\":29,\"id\":722}",
      "723": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watchersCount\":0},\"scanId\":29,\"id\":723}",
      "724": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watchersCount\":2},\"scanId\":29,\"id\":724}",
      "725": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watchersCount\":1},\"scanId\":29,\"id\":725}",
      "726": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watchersCount\":0},\"scanId\":29,\"id\":726}",
      "727": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watchersCount\":1},\"scanId\":29,\"id\":727}",
      "728": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watchersCount\":0},\"scanId\":29,\"id\":728}",
      "729": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watchersCount\":3},\"scanId\":29,\"id\":729}",
      "730": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watchersCount\":1},\"scanId\":29,\"id\":730}",
      "731": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watchersCount\":0},\"scanId\":29,\"id\":731}",
      "732": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watchersCount\":1},\"scanId\":29,\"id\":732}",
      "733": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watchersCount\":2},\"scanId\":29,\"id\":733}",
      "734": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watchersCount\":2},\"scanId\":29,\"id\":734}",
      "735": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watchersCount\":1},\"scanId\":29,\"id\":735}",
      "736": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watchersCount\":0},\"scanId\":29,\"id\":736}",
      "737": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watchersCount\":1},\"scanId\":29,\"id\":737}",
      "738": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watchersCount\":9},\"scanId\":29,\"id\":738}",
      "739": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watchersCount\":0},\"scanId\":29,\"id\":739}",
      "740": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watchersCount\":1},\"scanId\":29,\"id\":740}",
      "741": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watchersCount\":1},\"scanId\":29,\"id\":741}",
      "742": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watchersCount\":10},\"scanId\":29,\"id\":742}",
      "743": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watchersCount\":0},\"scanId\":29,\"id\":743}",
      "744": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watchersCount\":7},\"scanId\":29,\"id\":744}",
      "745": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watchersCount\":3},\"scanId\":29,\"id\":745}",
      "746": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watchersCount\":0},\"scanId\":29,\"id\":746}",
      "747": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watchersCount\":1},\"scanId\":29,\"id\":747}",
      "748": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"03cf7464cdaaaaa12419021b72ba98ba8a310839\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-02-04T04:51:05Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":29,\"id\":748}",
      "749": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6aecc47dc6c8bb5660435f7fa74cf925b43e6eef\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-17T05:57:21Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"Paper under review\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":29,\"id\":749}",
      "750": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f0800d6cfa76911fadad5796a0ff24caf833fb8e\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T11:41:42Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"Paper under review\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":29,\"id\":750}",
      "751": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4e3a1a661a49d6d5b408bcb07795e1d69d48c07a\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T11:37:56Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/MethodsLibraryPleEvaluation/blob/master/extras/OHDSI%20Protocol%20Method%20Evaluation.docx)\",\"publications\":\"Paper under review\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":29,\"id\":751}",
      "752": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f72806df4060174f8d4291d45bd8c9d89b8634d6\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-09-02T12:35:03Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\\\"> <img src=\\\"https://img.shields.io/badge/Study%20Type-Methods%20Research-blue.svg\\\" alt=\\\"Study Type: Methods Research\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/MethodsLibraryPleEvaluation/blob/master/extras/OHDSI%20Protocol%20Method%20Evaluation.docx)\",\"publications\":\"Paper under review\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":29,\"id\":752}",
      "753": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0cc444058def9e183922e4f33ea2c4045a2cf73d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-09-02T12:34:28Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\\\"> <img src=\\\"https://img.shields.io/badge/Study%20Type-Methods%20Research-blue.svg\\\" alt=\\\"Study Type: Methods Research\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/MethodsLibraryPleEvaluation/blob/master/extras/OHDSI%20Protocol%20Method%20Evaluation.docx)\",\"publications\":\"Paper under review\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":29,\"id\":753}",
      "754": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0bdd50b112cc2c018da3fe2a6083be99627901bc\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-04-18T07:07:50Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"studyLeads\":null}},\"scanId\":29,\"id\":754}",
      "755": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"51f4d2bcaf69c6544482701b0fc55c8a08541335\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2018-12-13T05:57:29Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"studyLeads\":null}},\"scanId\":29,\"id\":755}",
      "756": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1762d6ea91fa6bb24e1c6833dda4bc8a818263b2\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2018-11-07T07:58:18Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"studyLeads\":null}},\"scanId\":29,\"id\":756}",
      "757": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ce79787dc2370fbeb18f4e9002bf8040f1f41245\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-05-13T12:15:40Z\"},\"repoName\":\"TicagrelorVsClopidogrel\",\"summary\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":29,\"id\":757}",
      "758": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"05a4d406fd21dcb8088755688a53f4b985ae74ec\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-17T05:24:05Z\"},\"repoName\":\"TicagrelorVsClopidogrel\",\"summary\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":29,\"id\":758}",
      "759": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c29355c3f78caeebc1dfb67f7132367a5b3e899e\",\"author\":{\"name\":\"Kim Chungsoo\",\"email\":\"42205861+ted9219@users.noreply.github.com\",\"date\":\"2020-02-19T07:11:53Z\"},\"repoName\":\"CauseSpecificMortality\",\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":29,\"id\":759}",
      "760": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d8d07ee5f30fe78273373001d482a08a582d65ac\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:06:40Z\"},\"repoName\":\"CauseSpecificMortality\",\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":29,\"id\":760}",
      "761": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a341bcfdbf51a1840b24f3db8c2930b5ba66c23f\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:03:15Z\"},\"repoName\":\"CauseSpecificMortality\",\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":29,\"id\":761}",
      "762": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9ec5c60f4ae4b23d4f71637cb702de24411bb331\",\"author\":{\"name\":\"Kim Chungsoo\",\"email\":\"42205861+ted9219@users.noreply.github.com\",\"date\":\"2020-01-17T07:54:49Z\"},\"repoName\":\"CauseSpecificMortality\",\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"June, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":29,\"id\":762}",
      "763": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a976806e2322b2ea8523985f3ebb43635bdf4da3\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2021-04-07T02:57:33Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":29,\"id\":763}",
      "764": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eacb6c08e26c266d9b2b10273ad547e318e1861b\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2021-01-13T23:59:34Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":29,\"id\":764}",
      "765": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d51d8c9f0375e21f43edce1f00109962b4ec14fa\",\"author\":{\"name\":\"Seng Chan You\",\"email\":\"applegna@gmail.com\",\"date\":\"2021-01-13T23:53:00Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":29,\"id\":765}",
      "766": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4237c7dc0d949feff2f6f36e0b8279d90de27d60\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-02T23:16:50Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":29,\"id\":766}",
      "767": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"22588d6d57fcfcbd58987cf9307ecee9ca5da0c9\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-29T07:38:27Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":29,\"id\":767}",
      "768": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e83369b0ed009f035c69e248e6c1a5062a004e1f\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-29T06:58:14Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":29,\"id\":768}",
      "769": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"67e3f3fa9358efd761e4a2937aae2cd41ccaeb85\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-13T04:49:37Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"Not avialble now\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":29,\"id\":769}",
      "770": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2df2ad9bacc60ccf3a662deea8d62b125207f1f0\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-31T11:46:43Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"Not avialble now\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":29,\"id\":770}",
      "771": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d5613000110bbd86436388cd0a1d964292c994f9\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-31T10:48:24Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"Not avialble now\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":29,\"id\":771}",
      "772": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d1b9cdf9aa1dcccbc78cd254d57176257bbfc03e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-06-25T13:58:19Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":772}",
      "773": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cd910db439a30cdbe24c1cc5e1d08c76323097a4\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-13T09:06:48Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":773}",
      "774": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"20a7b33ac4f03e05ef0441017de45fe1aac98c4b\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-08T06:16:58Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":774}",
      "775": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"dc33808fa3ed5243c03f6781a36a105a20c3e0f0\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-04T07:24:07Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":775}",
      "776": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d80502e286e206b63a8c78ddd368c00bb1e1bf8d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-04T07:08:33Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":776}",
      "777": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0a24c7b0b872e2ce796c8a79a16aa82c8ac0a8b6\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-17T05:49:40Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":777}",
      "778": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"92c2590daee478fc141ff40287aa1281776a4cb8\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-17T05:46:17Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":778}",
      "779": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3069500e74a6f6293deacface9697f725f656a19\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T10:34:11Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":779}",
      "780": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2a9f81688d4dcd3caab2f20bedc52ebcccfe7153\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T09:23:08Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\\\"> | The study repository has just been created. Work has not yet commenced. | <button onclick=\\\"copyToClipboard('<img src=&quot;Study%20Status-Repo%20Created-lightgray.svg&quot; alt=&quot;Study Status: Repo Created&quot;>')\",\"studyLeads\":null}},\"scanId\":29,\"id\":780}",
      "781": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f09bdbdbd798f5fa3a8e0445044054b34e478ffa\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-12-16T07:12:11Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":null,\"studyLeads\":null}},\"scanId\":29,\"id\":781}",
      "782": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"33cb4f3a3bc3f6469ff88cba9782d7434b169398\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-19T17:09:39Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":782}",
      "783": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"344aa13a10781f2615f897e59d2a14c1c6e082d6\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T21:11:54Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":783}",
      "784": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7d1473227d4f839d415a95d7138a039e2e181079\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T18:57:41Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":784}",
      "785": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"235f6f7969d060aeadea64e4add1500074d1d3b2\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T17:47:47Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":785}",
      "786": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"796214333e19a3255ac532a0157eb8bb0767b93d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T17:46:44Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":786}",
      "787": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6d4e21df72cef9649b0441eb91e71cf96b255dd3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-05T23:17:55Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":787}",
      "788": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ce0d728ca8ee692885a057709e895265bd088cb3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-05T23:17:07Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":788}",
      "789": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b2f2afb16cec44cc0dd338847ac71b4aa94b9159\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:11:37Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"Early Spring 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":789}",
      "790": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"432552ede0413ab22d9dadc6f9af819f5468ec38\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-16T17:59:55Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, Rheumatoid Arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"Early Spring 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":790}",
      "791": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"707da9cf486ad088d6147ea3e0e6bf7b262abd36\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-03T14:22:32Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"Early Spring 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":791}",
      "792": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a9701894cdc904847ed088b580503d9b01ab5ef0\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T22:49:27Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":792}",
      "793": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a542ec6ab6e411c249dda319d97fc79b508469e3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T20:21:42Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":793}",
      "794": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"39e7660f8554761ef77f26a1dbd1a1a4f4a1d0bd\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T19:25:08Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":794}",
      "795": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d53b4844a8c0e26e8aacd83879a691fa16e454e4\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T19:19:55Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":null,\"studyLeads\":null}},\"scanId\":29,\"id\":795}",
      "796": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"24def2bc735fdcd45ff97870a56b9f231f76d9f9\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:57:37Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":796}",
      "797": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"27ac2fe2f9c3f7e33ae31359b263d498f641f0db\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:56:51Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":797}",
      "798": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b8232e42252a074a3d2e350401235059ebfcc1d6\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:56:11Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":798}",
      "799": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cf6563681641c1c4aef0d48a86d9a2d7e960d802\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:53:38Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":799}",
      "800": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"482db713fdc786b560c733ea5dff4664724bcc2f\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:42:13Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"[Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis]\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":800}",
      "801": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5ffefd65e4c66c09eeb84d6c8dad6f5da3821f4d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:39:25Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"[Tofacitinib Safety in Rheumatoid Arthritis]\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":801}",
      "802": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7bab7baba89139768edff939f554de7bce3f2a71\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:38:35Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"[Tofacitinib Safety in Rheumatoid Arthritis]\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"F2F, rheumatoid arthritis, drug safety, tofacitinib, etanercept, adalimumab, Xeljanz, Enbrel, Humira, RWD, RWE\",\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":29,\"id\":802}",
      "803": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b3d561948afe47655c540ac504bf787639976989\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:38:02Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLeads\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}},\"scanId\":29,\"id\":803}",
      "804": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f428ed3c6e346ae6b34bb24a5e7bad19549ef78e\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:27:11Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":804}",
      "805": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"03c65960e7e79427bc28eeb35e34feee6cd02c8b\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2021-07-07T16:02:30Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":29,\"id\":805}",
      "806": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f8fe2d9b1983128271260f566b3343ed47cfdf99\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:08:38Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":29,\"id\":806}",
      "807": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2ee98f15c9043acc087cc12f8934e69ef4703524\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-17T11:09:54Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":29,\"id\":807}",
      "808": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c41a3260fb9c333c6a8c1ceb1891dcbc064f3ab1\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:09:32Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":29,\"id\":808}",
      "809": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"544f7bac170051aab0434fdd0d145961f86fb607\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-15T23:09:32Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":29,\"id\":809}",
      "810": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"200ccb07ef0b97e5f8a425cd1949de6d7c865f6a\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-14T23:20:31Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":29,\"id\":810}",
      "811": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aa7d9e64c4fa715918de2c16dbae21ed03742d14\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-12T16:40:26Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"Rheumatoid arthritis, Drug Utilization, EHDEN\",\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":29,\"id\":811}",
      "812": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"95f7ad96896d107561f73cd308710f10ef15c162\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-12T16:25:32Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":812}",
      "813": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b6a3c482be29780e026329fcc351bdceb9226d7e\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-09T14:47:46Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\",\"studyLead\":[\"Jamie Weaver\",\"Ed Burn\"]}},\"scanId\":29,\"id\":813}",
      "814": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"daf4ac2378d8ed3b964ae07154bc8546f68db3e1\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-09T14:44:45Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":29,\"id\":814}",
      "815": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b05436fbef86476606bc3b0497a34d3e45b3ad74\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-22T20:33:56Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":29,\"id\":815}",
      "816": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c2da6ca11e7ce9ed5c9480e5c77c53c82892b21a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T15:00:58Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":29,\"id\":816}",
      "817": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7be0d549b90b728dccad2133105cfdbb41c6a56e\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T14:58:24Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":29,\"id\":817}",
      "818": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"609c2abe26c1e2d0915e26918ccff47f73c32279\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T14:55:22Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":29,\"id\":818}",
      "819": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4e25e8555ced93d5fcb2d4f9635a0c16adc43bc4\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T14:51:46Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":29,\"id\":819}",
      "820": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"988a35ade5804cac844d7157f5e2aa47f406ca4a\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:07:09Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":29,\"id\":820}",
      "821": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"24dc2a8da60ab9d7f4e03032cf9f12601cec3eb0\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-12T18:28:30Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":821}",
      "822": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0325f45de87df07e8a08332b751e469796e01e9b\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2020-01-12T17:49:27Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":822}",
      "823": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5fb9f9ff028df1a60bd30c27e51574b1429a9d18\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:14:17Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"\",\"\"]}},\"scanId\":29,\"id\":823}",
      "824": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"24b9054828289da401fc257222d5a3cf6314846d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T13:47:57Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"\",\"\"]}},\"scanId\":29,\"id\":824}",
      "825": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4b27524a375a49e9cb80fb8994965cebd0c34c74\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T13:08:19Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"[Complication of intravitreous injection]\",\"status\":\"Started\",\"useCases\":\"`Characterization`\",\"studyType\":\"`Clinical Application`\",\"tags\":\"`OHDSI-Korea`,`FEEDER-NET`\",\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"\",\"\"]}},\"scanId\":29,\"id\":825}",
      "826": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"82c91839fffa3579cef3db7df80034ef6cd7b1d6\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T09:00:06Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection \",\"status\":\"Started\",\"studyLeads\":null}},\"scanId\":29,\"id\":826}",
      "827": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"22e3fc0e1c5b4908f8b68fc8b1422e1fd0a5e281\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T02:57:13Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection \",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":827}",
      "828": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2b35fb2d3d951384bda88e09960bb3586b429539\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T02:39:35Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":29,\"id\":828}",
      "829": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"40a19ce3da119f536ef49e9846873ae297b37b7d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T13:08:40Z\"},\"repoName\":\"EmptyStudyRepository\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":829}",
      "830": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c04b9bc1163f8bee80ee442e3346b5ee40a888d7\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T09:14:09Z\"},\"repoName\":\"EmptyStudyRepository\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":830}",
      "831": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d1431f38249143579ef5f3447e10319b3b31701d\",\"author\":{\"name\":\"mattspotnitz\",\"email\":\"43792067+mattspotnitz@users.noreply.github.com\",\"date\":\"2022-10-10T14:29:41Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":29,\"id\":831}",
      "832": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f760690521e215e253c66746945bd14bcc4bf20a\",\"author\":{\"name\":\"cukarthik\",\"email\":\"cukarthik@users.noreply.github.com\",\"date\":\"2022-10-05T19:33:12Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":29,\"id\":832}",
      "833": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f3fb9ebaa76dad451e964ee36d4f492db216b153\",\"author\":{\"name\":\"cukarthik\",\"email\":\"cukarthik@users.noreply.github.com\",\"date\":\"2020-06-19T01:23:01Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":29,\"id\":833}",
      "834": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2f3d3df095295a68e32b9236be3f616393ddc984\",\"author\":{\"name\":\"cukarthik\",\"email\":\"kn2174@cumc.columbia.edu\",\"date\":\"2020-02-21T04:06:55Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":29,\"id\":834}",
      "835": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a5031d8ec1f3a8db12b303ded820b41fbbd0f6e7\",\"author\":{\"name\":\"cukarthik\",\"email\":\"kn2174@cumc.columbia.edu\",\"date\":\"2020-02-21T01:35:05Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":29,\"id\":835}",
      "836": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"94ad2913189fd7095cad6ce081fe312189af9b0a\",\"author\":{\"name\":\"cukarthik\",\"email\":\"kn2174@cumc.columbia.edu\",\"date\":\"2020-02-11T04:40:41Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: <br> Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"`Characterization` and `Population-Level Estimation`\",\"studyType\":\"`Clinical Application`\",\"tags\":\"iud\",\"studyLeads\":null,\"startDate\":\"09/23/2019\",\"endDate\":\"-\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"[Prior single site study](https://journals.lww.com/greenjournal/fulltext/2020/02000/relative_risk_of_cervical_neoplasms_among_copper.11.aspx)\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz and Karthik Natarajan\"]}},\"scanId\":29,\"id\":836}",
      "837": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"efe6bd17883254013509a1038e9a3c4c3a623a83\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T09:16:58Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":837}",
      "838": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"441fae07fef60705584537e23ebf48f46d0f96dc\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-07-10T17:19:30Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":838}",
      "839": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a8c0900730bac59ded0c9bcfd50413be89e18e53\",\"author\":{\"name\":\"Christophe Lambert\",\"email\":\"ChristopheLambert@users.noreply.github.com\",\"date\":\"2020-03-13T16:53:06Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":839}",
      "840": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd8f998b291f1f2c883d590ea6db6294b44765c9\",\"author\":{\"name\":\"Christophe Lambert\",\"email\":\"ChristopheLambert@users.noreply.github.com\",\"date\":\"2020-03-13T15:46:25Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":840}",
      "841": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7756bdeb821f231f56f5e8da0a69069b7222df4b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-13T15:39:03Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":841}",
      "842": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"06c9c64894931504777ea9a3a411efc68b95a49b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-13T15:15:28Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":842}",
      "843": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"72daa9786d764a008739caa64cd0749ff5fbd150\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-13T15:14:59Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":843}",
      "844": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7df9f56fe912c4ca12bf3658f94f03e52df8930e\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-12T13:12:59Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":844}",
      "845": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6d083c23eb5c4459910935a5a1266a20dea237ab\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-09T19:06:05Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":845}",
      "846": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c1aebdc574bd667b50f39b03d2edbeee5b989d1b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T19:15:33Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":846}",
      "847": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8a1f25acee9934b28ed5abb4c812ee7fd6c62dfd\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T19:10:51Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":847}",
      "848": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9fe9d06eeda114121b4335fef7fe95acd12cd12e\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T19:09:29Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":848}",
      "849": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6200258dd010b289df065a6ea183fef0f248f818\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:58:22Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":849}",
      "850": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"faf3f82e283f5681c8409057f0e8ad14ec51d3be\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:53:36Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":850}",
      "851": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eda681962576b5e79eb3b55387948dc37d4736ff\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:52:00Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":851}",
      "852": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"990305fecabfbf896d7d8e038f454f617f574838\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:46:17Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":852}",
      "853": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3418566cda0d417da1ae8251828fd32575f28211\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:46:13Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":853}",
      "854": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"90ea55a7d699a27bc91bf3ea7a4280bf39a9f15a\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-25T17:05:13Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":854}",
      "855": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b533a94966ae72db7b6279ba3e0c6f207b90a6c9\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-21T16:27:36Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":855}",
      "856": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2d29262936d06a1ca734cb9ed614c56263b603a4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-21T16:26:06Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":856}",
      "857": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"26ffc65bc835a444f4e02592f73d41fcc23f7c13\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-21T15:56:23Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":857}",
      "858": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e6575280d7c4f0eb268d4ce91c3a8f29d7168870\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-17T14:21:52Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":858}",
      "859": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"067563321fcc101bdcc8ed05fe62338739fd5ab0\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-17T14:21:48Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":859}",
      "860": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8851b3453e13ccabf1fa99454d44899eadccc524\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T06:10:21Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":860}",
      "861": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"582d9f8a36ecdbfd349f7621584bf42564e63086\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T06:00:24Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":861}",
      "862": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd98870ba20c389be94032663c4b7e3c45409cae\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:10:53Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":862}",
      "863": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"bb68a01b0a8b21c3facd0abb6721a18fb061a416\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-15T18:45:10Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":863}",
      "864": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0f3e3104d48fc69aa26abeb48d0ea6d15f28e7b6\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-15T18:41:16Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"[External Validation of Model Predicting Bipolar Misdiagnosed as MDD]\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":29,\"id\":864}",
      "865": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6154650335dbf9a8b9c08bbfaed13d01fd99a0d4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-15T16:04:18Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":865}",
      "866": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"408347f43218324176274f1601c48c79c5cd3815\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2021-09-09T12:25:07Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\",\"studyLead\":[\"Cynthia Yang\",\"Ross Williams\"]}},\"scanId\":29,\"id\":866}",
      "867": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"17b070994e9074e61d6a55165f62ae8ef2e02587\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-01-27T11:25:52Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Cynthia Yang\"]}},\"scanId\":29,\"id\":867}",
      "868": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ad59e3f12eb5a2f4fb9985035c051728a6674869\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-01-27T11:01:19Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Cynthia Yang\"]}},\"scanId\":29,\"id\":868}",
      "869": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c0dc4432a3bdff52c327761922790e7637a38848\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-01-27T10:57:23Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":29,\"id\":869}",
      "870": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"05477c3d99b5b9cd20c712a3fa28d0f20164eb36\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-21T09:29:57Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":29,\"id\":870}",
      "871": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"51c727707e8947b95d693b90af4e609c3967b367\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:10:02Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":29,\"id\":871}",
      "872": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"089c7dc11e6ce330cb12ec14e29addae97732599\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-17T09:58:40Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":29,\"id\":872}",
      "873": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5e8a80b5ccb04f02da117f3f7befd3853c487419\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-17T09:53:25Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":29,\"id\":873}",
      "874": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"be0d31cd90524262518611f11f7bb78df67c9420\",\"author\":{\"name\":\"RossDWilliams\",\"email\":\"r.williams@erasmusmc.nl\",\"date\":\"2020-01-17T09:52:16Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":29,\"id\":874}",
      "875": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9c09c671c1631d7ffb43b39fa5f2af99db474ac1\",\"author\":{\"name\":\"RossDWilliams\",\"email\":\"r.williams@erasmusmc.nl\",\"date\":\"2020-01-17T09:47:43Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":29,\"id\":875}",
      "876": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"16c8f275053262d47bab39563c0d73ab65dae1dc\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-17T09:36:19Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":29,\"id\":876}",
      "877": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4368b4f23904596b285e574d25ecdf04188114a2\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-16T16:32:09Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":29,\"id\":877}",
      "878": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b182d1b0b5f16e7a5cd304778576533959cb6908\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-16T14:40:20Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":29,\"id\":878}",
      "879": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"72d94ae63502c01064b0c36dffa41f7bc616e2cb\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-16T13:39:48Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":\"Patient Level Prediction\",\"studyType\":\"Patient-Level Prediction\",\"tags\":\"EHDEN\",\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":29,\"id\":879}",
      "880": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"388a8717daab3710c558499034a7c45aa9b25545\",\"author\":{\"name\":\"Joel Swerdel\",\"email\":\"jswerdel@its.jnj.com\",\"date\":\"2020-01-16T13:29:11Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"A Package Skeleton for Patientl-Level Prediction Studies\",\"studyLeads\":null}},\"scanId\":29,\"id\":880}",
      "881": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"92e29b70e535a6c5e0dead9f4b774bbbbdae478a\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-16T13:16:48Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":881}",
      "882": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"39e574789da2d7c231081917d49fbad39d244915\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-17T08:20:53Z\"},\"repoName\":\"EhdenRaPredictionValidation\",\"summary\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLeads\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}},\"scanId\":29,\"id\":882}",
      "883": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"93753ef640069cd3d01a7373a5875d9792c1a399\",\"author\":{\"name\":\"Joel Swerdel\",\"email\":\"jswerdel@its.jnj.com\",\"date\":\"2020-01-17T08:06:15Z\"},\"repoName\":\"EhdenRaPredictionValidation\",\"summary\":{\"exists\":false,\"title\":\"EHDENRAPredictionValidation\",\"studyLeads\":null}},\"scanId\":29,\"id\":883}",
      "884": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0bee36097132db98d0cc134a8521322828351fb0\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-17T08:00:13Z\"},\"repoName\":\"EhdenRaPredictionValidation\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":884}",
      "885": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd660aa41a9931788f31062ff241a71e3545eae9\",\"author\":{\"name\":\"Jennifer Lane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-09-09T00:31:15Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":885}",
      "886": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cf215963c9ba30d911c7b7efe15b01ac3cdf9952\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2021-04-07T09:25:31Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":886}",
      "887": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d9f38e2d61081aa81f854bbbcdbb549ed1d029d6\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:23:24Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":887}",
      "888": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"56efde3877ec7cec3e56bb19cbbbdf7f13947928\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:07:33Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":888}",
      "889": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ceddc253d7488f10fed912f0bcdedf5b371c3244\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:03:20Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":889}",
      "890": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"87459109fba5811d910551184c8d5e188bafa553\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:01:36Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":890}",
      "891": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"adc6f3926c9dee4870f60c0b9a84273f9b4de04f\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T15:31:17Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":891}",
      "892": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"33278d67f3ecc06830271d1df7cb3621b583a97d\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T14:30:39Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":892}",
      "893": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"27fa7a2e9c293dcd50a8854c1579cfe70e083604\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T14:49:20Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization & Population Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":893}",
      "894": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6dc3de410a7f9c3c7db3fa8706c8daa1706e59ea\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T14:48:42Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":894}",
      "895": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b069d63fc103b02562a08a3643d0b2314e36e858\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:54:39Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":895}",
      "896": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1652dd39876b794e097879464929595f09a3d473\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:48:37Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":896}",
      "897": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cecd3e84ad7bf0321c955fc7fdab97ba415e73bf\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:42:16Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer:\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":897}",
      "898": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"287d79653e45a096f1420ae77f57d93062c5a741\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:41:05Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer:\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":898}",
      "899": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a275cdf3f041a583ae30d19738a28d3a5d0c7282\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:35:35Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":899}",
      "900": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"71aa7961f8e0453a8bef42b072aade88b157810e\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:33:36Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics & Final Population Level Estimation Package\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":900}",
      "901": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5e0a485f1a9d771d2b4fb21de055590995cfc15c\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:30:09Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics & Final Population Level Estimation Package\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":901}",
      "902": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a5f274992ed72fc7f320b8a148571cf0bccde0ae\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:29:34Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility & Final Population Level Estimation Package\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":902}",
      "903": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8e8696cb76c44ce207e1e2454765eb5715b394b0\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:28:23Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":903}",
      "904": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c36d38c6845345bc9e5ff17e9410311352af5227\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-29T12:03:05Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[ShinyApp](https://jenniferlane.shinyapps.io/CohortDiagnosticsMSKAI_FinalDesign/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":904}",
      "905": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e1548c31de6463c985b743fedd59d5dedbb7423d\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-02-10T17:47:28Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":905}",
      "906": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"98d975fd9a0eea535a27ed55edaacffc50750155\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2021-01-12T07:55:14Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":906}",
      "907": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a4cf02600761f9a52989cacf4eb36fa076b1aa17\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-01-11T09:24:58Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":907}",
      "908": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5091190e4ab17586c443a9d788eb8521e32f247b\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-01-11T09:22:40Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":908}",
      "909": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"50df1063b23f836f4da01b2cfd07b6c2900a64d4\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-01-11T09:20:41Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"Cohort Diagnostics to establish the feasibility of investigating musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":909}",
      "910": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"75f83b5aac7cd1a1f4519757cdef50f9b3c38ca6\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2021-01-07T09:19:33Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"A Cohort Diagnostics package to establish the feasibility of investigating musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":910}",
      "911": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8aedc25f50d96bd78baf6b2e95b3250ad455b8b0\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2020-12-18T09:05:26Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":911}",
      "912": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1d1adc4153ecdfdb196a8081d1130dc779ce705c\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2020-12-18T08:43:07Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Shiny app](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":912}",
      "913": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3696705fba1b1aa268df0c045132529794d03b80\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2020-12-17T10:34:13Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI\",\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Shiny app](https://jenniferlane.shinyapps.io/CohortDiagnostics_MSK_AI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":29,\"id\":913}",
      "914": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"26a204a7b1adec83521b388efc53efae5607a0fd\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-21T16:31:46Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"Musculoskeletal adverse outcomes after treatment with aromatase inhibitors for breast cancer: an OHDSI based population level estimate cohort study\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"PLE\",\"studyLeads\":null,\"startDate\":\"January 20, 2020\",\"endDate\":\"July 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Dr. Jenny Lane\"]}},\"scanId\":29,\"id\":914}",
      "915": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"01cdb142bf2da987190f2ab0f93111df727d12ac\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-02-28T21:04:16Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":29,\"id\":915}",
      "916": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b746ff403d1453a6fa265c5af015937c65ceb46d\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-02-28T21:03:32Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":29,\"id\":916}",
      "917": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4fe8742450616e20e3dd5c8c09588d5ed336b492\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-02-28T21:01:50Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":29,\"id\":917}",
      "918": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b6461ccd8ee3506196ea7b3edd85c3585a5f962e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-30T08:18:41Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":29,\"id\":918}",
      "919": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aa61ef7f52b4003bd561fa784e6f86cac5c67ef3\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-01-28T07:01:06Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Methods Research\",\"tags\":\"ConceptPrevalence\",\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx\",\"publications\":\"TBD\",\"results\":\"TBD\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":29,\"id\":919}",
      "920": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"925aa0d261cb41c5665d97c7af8290f600f3c1d8\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-27T14:54:12Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":920}",
      "921": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"098c81b8171f275fe16b863e31926361e37f9281\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-12T02:15:39Z\"},\"repoName\":\"BreastCancerBetweenScreen\",\"summary\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\",\"studyLead\":[\"Maura Beaton\",\"Jill Hardin\",\"Kristin Kostka\",\"Anna Ostropolets\",\"Jenna Reps\",\"Erica Voss\"]}},\"scanId\":29,\"id\":921}",
      "922": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"360f005fd98671dd84b5e21e0e9702213a99b32e\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-11T01:44:00Z\"},\"repoName\":\"BreastCancerBetweenScreen\",\"summary\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\",\"studyLead\":[\"Maura Beaton\",\"Jill Hardin\",\"Kristin Kostka\",\"Anna Ostropolets\",\"Jenna Reps\",\"Erica Voss\"]}},\"scanId\":29,\"id\":922}",
      "923": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"080654fabe1a8b0d1e6b908ee6d7bb02b46bdad4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-11T01:41:26Z\"},\"repoName\":\"BreastCancerBetweenScreen\",\"summary\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/ProtocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\",\"studyLead\":[\"Maura Beaton\",\"Jill Hardin\",\"Kristin Kostka\",\"Anna Ostropolets\",\"Jenna Reps\",\"Erica Voss\"]}},\"scanId\":29,\"id\":923}",
      "924": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"59ce5606a50d1d6d07889d612f4f341c8ab08a26\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-11T01:27:52Z\"},\"repoName\":\"BreastCancerBetweenScreen\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":924}",
      "925": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"11f1bbc2dba6a2dfe99b1115da729e8bdb004e47\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-02-12T08:54:26Z\"},\"repoName\":\"DMCharacterizationAP\",\"summary\":{\"exists\":false,\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"OHDSI-AP\"]}},\"scanId\":29,\"id\":925}",
      "926": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"506e9aabaa9bd551be760127d9efbd33e1d3741b\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-11T04:03:53Z\"},\"repoName\":\"DMCharacterizationAP\",\"summary\":{\"exists\":false,\"title\":\"[Characterization of DM in OHDSI-AP network]\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-AP\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"OHDSI-AP\"]}},\"scanId\":29,\"id\":926}",
      "927": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"feea0a53c0fd316da207c5f763018f3e7703b10f\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-11T04:00:30Z\"},\"repoName\":\"DMCharacterizationAP\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":927}",
      "928": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"50e0efdb41528812fd0c36633f7f8821f813054b\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2021-04-07T20:31:25Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":29,\"id\":928}",
      "929": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"78efc21af1986bef5828b8bfbc35e91553b38540\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2021-04-07T20:30:32Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":29,\"id\":929}",
      "930": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"256648dce72772af1127ddbb7d0d1aae1dcad57a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2021-04-07T20:28:02Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskElderlyApUsers/), [StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":29,\"id\":930}",
      "931": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4f5293dfd8bf546ceee976403ba7dfbbad326658\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-10-28T18:44:01Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":29,\"id\":931}",
      "932": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"60dcd9a55d2d51dc6e93eb2fe0fd04a80c67d2cd\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-02-21T21:20:02Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":29,\"id\":932}",
      "933": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3735eb343ca416b6be7c4d5a558228e9f73378e9\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-02-21T21:15:24Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":29,\"id\":933}",
      "934": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c1385a3130dcb46595be0df4cb5adaab9735c2e6\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-02-19T14:54:26Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":934}",
      "935": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e72fea56d38a9cfe1acca47e05f82c1d1e0c5094\",\"author\":{\"name\":\"neal1202\",\"email\":\"47546151+neal1202@users.noreply.github.com\",\"date\":\"2020-03-09T15:09:08Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":935}",
      "936": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6f511fde5b06d5403cfd83dc0d10d12925b4f5a4\",\"author\":{\"name\":\"neal1202\",\"email\":\"47546151+neal1202@users.noreply.github.com\",\"date\":\"2020-03-09T15:08:31Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":936}",
      "937": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"03f538809c92e139e2a8fcf72481c3f37afc4153\",\"author\":{\"name\":\"neal1202\",\"email\":\"47546151+neal1202@users.noreply.github.com\",\"date\":\"2020-03-09T14:56:56Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":937}",
      "938": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"44a40ca7eb4d549b82892dc2c3548350652fc656\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-25T07:07:37Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":938}",
      "939": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cc492cfe4c0cbc26f74c657991e57ae3c1e57979\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-25T07:06:52Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI-Korea, FEEDER-NET, Oncology WG\",\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":939}",
      "940": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4a14da3317f525650a370428d31583ab8860f79e\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-25T07:02:22Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":940}",
      "941": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"bb735572e0a2f0a2fe7bdd68f8c6eb6a112d0514\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-05-13T03:09:31Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":941}",
      "942": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd5f78c23c1e6a6e88e05c1bc1ff22add77a39b3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-05-13T03:09:18Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv]](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":942}",
      "943": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1dcba242e3898967ef9ff04a9c2f7e774105fc9b\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-05-13T03:07:35Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"\",\"results\":\"[Influenza Cohort Diagnostics](https://data.ohdsi.org/Covid19InfluenzaHospitalizations/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":943}",
      "944": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"21e7323ff4594c341cedc757af71d2f08983c15a\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-08T01:04:10Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"\",\"results\":\"[Influenza Cohort Diagnostics](https://data.ohdsi.org/Covid19InfluenzaHospitalizations/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":944}",
      "945": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b6b22a47dcca62e7e2556337eaef3065353fac5d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-08T01:03:51Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"\",\"results\":\"[Influenza Cohort Diagnostics](https://data.ohdsi.org/Covid19InfluenzaHospitalizations/\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":945}",
      "946": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"273671d17cad9222aa582693f1f00ba1bea3489d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-08T01:00:19Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":946}",
      "947": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1084813b756bc42efa30ae6172b47fe8664dcc54\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T23:54:22Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":947}",
      "948": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a1e9ea255f3b144d2d43228a86c6f56dc4afc8b9\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T23:51:52Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":948}",
      "949": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"abfeb9d4d164e8ac75b0c374549eb3b1a3014a5a\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T23:38:53Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":949}",
      "950": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aaf120977f92300b55a331d7589b5b138a1e774c\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-03-19T07:36:13Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of COVID-19\\r\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":29,\"id\":950}",
      "951": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7b3926453105308d8febaeb58a42c72d28dbcda3\",\"author\":{\"name\":\"Seng Chan You\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-16T06:34:17Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of COVID-19\\r\",\"status\":\"Started\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon\",\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":29,\"id\":951}",
      "952": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"da40825f5f3831ea1603b20f56cf1e5485216422\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-19T08:18:54Z\"},\"repoName\":\"Covid19DrugRepurposing\",\"summary\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Martijn Schuemie\",\"Daniel Prieto-Alhambra\"]}},\"scanId\":29,\"id\":952}",
      "953": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9e3607fe75078d861da809d67c91906c0db387cb\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-19T07:32:06Z\"},\"repoName\":\"Covid19DrugRepurposing\",\"summary\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":29,\"id\":953}",
      "954": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"31a19598e52da5348a88c5b89b46ec74dfa24724\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-03-19T07:15:35Z\"},\"repoName\":\"Covid19DrugRepurposing\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":954}",
      "955": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7c926d4116c5ab733758ee75826c32cb4d6c5399\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-19T23:20:02Z\"},\"repoName\":\"CovidSeverityPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":29,\"id\":955}",
      "956": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"081a047766edfb7af6a243b4c4f1e159973ed3ea\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-19T23:14:57Z\"},\"repoName\":\"CovidSeverityPrediction\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":956}",
      "957": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"50b3254b856a8e696794f1bcc982d3eddae914c3\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-25T07:47:08Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":29,\"id\":957}",
      "958": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7c078e4f6bf9162d36de335ab3a353bb22564cd4\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-25T05:36:05Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":29,\"id\":958}",
      "959": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a4eb253774c6c0d4899668a386f6041fa4c81af3\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-24T16:50:32Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":29,\"id\":959}",
      "960": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aca774db8c3cd87b36fe8eeea272b7e9f7252c82\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-24T16:09:08Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":29,\"id\":960}",
      "961": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7dabe0cf615f8c61c494b16b7805d721bc7a2fdd\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-24T15:38:30Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":29,\"id\":961}",
      "962": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ada984610aed1800ceec11d6202ab36457d39030\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-23T16:25:16Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":29,\"id\":962}",
      "963": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"af65b1fc84c04c14956acbbf5541e6d29e571ec5\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-08-17T01:32:30Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":963}",
      "964": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2ecc070799db12cb811743bb3e32eb8d5b32f366\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-24T14:13:01Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":964}",
      "965": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f90f5bf727f0f8bfd256d70bbde7ddffb45f4c8d\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-22T12:14:58Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":965}",
      "966": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"36d56c063ad27321eb2560891af9c84d1583a4f1\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-22T09:52:31Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Validation of simple patient-level prediction models for predicting short-term and long-term survival in patients hospitalized with pneumonia and ARDS and requiring intensive care: a rapid network study to inform the management of COVID-19\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":966}",
      "967": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"61916c5ee5b142e539cef15686a604ea8875cf4b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-20T19:43:30Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":967}",
      "968": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e8a8440a5db3bcab0b721531a0262b2cf1c03e02\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-17T16:06:29Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":968}",
      "969": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e02e1ff68ad47e31f3457a6ab78ed5966e4897e3\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-16T19:40:29Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":969}",
      "970": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a82dca17db1c37b16c0a8dfa92a52e4699f74f2c\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-16T15:47:52Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":970}",
      "971": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f02dc12a50a721f36620a6e1b34e01f99966e90e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-06T03:36:45Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":971}",
      "972": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7f1ef8141508c45daf8ef4626376c906892f0355\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-04T04:21:38Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":972}",
      "973": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"84ae56af21a897fab6ca0baa8e0a8f4147ee0d33\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-03T02:54:05Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":973}",
      "974": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eb300df831fb67b73559640b7710b80e89f3bce8\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T23:13:50Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":974}",
      "975": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0a5e54d900dd7c72593feedce7ce6289dcec42ae\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T19:37:05Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":975}",
      "976": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e7bab20bcc920e551162373e0e1c311bb76723ab\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-03-29T19:07:56Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":976}",
      "977": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"90ccfb77e692def449f0b424ea7d7c8ab8b6001d\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-03-29T19:03:07Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":977}",
      "978": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0437081bc815fdef85ca8904df07bc4e6257037d\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-03-29T18:34:04Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":978}",
      "979": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4bd9e124269c74acfa67a2dce23a6010ff33818b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T07:42:39Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":979}",
      "980": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a8fd552ca7a91f855b2667b1672310d6568927e7\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T06:18:55Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":980}",
      "981": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9798d737ef16d44c63b61fbe497e19d22882009a\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T05:52:49Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":981}",
      "982": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"baafb0d689e60baafcea2df9d276d8c6f6ec58a1\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T05:47:36Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":982}",
      "983": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eb1a110aec8e29a3ac3f2ac14148c33bcd7f0b47\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T04:19:52Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":983}",
      "984": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a88b3c6e8ec03dbbdf4f5f2d859052237fd8e64f\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T22:24:47Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":984}",
      "985": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a121b79c2ef256cd0713fe9e30296807dd0245a4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T22:24:05Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":985}",
      "986": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"17cdee6cab09f701014fb2c768010e0de4ae54d5\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T22:20:31Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":986}",
      "987": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8f1bd884d676c0fa61bad11433e8e11764905b2b\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-03-28T18:34:41Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":987}",
      "988": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5b4827be873507fb2b0bc53bd62b4ee4349dfa12\",\"author\":{\"name\":\"RossDWilliams\",\"email\":\"r.williams@erasmusmc.nl\",\"date\":\"2020-03-28T18:30:28Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":988}",
      "989": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1a468d33fb4faca0cb0c8efc80cd23dbac97474d\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T17:46:57Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":989}",
      "990": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6ceaf041f80d9cbe297af11134eccd3d26a66dd5\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-27T04:04:17Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":990}",
      "991": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"99d3a123bd7391a2375e6f46da76d559e17cffcf\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-27T02:22:49Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":\"Patient-Level Prediction\",\"studyType\":\"Clinical Application\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":29,\"id\":991}",
      "992": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3ca0a27f5f8f83ca447260b330f83f4e438ce60b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-27T00:03:44Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":992}",
      "993": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d010dae8dce9e9530825599d24a00a0c08d6230a\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-06-22T09:43:37Z\"},\"repoName\":\"Covid19EstimationIl6JakInhibitors\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\",\"studyLead\":[\"Daniel Prieto-Alhambra\"]}},\"scanId\":29,\"id\":993}",
      "994": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7da682d025eb22eaf00b44be69acfc6e19ca1eba\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-28T16:42:10Z\"},\"repoName\":\"Covid19EstimationIl6JakInhibitors\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/\",\"studyLead\":[\"Daniel Prieto-Alhambra\"]}},\"scanId\":29,\"id\":994}",
      "995": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a27c5a799ad95f23326fdabb57533c51172cceaa\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2020-03-28T15:15:41Z\"},\"repoName\":\"Covid19EstimationIl6JakInhibitors\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":995}",
      "996": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d5ab703f48bec9aede5542f530b34a4260b67abf\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-10-28T18:40:56Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":996}",
      "997": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9ab2e646d4c7138bebb25a770fb7f3e22bbdcc8a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-11T06:20:50Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Results Available\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":997}",
      "998": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5a57adb42c28c1ed4300457f61733ebe9a796667\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-07T08:56:38Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":998}",
      "999": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2b3cd5a2e118a332830599adcb83f5910aecb121\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T22:41:31Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":999}",
      "1000": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eabb1a91ef2b4b8117bef73168bd00f9f66a7dd8\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T17:27:51Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":1000}",
      "1001": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1e77318c70aefe0f37583e821642b106eee3547b\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-05T08:44:50Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":1001}",
      "1002": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2a1dbc82fd0535ebef3c345a8bce0f241ae677f3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-04T20:52:39Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":1002}",
      "1003": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"811951eb287c74bd2a6042866b553a4c98778ac9\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-03T23:20:51Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":1003}",
      "1004": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"584bb31e643d118125f11ca07cb987588549be5b\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-03T23:20:13Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":1004}",
      "1005": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3b350b61765cda0aaf7f043ec879d870d3d22731\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-03T23:19:18Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":1005}",
      "1006": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aab35d9876e94aa25f8f0e6ffaaabf5221d32d2d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-02T17:49:40Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":1006}",
      "1007": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3d78be016a56e8c2a2badbc8de64a3a54b7155a5\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-01T00:51:30Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":1007}",
      "1008": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"268244ae9279ecfb89953c6b00743803f71188fb\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-31T20:36:12Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":1008}",
      "1009": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fc719f1433da9e0bde47d5e34d94e8480db52d37\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-31T17:26:32Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":29,\"id\":1009}",
      "1010": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e4b02691a00a2173b3fa8000a954cdeba07f7254\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-29T19:53:55Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\"]}},\"scanId\":29,\"id\":1010}",
      "1011": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4f73a6f95fa27adea563023c8fab179e7df6c20a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-29T02:20:24Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\"]}},\"scanId\":29,\"id\":1011}",
      "1012": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"dbe2a1c4416f15ab54690f10e3fb536f9dcc7d70\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2020-03-28T17:37:26Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":1012}",
      "1013": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"77e8176adbfa6ba62126ba427afbad780404ff03\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-06-05T13:45:48Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":29,\"id\":1013}",
      "1014": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7d1a38158624f614a2ce7f0559b9071e14dd70e8\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-06-05T13:42:05Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":29,\"id\":1014}",
      "1015": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6808f3b0835d6ce830b702a76cec0a8fa211e0a1\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-06-04T12:54:43Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":29,\"id\":1015}",
      "1016": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"422de1c8ea30e32c093ada52ab7da934e3dfd3cc\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-05-19T15:37:10Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":29,\"id\":1016}",
      "1017": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"633758e75af5623b58a51b07cba8271299f1f7f1\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T22:42:05Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":29,\"id\":1017}",
      "1018": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4f925bb70675f35e560c5f604e9bd7f2e7c1a005\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T18:08:19Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":29,\"id\":1018}",
      "1019": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0391de3e4e15d8a18d5c1a58acd68457c7e3f5f5\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T17:59:37Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":29,\"id\":1019}",
      "1020": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7f9c6e1c16c7cc188810f936f5f3d7610bf18e30\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T17:58:59Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Design Finalized\",\"useCases\":\"Population-Level Estimation\",\"studyType\":\"Clinical Application\",\"tags\":\"Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":29,\"id\":1020}",
      "1021": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f496d0bb02f7da9e88a02b0469259b4411d79dc1\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-04-02T20:20:45Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":null,\"studyLeads\":null}},\"scanId\":29,\"id\":1021}",
      "1022": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c0b95e61d0fce1d3de1a5e7ef87cc79f99784f1e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-06-22T10:01:35Z\"},\"repoName\":\"Covid19TestCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":1022}",
      "1023": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9af773f78cede486f8b18632eb672df71b905d7c\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-04-17T02:34:20Z\"},\"repoName\":\"Covid19TestCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":1023}",
      "1024": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6e593c1e4f1030061f0f7cd34bb0b23f29cc75b2\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-04-17T02:32:30Z\"},\"repoName\":\"Covid19TestCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":1024}",
      "1025": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f8e98a4e0083ff6815274aa45e5b6743fdd7eedc\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-04-17T02:28:01Z\"},\"repoName\":\"Covid19TestCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical Application\",\"tags\":\"OHDSI, Study-a-thon, COVID-19\",\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":29,\"id\":1025}",
      "1026": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0631e7d767ece6463392e383656e290c77d962f9\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-28T03:43:14Z\"},\"repoName\":\"COVID19CancerBaselineCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Characterization\",\"studyType\":\"Clinical application\",\"tags\":\"COVID-19, Oncology\",\"studyLeads\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Talita Duarte-Salles\",\"Shilpa Ratwani\"]}},\"scanId\":29,\"id\":1026}",
      "1027": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e1b08f5b3626e2adaa391089c266e03efad2ea15\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T20:58:53Z\"},\"repoName\":\"COVID19CancerBaselineCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Clinical application\",\"studyType\":\"Characterization\",\"tags\":\"COVID-19, Oncology\",\"studyLeads\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Talita Duarte-Salles\",\"Shilpa Ratwani\"]}},\"scanId\":29,\"id\":1027}",
      "1028": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7842ff2b717987e3f4f78be70f8ffbbb984de6dc\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T20:58:40Z\"},\"repoName\":\"COVID19CancerBaselineCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":\"Clinical application\",\"studyType\":\"Characterization\",\"tags\":\"COVID-19, Oncology\",\"studyLeads\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Talita Duarte-Salles\",\"Shilpa Ratwani\"]}},\"scanId\":29,\"id\":1028}",
      "1029": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9767d71459e17a5528ffe070d501ed98b0d3845d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T20:53:49Z\"},\"repoName\":\"COVID19CancerBaselineCharacterization\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":\"-\",\"studyType\":\"-\",\"tags\":\"-\",\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":29,\"id\":1029}",
      "1030": "{\"status\":\"complete\",\"scanId\":29,\"id\":1030}",
      "1031": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MethodsLibraryPleEvaluation\",\"updatedAt\":\"2023-01-27T00:49:38Z\",\"watchersCount\":7},\"scanId\":30,\"id\":1031}",
      "1032": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TicagrelorVsClopidogrel\",\"updatedAt\":\"2021-10-09T03:00:22Z\",\"watchersCount\":1},\"scanId\":30,\"id\":1032}",
      "1033": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CauseSpecificMortality\",\"updatedAt\":\"2020-02-19T07:11:57Z\",\"watchersCount\":0},\"scanId\":30,\"id\":1033}",
      "1034": "{\"status\":\"in progress\",\"repository\":{\"name\":\"RanitidineCancerRisk\",\"updatedAt\":\"2022-05-16T08:10:21Z\",\"watchersCount\":5},\"scanId\":30,\"id\":1034}",
      "1035": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StudyRepoTemplate\",\"updatedAt\":\"2021-06-10T17:06:45Z\",\"watchersCount\":4},\"scanId\":30,\"id\":1035}",
      "1036": "{\"status\":\"in progress\",\"repository\":{\"name\":\"TofacitinibSafetyinRA\",\"updatedAt\":\"2020-06-19T17:09:43Z\",\"watchersCount\":0},\"scanId\":30,\"id\":1036}",
      "1037": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDrugUtilization\",\"updatedAt\":\"2021-07-12T19:59:12Z\",\"watchersCount\":2},\"scanId\":30,\"id\":1037}",
      "1038": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaDmardsEstimation\",\"updatedAt\":\"2020-12-09T22:09:29Z\",\"watchersCount\":1},\"scanId\":30,\"id\":1038}",
      "1039": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IntraVitrealCx\",\"updatedAt\":\"2020-01-16T05:14:19Z\",\"watchersCount\":0},\"scanId\":30,\"id\":1039}",
      "1040": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EmptyStudyRepository\",\"updatedAt\":\"2020-10-13T04:36:38Z\",\"watchersCount\":1},\"scanId\":30,\"id\":1040}",
      "1041": "{\"status\":\"in progress\",\"repository\":{\"name\":\"IUDEHREstimationStudy\",\"updatedAt\":\"2022-10-05T19:33:19Z\",\"watchersCount\":0},\"scanId\":30,\"id\":1041}",
      "1042": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BipolarMisclassificationValidation\",\"updatedAt\":\"2023-01-04T18:29:52Z\",\"watchersCount\":3},\"scanId\":30,\"id\":1042}",
      "1043": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPrediction\",\"updatedAt\":\"2021-09-09T12:25:14Z\",\"watchersCount\":1},\"scanId\":30,\"id\":1043}",
      "1044": "{\"status\":\"in progress\",\"repository\":{\"name\":\"EhdenRaPredictionValidation\",\"updatedAt\":\"2020-01-17T08:22:21Z\",\"watchersCount\":0},\"scanId\":30,\"id\":1044}",
      "1045": "{\"status\":\"in progress\",\"repository\":{\"name\":\"MusculoskeletalAEsAfterAIs\",\"updatedAt\":\"2022-11-25T18:47:22Z\",\"watchersCount\":1},\"scanId\":30,\"id\":1045}",
      "1046": "{\"status\":\"in progress\",\"repository\":{\"name\":\"ConceptPrevalence\",\"updatedAt\":\"2020-10-23T18:53:37Z\",\"watchersCount\":2},\"scanId\":30,\"id\":1046}",
      "1047": "{\"status\":\"in progress\",\"repository\":{\"name\":\"BreastCancerBetweenScreen\",\"updatedAt\":\"2021-04-07T15:12:23Z\",\"watchersCount\":2},\"scanId\":30,\"id\":1047}",
      "1048": "{\"status\":\"in progress\",\"repository\":{\"name\":\"DMCharacterizationAP\",\"updatedAt\":\"2020-02-12T13:07:59Z\",\"watchersCount\":1},\"scanId\":30,\"id\":1048}",
      "1049": "{\"status\":\"in progress\",\"repository\":{\"name\":\"StrokeRiskInApUsers\",\"updatedAt\":\"2021-04-07T20:32:47Z\",\"watchersCount\":0},\"scanId\":30,\"id\":1049}",
      "1050": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CancerTxPathway\",\"updatedAt\":\"2020-03-12T09:04:52Z\",\"watchersCount\":1},\"scanId\":30,\"id\":1050}",
      "1051": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19HospitalizationCharacterization\",\"updatedAt\":\"2021-02-09T18:24:29Z\",\"watchersCount\":9},\"scanId\":30,\"id\":1051}",
      "1052": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19DrugRepurposing\",\"updatedAt\":\"2020-04-06T04:50:19Z\",\"watchersCount\":0},\"scanId\":30,\"id\":1052}",
      "1053": "{\"status\":\"in progress\",\"repository\":{\"name\":\"CovidSeverityPrediction\",\"updatedAt\":\"2020-03-20T04:51:02Z\",\"watchersCount\":1},\"scanId\":30,\"id\":1053}",
      "1054": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19CohortEvaluation\",\"updatedAt\":\"2020-05-19T13:28:36Z\",\"watchersCount\":1},\"scanId\":30,\"id\":1054}",
      "1055": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19PredictionStudies\",\"updatedAt\":\"2021-07-04T15:22:24Z\",\"watchersCount\":10},\"scanId\":30,\"id\":1055}",
      "1056": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationIl6JakInhibitors\",\"updatedAt\":\"2020-06-22T09:43:42Z\",\"watchersCount\":0},\"scanId\":30,\"id\":1056}",
      "1057": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19EstimationHydroxychloroquine\",\"updatedAt\":\"2021-09-27T08:30:37Z\",\"watchersCount\":7},\"scanId\":30,\"id\":1057}",
      "1058": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19Icarius\",\"updatedAt\":\"2021-04-08T23:24:12Z\",\"watchersCount\":3},\"scanId\":30,\"id\":1058}",
      "1059": "{\"status\":\"in progress\",\"repository\":{\"name\":\"Covid19TestCharacterization\",\"updatedAt\":\"2020-06-22T10:01:38Z\",\"watchersCount\":0},\"scanId\":30,\"id\":1059}",
      "1060": "{\"status\":\"in progress\",\"repository\":{\"name\":\"COVID19CancerBaselineCharacterization\",\"updatedAt\":\"2020-04-28T03:43:17Z\",\"watchersCount\":1},\"scanId\":30,\"id\":1060}",
      "1061": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"03cf7464cdaaaaa12419021b72ba98ba8a310839\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-02-04T04:51:05Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Methods Research\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"[How Confident Are We About Observational Findings in Health Care: A Benchmark Study](https://doi.org/10.1162/99608f92.147cc28e)\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":30,\"id\":1061}",
      "1062": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6aecc47dc6c8bb5660435f7fa74cf925b43e6eef\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-17T05:57:21Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Results Available\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Methods Research\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"Paper under review\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":30,\"id\":1062}",
      "1063": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f0800d6cfa76911fadad5796a0ff24caf833fb8e\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T11:41:42Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Results Available\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Methods Research\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[\",\"publications\":\"Paper under review\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":30,\"id\":1063}",
      "1064": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4e3a1a661a49d6d5b408bcb07795e1d69d48c07a\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T11:37:56Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Results Available\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Methods Research\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/MethodsLibraryPleEvaluation/blob/master/extras/OHDSI%20Protocol%20Method%20Evaluation.docx)\",\"publications\":\"Paper under review\",\"results\":\"[MethodEvalViewer](https://data.ohdsi.org/MethodEvalViewer/)\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":30,\"id\":1064}",
      "1065": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f72806df4060174f8d4291d45bd8c9d89b8634d6\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-09-02T12:35:03Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\\\"> <img src=\\\"https://img.shields.io/badge/Study%20Type-Methods%20Research-blue.svg\\\" alt=\\\"Study Type: Methods Research\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/MethodsLibraryPleEvaluation/blob/master/extras/OHDSI%20Protocol%20Method%20Evaluation.docx)\",\"publications\":\"Paper under review\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":30,\"id\":1065}",
      "1066": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0cc444058def9e183922e4f33ea2c4045a2cf73d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-09-02T12:34:28Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"status\":\"Complete\\\"> <img src=\\\"https://img.shields.io/badge/Study%20Type-Methods%20Research-blue.svg\\\" alt=\\\"Study Type: Methods Research\",\"studyLeads\":null,\"startDate\":\"November 1, 2018\",\"endDate\":\"August 1, 2019\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/MethodsLibraryPleEvaluation/blob/master/extras/OHDSI%20Protocol%20Method%20Evaluation.docx)\",\"publications\":\"Paper under review\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":30,\"id\":1066}",
      "1067": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0bdd50b112cc2c018da3fe2a6083be99627901bc\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-04-18T07:07:50Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"studyLeads\":null}},\"scanId\":30,\"id\":1067}",
      "1068": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"51f4d2bcaf69c6544482701b0fc55c8a08541335\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2018-12-13T05:57:29Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"studyLeads\":null}},\"scanId\":30,\"id\":1068}",
      "1069": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1762d6ea91fa6bb24e1c6833dda4bc8a818263b2\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2018-11-07T07:58:18Z\"},\"repoName\":\"MethodsLibraryPleEvaluation\",\"summary\":{\"exists\":false,\"title\":\"OHDSI Evaluation of Population-Level Estimation Methods\",\"studyLeads\":null}},\"scanId\":30,\"id\":1069}",
      "1070": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ce79787dc2370fbeb18f4e9002bf8040f1f41245\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-05-13T12:15:40Z\"},\"repoName\":\"TicagrelorVsClopidogrel\",\"summary\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":30,\"id\":1070}",
      "1071": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"05a4d406fd21dcb8088755688a53f4b985ae74ec\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-17T05:24:05Z\"},\"repoName\":\"TicagrelorVsClopidogrel\",\"summary\":{\"exists\":false,\"title\":\"Ticagrelor Vs Clopidogrel\",\"status\":\"Results Available\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"December 11, 2018\",\"endDate\":\"\",\"protocol\":\"[\",\"publications\":\"\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/TicagrelorVsClopidogrel/)\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":30,\"id\":1071}",
      "1072": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c29355c3f78caeebc1dfb67f7132367a5b3e899e\",\"author\":{\"name\":\"Kim Chungsoo\",\"email\":\"42205861+ted9219@users.noreply.github.com\",\"date\":\"2020-02-19T07:11:53Z\"},\"repoName\":\"CauseSpecificMortality\",\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":30,\"id\":1072}",
      "1073": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d8d07ee5f30fe78273373001d482a08a582d65ac\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:06:40Z\"},\"repoName\":\"CauseSpecificMortality\",\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":30,\"id\":1073}",
      "1074": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a341bcfdbf51a1840b24f3db8c2930b5ba66c23f\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:03:15Z\"},\"repoName\":\"CauseSpecificMortality\",\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"June 1, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":30,\"id\":1074}",
      "1075": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9ec5c60f4ae4b23d4f71637cb702de24411bb331\",\"author\":{\"name\":\"Kim Chungsoo\",\"email\":\"42205861+ted9219@users.noreply.github.com\",\"date\":\"2020-01-17T07:54:49Z\"},\"repoName\":\"CauseSpecificMortality\",\"summary\":{\"exists\":false,\"title\":\"Cause-specific mortality prediction\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"June, 2019\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Chungsoo Kim\"]}},\"scanId\":30,\"id\":1075}",
      "1076": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a976806e2322b2ea8523985f3ebb43635bdf4da3\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2021-04-07T02:57:33Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\"],\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":30,\"id\":1076}",
      "1077": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eacb6c08e26c266d9b2b10273ad547e318e1861b\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2021-01-13T23:59:34Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\"],\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":30,\"id\":1077}",
      "1078": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d51d8c9f0375e21f43edce1f00109962b4ec14fa\",\"author\":{\"name\":\"Seng Chan You\",\"email\":\"applegna@gmail.com\",\"date\":\"2021-01-13T23:53:00Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\"],\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":30,\"id\":1078}",
      "1079": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4237c7dc0d949feff2f6f36e0b8279d90de27d60\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-02T23:16:50Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\"],\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":30,\"id\":1079}",
      "1080": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"22588d6d57fcfcbd58987cf9307ecee9ca5da0c9\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-29T07:38:27Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\"],\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":30,\"id\":1080}",
      "1081": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e83369b0ed009f035c69e248e6c1a5062a004e1f\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-29T06:58:14Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\"],\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/RanitidineCancerRisk/blob/master/documents/)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":30,\"id\":1081}",
      "1082": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"67e3f3fa9358efd761e4a2937aae2cd41ccaeb85\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-13T04:49:37Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\"],\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"Not avialble now\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":30,\"id\":1082}",
      "1083": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2df2ad9bacc60ccf3a662deea8d62b125207f1f0\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-31T11:46:43Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\"],\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"Not avialble now\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":30,\"id\":1083}",
      "1084": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d5613000110bbd86436388cd0a1d964292c994f9\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-31T10:48:24Z\"},\"repoName\":\"RanitidineCancerRisk\",\"summary\":{\"exists\":false,\"title\":\"Cancer Risk between H2 blockers\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\"],\"studyLeads\":null,\"startDate\":\"January 31, 2020\",\"endDate\":\"\",\"protocol\":\"Not avialble now\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\",\"Seung In Seo\",\"Chan Hyuk Park\"]}},\"scanId\":30,\"id\":1084}",
      "1085": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d1b9cdf9aa1dcccbc78cd254d57176257bbfc03e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-06-25T13:58:19Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1085}",
      "1086": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cd910db439a30cdbe24c1cc5e1d08c76323097a4\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-13T09:06:48Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1086}",
      "1087": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"20a7b33ac4f03e05ef0441017de45fe1aac98c4b\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-08T06:16:58Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1087}",
      "1088": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"dc33808fa3ed5243c03f6781a36a105a20c3e0f0\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-01-04T07:24:07Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1088}",
      "1089": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d80502e286e206b63a8c78ddd368c00bb1e1bf8d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-04T07:08:33Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1089}",
      "1090": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0a24c7b0b872e2ce796c8a79a16aa82c8ac0a8b6\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-17T05:49:40Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1090}",
      "1091": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"92c2590daee478fc141ff40287aa1281776a4cb8\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-17T05:46:17Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1091}",
      "1092": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3069500e74a6f6293deacface9697f725f656a19\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T10:34:11Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1092}",
      "1093": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2a9f81688d4dcd3caab2f20bedc52ebcccfe7153\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2019-12-16T09:23:08Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\\\"> | The study repository has just been created. Work has not yet commenced. | <button onclick=\\\"copyToClipboard('<img src=&quot;Study%20Status-Repo%20Created-lightgray.svg&quot; alt=&quot;Study Status: Repo Created&quot;>')\",\"studyLeads\":null}},\"scanId\":30,\"id\":1093}",
      "1094": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f09bdbdbd798f5fa3a8e0445044054b34e478ffa\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2019-12-16T07:12:11Z\"},\"repoName\":\"StudyRepoTemplate\",\"summary\":{\"exists\":false,\"title\":null,\"studyLeads\":null}},\"scanId\":30,\"id\":1094}",
      "1095": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"33cb4f3a3bc3f6469ff88cba9782d7434b169398\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-19T17:09:39Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"Rheumatoid Arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1095}",
      "1096": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"344aa13a10781f2615f897e59d2a14c1c6e082d6\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T21:11:54Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"Rheumatoid Arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.2.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1096}",
      "1097": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7d1473227d4f839d415a95d7138a039e2e181079\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T18:57:41Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"Rheumatoid Arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1097}",
      "1098": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"235f6f7969d060aeadea64e4add1500074d1d3b2\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T17:47:47Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"Rheumatoid Arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1098}",
      "1099": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"796214333e19a3255ac532a0157eb8bb0767b93d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-16T17:46:44Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"Rheumatoid Arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1099}",
      "1100": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6d4e21df72cef9649b0441eb91e71cf96b255dd3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-05T23:17:55Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"Rheumatoid Arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1100}",
      "1101": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ce0d728ca8ee692885a057709e895265bd088cb3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-06-05T23:17:07Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"Rheumatoid Arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"June 30, 2020\",\"protocol\":\"[Final Protocol](https://github.com/ohdsi-studies/TofacitinibSafetyinRA/blob/master/Overall%20Documentation/OHDSI%20F2F%20protocol%20v2.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1101}",
      "1102": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b2f2afb16cec44cc0dd338847ac71b4aa94b9159\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:11:37Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"Rheumatoid Arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"Early Spring 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1102}",
      "1103": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"432552ede0413ab22d9dadc6f9af819f5468ec38\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-16T17:59:55Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"Rheumatoid Arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"Early Spring 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1103}",
      "1104": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"707da9cf486ad088d6147ea3e0e6bf7b262abd36\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-03T14:22:32Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"rheumatoid arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\",\"RWD\",\"RWE\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"Early Spring 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1104}",
      "1105": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a9701894cdc904847ed088b580503d9b01ab5ef0\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T22:49:27Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"rheumatoid arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\",\"RWD\",\"RWE\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"[Initial Protocol](https://github.com/ohdsi-studies/Tofacitinib-safety-in-RA/blob/master/OHDSI%20F2F%20Protocol%20V1.1.docx)\",\"publications\":\"TBD\",\"results\":\"In progress\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1105}",
      "1106": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a542ec6ab6e411c249dda319d97fc79b508469e3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T20:21:42Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"rheumatoid arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\",\"RWD\",\"RWE\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1106}",
      "1107": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"39e7660f8554761ef77f26a1dbd1a1a4f4a1d0bd\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T19:25:08Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"rheumatoid arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\",\"RWD\",\"RWE\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1107}",
      "1108": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d53b4844a8c0e26e8aacd83879a691fa16e454e4\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T19:19:55Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":null,\"studyLeads\":null}},\"scanId\":30,\"id\":1108}",
      "1109": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"24def2bc735fdcd45ff97870a56b9f231f76d9f9\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:57:37Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"rheumatoid arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\",\"RWD\",\"RWE\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1109}",
      "1110": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"27ac2fe2f9c3f7e33ae31359b263d498f641f0db\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:56:51Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"rheumatoid arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\",\"RWD\",\"RWE\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1110}",
      "1111": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b8232e42252a074a3d2e350401235059ebfcc1d6\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:56:11Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"rheumatoid arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\",\"RWD\",\"RWE\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1111}",
      "1112": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cf6563681641c1c4aef0d48a86d9a2d7e960d802\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:53:38Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"(OHDSI Community Face-to-Face Study-a-thon 2018) Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"rheumatoid arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\",\"RWD\",\"RWE\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1112}",
      "1113": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"482db713fdc786b560c733ea5dff4664724bcc2f\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:42:13Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"[Predicting randomized clinical trial results with real-world evidence: A case study in the comparative safety of tofacitinib, adalimumab and etanercept in patients with rheumatoid arthritis]\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"rheumatoid arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\",\"RWD\",\"RWE\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1113}",
      "1114": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5ffefd65e4c66c09eeb84d6c8dad6f5da3821f4d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:39:25Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"[Tofacitinib Safety in Rheumatoid Arthritis]\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"rheumatoid arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\",\"RWD\",\"RWE\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1114}",
      "1115": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7bab7baba89139768edff939f554de7bce3f2a71\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:38:35Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"[Tofacitinib Safety in Rheumatoid Arthritis]\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"F2F\",\"rheumatoid arthritis\",\"drug safety\",\"tofacitinib\",\"etanercept\",\"adalimumab\",\"Xeljanz\",\"Enbrel\",\"Humira\",\"RWD\",\"RWE\"],\"studyLeads\":null,\"startDate\":\"May 2, 2018\",\"endDate\":\"January 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Bridget Wang\"]}},\"scanId\":30,\"id\":1115}",
      "1116": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b3d561948afe47655c540ac504bf787639976989\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:38:02Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLeads\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}},\"scanId\":30,\"id\":1116}",
      "1117": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f428ed3c6e346ae6b34bb24a5e7bad19549ef78e\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-01-02T16:27:11Z\"},\"repoName\":\"TofacitinibSafetyinRA\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1117}",
      "1118": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"03c65960e7e79427bc28eeb35e34feee6cd02c8b\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2021-07-07T16:02:30Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Rheumatoid arthritis\",\"Drug Utilization\",\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/EhdenRaDrugUtilization/\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":30,\"id\":1118}",
      "1119": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f8fe2d9b1983128271260f566b3343ed47cfdf99\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:08:38Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Rheumatoid arthritis\",\"Drug Utilization\",\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":30,\"id\":1119}",
      "1120": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2ee98f15c9043acc087cc12f8934e69ef4703524\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-17T11:09:54Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Rheumatoid arthritis\",\"Drug Utilization\",\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":30,\"id\":1120}",
      "1121": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c41a3260fb9c333c6a8c1ceb1891dcbc064f3ab1\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:09:32Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Rheumatoid arthritis\",\"Drug Utilization\",\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":30,\"id\":1121}",
      "1122": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"544f7bac170051aab0434fdd0d145961f86fb607\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-15T23:09:32Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Rheumatoid arthritis\",\"Drug Utilization\",\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":30,\"id\":1122}",
      "1123": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"200ccb07ef0b97e5f8a425cd1949de6d7c865f6a\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-14T23:20:31Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Rheumatoid arthritis\",\"Drug Utilization\",\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":30,\"id\":1123}",
      "1124": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aa7d9e64c4fa715918de2c16dbae21ed03742d14\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-12T16:40:26Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"Rheumatoid arthritis (RA) Drug Utilization 2020 (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Repo Created\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Rheumatoid arthritis\",\"Drug Utilization\",\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 12, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anthony G. Sena\"]}},\"scanId\":30,\"id\":1124}",
      "1125": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"95f7ad96896d107561f73cd308710f10ef15c162\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-12T16:25:32Z\"},\"repoName\":\"EhdenRaDrugUtilization\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1125}",
      "1126": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b6a3c482be29780e026329fcc351bdceb9226d7e\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-09T14:47:46Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\",\"studyLead\":[\"Jamie Weaver\",\"Ed Burn\"]}},\"scanId\":30,\"id\":1126}",
      "1127": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"daf4ac2378d8ed3b964ae07154bc8546f68db3e1\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-09T14:44:45Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Results Available\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/EhdenRaDmardsEstimation/)\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":30,\"id\":1127}",
      "1128": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b05436fbef86476606bc3b0497a34d3e45b3ad74\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-22T20:33:56Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":30,\"id\":1128}",
      "1129": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c2da6ca11e7ce9ed5c9480e5c77c53c82892b21a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T15:00:58Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":30,\"id\":1129}",
      "1130": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7be0d549b90b728dccad2133105cfdbb41c6a56e\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T14:58:24Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":30,\"id\":1130}",
      "1131": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"609c2abe26c1e2d0915e26918ccff47f73c32279\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T14:55:22Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":30,\"id\":1131}",
      "1132": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4e25e8555ced93d5fcb2d4f9635a0c16adc43bc4\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-17T14:51:46Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":30,\"id\":1132}",
      "1133": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"988a35ade5804cac844d7157f5e2aa47f406ca4a\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:07:09Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jamie Weaver\"]}},\"scanId\":30,\"id\":1133}",
      "1134": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"24dc2a8da60ab9d7f4e03032cf9f12601cec3eb0\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-01-12T18:28:30Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"DMARDs comparative safety in RA (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1134}",
      "1135": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0325f45de87df07e8a08332b751e469796e01e9b\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2020-01-12T17:49:27Z\"},\"repoName\":\"EhdenRaDmardsEstimation\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1135}",
      "1136": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5fb9f9ff028df1a60bd30c27e51574b1429a9d18\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:14:17Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\"],\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"\",\"\"]}},\"scanId\":30,\"id\":1136}",
      "1137": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"24b9054828289da401fc257222d5a3cf6314846d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T13:47:57Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\"],\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"\",\"\"]}},\"scanId\":30,\"id\":1137}",
      "1138": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4b27524a375a49e9cb80fb8994965cebd0c34c74\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T13:08:19Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"[Complication of intravitreous injection]\",\"status\":\"Started\",\"useCases\":[\"`Characterization`\"],\"studyType\":[\"`Clinical Application`\"],\"tags\":[\"`OHDSI-Korea`\",\"`FEEDER-NET`\"],\"studyLeads\":null,\"startDate\":\"January 13, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"\",\"\"]}},\"scanId\":30,\"id\":1138}",
      "1139": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"82c91839fffa3579cef3db7df80034ef6cd7b1d6\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T09:00:06Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection \",\"status\":\"Started\",\"studyLeads\":null}},\"scanId\":30,\"id\":1139}",
      "1140": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"22e3fc0e1c5b4908f8b68fc8b1422e1fd0a5e281\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T02:57:13Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"Complication of intravitreous injection \",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1140}",
      "1141": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2b35fb2d3d951384bda88e09960bb3586b429539\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-01-13T02:39:35Z\"},\"repoName\":\"IntraVitrealCx\",\"summary\":{\"exists\":false,\"title\":\"StudyRepoTemplate\",\"status\":\"Repo Created\",\"studyLeads\":null}},\"scanId\":30,\"id\":1141}",
      "1142": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"40a19ce3da119f536ef49e9846873ae297b37b7d\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T13:08:40Z\"},\"repoName\":\"EmptyStudyRepository\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1142}",
      "1143": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c04b9bc1163f8bee80ee442e3346b5ee40a888d7\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T09:14:09Z\"},\"repoName\":\"EmptyStudyRepository\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1143}",
      "1144": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d1431f38249143579ef5f3447e10319b3b31701d\",\"author\":{\"name\":\"mattspotnitz\",\"email\":\"43792067+mattspotnitz@users.noreply.github.com\",\"date\":\"2022-10-10T14:29:41Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"iud\"],\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":30,\"id\":1144}",
      "1145": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f760690521e215e253c66746945bd14bcc4bf20a\",\"author\":{\"name\":\"cukarthik\",\"email\":\"cukarthik@users.noreply.github.com\",\"date\":\"2022-10-05T19:33:12Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"iud\"],\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":30,\"id\":1145}",
      "1146": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f3fb9ebaa76dad451e964ee36d4f492db216b153\",\"author\":{\"name\":\"cukarthik\",\"email\":\"cukarthik@users.noreply.github.com\",\"date\":\"2020-06-19T01:23:01Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"iud\"],\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":30,\"id\":1146}",
      "1147": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2f3d3df095295a68e32b9236be3f616393ddc984\",\"author\":{\"name\":\"cukarthik\",\"email\":\"kn2174@cumc.columbia.edu\",\"date\":\"2020-02-21T04:06:55Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"iud\"],\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":30,\"id\":1147}",
      "1148": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a5031d8ec1f3a8db12b303ded820b41fbbd0f6e7\",\"author\":{\"name\":\"cukarthik\",\"email\":\"kn2174@cumc.columbia.edu\",\"date\":\"2020-02-21T01:35:05Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"iud\"],\"studyLeads\":null,\"startDate\":\"September 23, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz\"]}},\"scanId\":30,\"id\":1148}",
      "1149": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"94ad2913189fd7095cad6ce081fe312189af9b0a\",\"author\":{\"name\":\"cukarthik\",\"email\":\"kn2174@cumc.columbia.edu\",\"date\":\"2020-02-11T04:40:41Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"Relative Risk of Cervical Neoplasms Associated with Copper and Levonorgestrel Secreting Intrauterine Devices: <br> Real World Evidence from the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":[\"`Characterization` and `Population-Level Estimation`\"],\"studyType\":[\"`Clinical Application`\"],\"tags\":[\"iud\"],\"studyLeads\":null,\"startDate\":\"09/23/2019\",\"endDate\":\"-\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/IUDEHREstimationStudy/blob/master/documents/IUD%20Cervical%20Neoplasms%20Estimation%20Protocol.docx)\",\"publications\":\"[Prior single site study](https://journals.lww.com/greenjournal/fulltext/2020/02000/relative_risk_of_cervical_neoplasms_among_copper.11.aspx)\",\"results\":\"-\",\"studyLead\":[\"Matthew Spotnitz and Karthik Natarajan\"]}},\"scanId\":30,\"id\":1149}",
      "1150": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"efe6bd17883254013509a1038e9a3c4c3a623a83\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-13T09:16:58Z\"},\"repoName\":\"IUDEHREstimationStudy\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1150}",
      "1151": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"441fae07fef60705584537e23ebf48f46d0f96dc\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-07-10T17:19:30Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1151}",
      "1152": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a8c0900730bac59ded0c9bcfd50413be89e18e53\",\"author\":{\"name\":\"Christophe Lambert\",\"email\":\"ChristopheLambert@users.noreply.github.com\",\"date\":\"2020-03-13T16:53:06Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 30, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1152}",
      "1153": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd8f998b291f1f2c883d590ea6db6294b44765c9\",\"author\":{\"name\":\"Christophe Lambert\",\"email\":\"ChristopheLambert@users.noreply.github.com\",\"date\":\"2020-03-13T15:46:25Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1153}",
      "1154": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7756bdeb821f231f56f5e8da0a69069b7222df4b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-13T15:39:03Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1154}",
      "1155": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"06c9c64894931504777ea9a3a411efc68b95a49b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-13T15:15:28Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1155}",
      "1156": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"72daa9786d764a008739caa64cd0749ff5fbd150\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-13T15:14:59Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1156}",
      "1157": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7df9f56fe912c4ca12bf3658f94f03e52df8930e\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-12T13:12:59Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1157}",
      "1158": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6d083c23eb5c4459910935a5a1266a20dea237ab\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-09T19:06:05Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1158}",
      "1159": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c1aebdc574bd667b50f39b03d2edbeee5b989d1b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T19:15:33Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1159}",
      "1160": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8a1f25acee9934b28ed5abb4c812ee7fd6c62dfd\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T19:10:51Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1160}",
      "1161": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9fe9d06eeda114121b4335fef7fe95acd12cd12e\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T19:09:29Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1161}",
      "1162": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6200258dd010b289df065a6ea183fef0f248f818\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:58:22Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1162}",
      "1163": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"faf3f82e283f5681c8409057f0e8ad14ec51d3be\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:53:36Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1163}",
      "1164": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eda681962576b5e79eb3b55387948dc37d4736ff\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:52:00Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1164}",
      "1165": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"990305fecabfbf896d7d8e038f454f617f574838\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:46:17Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1165}",
      "1166": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3418566cda0d417da1ae8251828fd32575f28211\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-26T18:46:13Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1166}",
      "1167": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"90ea55a7d699a27bc91bf3ea7a4280bf39a9f15a\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-25T17:05:13Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Design Finalized\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1167}",
      "1168": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b533a94966ae72db7b6279ba3e0c6f207b90a6c9\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-21T16:27:36Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1168}",
      "1169": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2d29262936d06a1ca734cb9ed614c56263b603a4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-21T16:26:06Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1169}",
      "1170": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"26ffc65bc835a444f4e02592f73d41fcc23f7c13\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-21T15:56:23Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"April 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1170}",
      "1171": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e6575280d7c4f0eb268d4ce91c3a8f29d7168870\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-17T14:21:52Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1171}",
      "1172": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"067563321fcc101bdcc8ed05fe62338739fd5ab0\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-17T14:21:48Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1172}",
      "1173": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8851b3453e13ccabf1fa99454d44899eadccc524\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T06:10:21Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1173}",
      "1174": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"582d9f8a36ecdbfd349f7621584bf42564e63086\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T06:00:24Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1174}",
      "1175": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd98870ba20c389be94032663c4b7e3c45409cae\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-16T05:10:53Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1175}",
      "1176": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"bb68a01b0a8b21c3facd0abb6721a18fb061a416\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-15T18:45:10Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"External Validation of Model Predicting Bipolar Misdiagnosed as MDD\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/master/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1176}",
      "1177": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0f3e3104d48fc69aa26abeb48d0ea6d15f28e7b6\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-15T18:41:16Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"[External Validation of Model Predicting Bipolar Misdiagnosed as MDD]\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Jan 1, 2020\",\"endDate\":\"March 1, 2020\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BipolarMisclassificationValidation/blob/documents/ProtocolBipolarInMDD.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Christophe Lambert\"]}},\"scanId\":30,\"id\":1177}",
      "1178": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6154650335dbf9a8b9c08bbfaed13d01fd99a0d4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-01-15T16:04:18Z\"},\"repoName\":\"BipolarMisclassificationValidation\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1178}",
      "1179": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"408347f43218324176274f1601c48c79c5cd3815\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2021-09-09T12:25:07Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"[\",\"studyLead\":[\"Cynthia Yang\",\"Ross Williams\"]}},\"scanId\":30,\"id\":1179}",
      "1180": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"17b070994e9074e61d6a55165f62ae8ef2e02587\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-01-27T11:25:52Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Cynthia Yang\"]}},\"scanId\":30,\"id\":1180}",
      "1181": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ad59e3f12eb5a2f4fb9985035c051728a6674869\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-01-27T11:01:19Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Cynthia Yang\"]}},\"scanId\":30,\"id\":1181}",
      "1182": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c0dc4432a3bdff52c327761922790e7637a38848\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-01-27T10:57:23Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"[\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":30,\"id\":1182}",
      "1183": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"05477c3d99b5b9cd20c712a3fa28d0f20164eb36\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-21T09:29:57Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":30,\"id\":1183}",
      "1184": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"51c727707e8947b95d693b90af4e609c3967b367\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-20T06:10:02Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Patient-Level Prediction\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":30,\"id\":1184}",
      "1185": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"089c7dc11e6ce330cb12ec14e29addae97732599\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-17T09:58:40Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Patient-Level Prediction\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":30,\"id\":1185}",
      "1186": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5e8a80b5ccb04f02da117f3f7befd3853c487419\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-17T09:53:25Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Patient-Level Prediction\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":30,\"id\":1186}",
      "1187": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"be0d31cd90524262518611f11f7bb78df67c9420\",\"author\":{\"name\":\"RossDWilliams\",\"email\":\"r.williams@erasmusmc.nl\",\"date\":\"2020-01-17T09:52:16Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Patient-Level Prediction\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":30,\"id\":1187}",
      "1188": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9c09c671c1631d7ffb43b39fa5f2af99db474ac1\",\"author\":{\"name\":\"RossDWilliams\",\"email\":\"r.williams@erasmusmc.nl\",\"date\":\"2020-01-17T09:47:43Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Patient-Level Prediction\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":30,\"id\":1188}",
      "1189": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"16c8f275053262d47bab39563c0d73ab65dae1dc\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-17T09:36:19Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Patient-Level Prediction\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":30,\"id\":1189}",
      "1190": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4368b4f23904596b285e574d25ecdf04188114a2\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-16T16:32:09Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Patient-Level Prediction\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":30,\"id\":1190}",
      "1191": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b182d1b0b5f16e7a5cd304778576533959cb6908\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-01-16T14:40:20Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Patient-Level Prediction\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":30,\"id\":1191}",
      "1192": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"72d94ae63502c01064b0c36dffa41f7bc616e2cb\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-16T13:39:48Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcomes after methotrexate initiation (EHDEN Study-a-thon Barcelona 2020)\",\"status\":\"Started\",\"useCases\":[\"Patient Level Prediction\"],\"studyType\":[\"Patient-Level Prediction\"],\"tags\":[\"EHDEN\"],\"studyLeads\":null,\"startDate\":\"January 16, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Ross Williams\"]}},\"scanId\":30,\"id\":1192}",
      "1193": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"388a8717daab3710c558499034a7c45aa9b25545\",\"author\":{\"name\":\"Joel Swerdel\",\"email\":\"jswerdel@its.jnj.com\",\"date\":\"2020-01-16T13:29:11Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"A Package Skeleton for Patientl-Level Prediction Studies\",\"studyLeads\":null}},\"scanId\":30,\"id\":1193}",
      "1194": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"92e29b70e535a6c5e0dead9f4b774bbbbdae478a\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-16T13:16:48Z\"},\"repoName\":\"EhdenRaPrediction\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1194}",
      "1195": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"39e574789da2d7c231081917d49fbad39d244915\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"asena5@its.jnj.com\",\"date\":\"2020-01-17T08:20:53Z\"},\"repoName\":\"EhdenRaPredictionValidation\",\"summary\":{\"exists\":false,\"title\":null,\"status\":null,\"useCases\":null,\"studyType\":null,\"tags\":null,\"studyLeads\":null,\"startDate\":null,\"endDate\":null,\"protocol\":null,\"publications\":null,\"results\":null}},\"scanId\":30,\"id\":1195}",
      "1196": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"93753ef640069cd3d01a7373a5875d9792c1a399\",\"author\":{\"name\":\"Joel Swerdel\",\"email\":\"jswerdel@its.jnj.com\",\"date\":\"2020-01-17T08:06:15Z\"},\"repoName\":\"EhdenRaPredictionValidation\",\"summary\":{\"exists\":false,\"title\":\"EHDENRAPredictionValidation\",\"studyLeads\":null}},\"scanId\":30,\"id\":1196}",
      "1197": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0bee36097132db98d0cc134a8521322828351fb0\",\"author\":{\"name\":\"Anthony Sena\",\"email\":\"anthonysena@users.noreply.github.com\",\"date\":\"2020-01-17T08:00:13Z\"},\"repoName\":\"EhdenRaPredictionValidation\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1197}",
      "1198": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd660aa41a9931788f31062ff241a71e3545eae9\",\"author\":{\"name\":\"Jennifer Lane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-09-09T00:31:15Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization & Population Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1198}",
      "1199": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cf215963c9ba30d911c7b7efe15b01ac3cdf9952\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2021-04-07T09:25:31Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization & Population Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1199}",
      "1200": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d9f38e2d61081aa81f854bbbcdbb549ed1d029d6\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:23:24Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization & Population Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1200}",
      "1201": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"56efde3877ec7cec3e56bb19cbbbdf7f13947928\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:07:33Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization & Population Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1201}",
      "1202": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ceddc253d7488f10fed912f0bcdedf5b371c3244\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:03:20Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization & Population Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1202}",
      "1203": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"87459109fba5811d910551184c8d5e188bafa553\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T20:01:36Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization & Population Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1203}",
      "1204": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"adc6f3926c9dee4870f60c0b9a84273f9b4de04f\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T15:31:17Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization & Population Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1204}",
      "1205": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"33278d67f3ecc06830271d1df7cb3621b583a97d\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-04-01T14:30:39Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization & Population Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st May 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1205}",
      "1206": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"27fa7a2e9c293dcd50a8854c1579cfe70e083604\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T14:49:20Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization & Population Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1206}",
      "1207": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6dc3de410a7f9c3c7db3fa8706c8daa1706e59ea\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T14:48:42Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1207}",
      "1208": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b069d63fc103b02562a08a3643d0b2314e36e858\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:54:39Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1208}",
      "1209": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1652dd39876b794e097879464929595f09a3d473\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:48:37Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1209}",
      "1210": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cecd3e84ad7bf0321c955fc7fdab97ba415e73bf\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:42:16Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer:\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1210}",
      "1211": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"287d79653e45a096f1420ae77f57d93062c5a741\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:41:05Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer:\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1211}",
      "1212": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a275cdf3f041a583ae30d19738a28d3a5d0c7282\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:35:35Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1212}",
      "1213": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"71aa7961f8e0453a8bef42b072aade88b157810e\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:33:36Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics & Final Population Level Estimation Package\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1213}",
      "1214": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5e0a485f1a9d771d2b4fb21de055590995cfc15c\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:30:09Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics & Final Population Level Estimation Package\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1214}",
      "1215": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a5f274992ed72fc7f320b8a148571cf0bccde0ae\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:29:34Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility & Final Population Level Estimation Package\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1215}",
      "1216": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8e8696cb76c44ce207e1e2454765eb5715b394b0\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-30T13:28:23Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1216}",
      "1217": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c36d38c6845345bc9e5ff17e9410311352af5227\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-03-29T12:03:05Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[ShinyApp](https://jenniferlane.shinyapps.io/CohortDiagnosticsMSKAI_FinalDesign/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1217}",
      "1218": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e1548c31de6463c985b743fedd59d5dedbb7423d\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-02-10T17:47:28Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st April 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1218}",
      "1219": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"98d975fd9a0eea535a27ed55edaacffc50750155\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2021-01-12T07:55:14Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1219}",
      "1220": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a4cf02600761f9a52989cacf4eb36fa076b1aa17\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-01-11T09:24:58Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1220}",
      "1221": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5091190e4ab17586c443a9d788eb8521e32f247b\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-01-11T09:22:40Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1221}",
      "1222": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"50df1063b23f836f4da01b2cfd07b6c2900a64d4\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2021-01-11T09:20:41Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"Cohort Diagnostics to establish the feasibility of investigating musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1222}",
      "1223": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"75f83b5aac7cd1a1f4519757cdef50f9b3c38ca6\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2021-01-07T09:19:33Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"A Cohort Diagnostics package to establish the feasibility of investigating musculoskeletal adverse events following hormonal treatment for breast cancer\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1223}",
      "1224": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8aedc25f50d96bd78baf6b2e95b3250ad455b8b0\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2020-12-18T09:05:26Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Data.OHDSI](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1224}",
      "1225": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1d1adc4153ecdfdb196a8081d1130dc779ce705c\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2020-12-18T08:43:07Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Shiny app](https://data.ohdsi.org/CohortDiagnosticsMSKAI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1225}",
      "1226": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3696705fba1b1aa268df0c045132529794d03b80\",\"author\":{\"name\":\"jennifercelane\",\"email\":\"42356905+jennifercelane@users.noreply.github.com\",\"date\":\"2020-12-17T10:34:13Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\"],\"studyLeads\":null,\"startDate\":\"1st December 2020\",\"endDate\":\"1st March 2021\",\"protocol\":\"[EU PAS 38362](http://www.encepp.eu/encepp/viewResource.htm?id=38363)\",\"publications\":\"\",\"results\":\"[Shiny app](https://jenniferlane.shinyapps.io/CohortDiagnostics_MSK_AI/)\",\"studyLead\":[\"Jenny Lane\"]}},\"scanId\":30,\"id\":1226}",
      "1227": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"26a204a7b1adec83521b388efc53efae5607a0fd\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-21T16:31:46Z\"},\"repoName\":\"MusculoskeletalAEsAfterAIs\",\"summary\":{\"exists\":false,\"title\":\"Musculoskeletal adverse outcomes after treatment with aromatase inhibitors for breast cancer: an OHDSI based population level estimate cohort study\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"PLE\"],\"studyLeads\":null,\"startDate\":\"January 20, 2020\",\"endDate\":\"July 31, 2020\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Dr. Jenny Lane\"]}},\"scanId\":30,\"id\":1227}",
      "1228": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"01cdb142bf2da987190f2ab0f93111df727d12ac\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-02-28T21:04:16Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Methods Research\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":30,\"id\":1228}",
      "1229": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b746ff403d1453a6fa265c5af015937c65ceb46d\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-02-28T21:03:32Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Methods Research\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":30,\"id\":1229}",
      "1230": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4fe8742450616e20e3dd5c8c09588d5ed336b492\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-02-28T21:01:50Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Methods Research\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":30,\"id\":1230}",
      "1231": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b6461ccd8ee3506196ea7b3edd85c3585a5f962e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-30T08:18:41Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Methods Research\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"[Word file](https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":30,\"id\":1231}",
      "1232": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aa61ef7f52b4003bd561fa784e6f86cac5c67ef3\",\"author\":{\"name\":\"Anna Ostropolets\",\"email\":\"anna.ostropolets@odysseusinc.com\",\"date\":\"2020-01-28T07:01:06Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"Investigating Concept Heterogeneity and Granularity in the OHDSI Network\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Methods Research\"],\"tags\":[\"ConceptPrevalence\"],\"studyLeads\":null,\"startDate\":\"March 15, 2019\",\"endDate\":\"-\",\"protocol\":\"https://github.com/ohdsi-studies/ConceptPrevalence/extras/ConceptPrevalenceStudyProtocol_v1.0.docx\",\"publications\":\"TBD\",\"results\":\"TBD\",\"studyLead\":[\"Anna Ostropolets\"]}},\"scanId\":30,\"id\":1232}",
      "1233": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"925aa0d261cb41c5665d97c7af8290f600f3c1d8\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-01-27T14:54:12Z\"},\"repoName\":\"ConceptPrevalence\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1233}",
      "1234": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"098c81b8171f275fe16b863e31926361e37f9281\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-12T02:15:39Z\"},\"repoName\":\"BreastCancerBetweenScreen\",\"summary\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\",\"studyLead\":[\"Maura Beaton\",\"Jill Hardin\",\"Kristin Kostka\",\"Anna Ostropolets\",\"Jenna Reps\",\"Erica Voss\"]}},\"scanId\":30,\"id\":1234}",
      "1235": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"360f005fd98671dd84b5e21e0e9702213a99b32e\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-11T01:44:00Z\"},\"repoName\":\"BreastCancerBetweenScreen\",\"summary\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/protocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\",\"studyLead\":[\"Maura Beaton\",\"Jill Hardin\",\"Kristin Kostka\",\"Anna Ostropolets\",\"Jenna Reps\",\"Erica Voss\"]}},\"scanId\":30,\"id\":1235}",
      "1236": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"080654fabe1a8b0d1e6b908ee6d7bb02b46bdad4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-11T01:41:26Z\"},\"repoName\":\"BreastCancerBetweenScreen\",\"summary\":{\"exists\":false,\"title\":\"Predicting breast cancer within 3 years of a negative mammography\",\"status\":\"Complete\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Aug 9, 2019\",\"endDate\":\"Sep 16, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/BreastCancerBetweenScreen/blob/master/documents/ProtocolWoo2019.docx)\",\"publications\":\"-\",\"results\":\"[Shiny App](https://data.ohdsi.org/WoO2019/)\",\"studyLead\":[\"Maura Beaton\",\"Jill Hardin\",\"Kristin Kostka\",\"Anna Ostropolets\",\"Jenna Reps\",\"Erica Voss\"]}},\"scanId\":30,\"id\":1236}",
      "1237": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"59ce5606a50d1d6d07889d612f4f341c8ab08a26\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-02-11T01:27:52Z\"},\"repoName\":\"BreastCancerBetweenScreen\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1237}",
      "1238": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"11f1bbc2dba6a2dfe99b1115da729e8bdb004e47\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-02-12T08:54:26Z\"},\"repoName\":\"DMCharacterizationAP\",\"summary\":{\"exists\":false,\"title\":\"Characterization of DM in the OHDSI-AP network\",\"status\":\"Repo Created\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-AP\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"OHDSI-AP\"]}},\"scanId\":30,\"id\":1238}",
      "1239": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"506e9aabaa9bd551be760127d9efbd33e1d3741b\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-11T04:03:53Z\"},\"repoName\":\"DMCharacterizationAP\",\"summary\":{\"exists\":false,\"title\":\"[Characterization of DM in OHDSI-AP network]\",\"status\":\"Repo Created\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-AP\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"OHDSI-AP\"]}},\"scanId\":30,\"id\":1239}",
      "1240": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"feea0a53c0fd316da207c5f763018f3e7703b10f\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-11T04:00:30Z\"},\"repoName\":\"DMCharacterizationAP\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1240}",
      "1241": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"50e0efdb41528812fd0c36633f7f8821f813054b\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2021-04-07T20:31:25Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInNonElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":30,\"id\":1241}",
      "1242": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"78efc21af1986bef5828b8bfbc35e91553b38540\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2021-04-07T20:30:32Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/), [StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":30,\"id\":1242}",
      "1243": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"256648dce72772af1127ddbb7d0d1aae1dcad57a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2021-04-07T20:28:02Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly and non-Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskElderlyApUsers/), [StrokeRiskInElderlyApUsers](https://data.ohdsi.org/StrokeRiskInNonElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":30,\"id\":1243}",
      "1244": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4f5293dfd8bf546ceee976403ba7dfbbad326658\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-10-28T18:44:01Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Complete\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":30,\"id\":1244}",
      "1245": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"60dcd9a55d2d51dc6e93eb2fe0fd04a80c67d2cd\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-02-21T21:20:02Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Results Available\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":30,\"id\":1245}",
      "1246": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3735eb343ca416b6be7c4d5a558228e9f73378e9\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-02-21T21:15:24Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"Stroke Risk among Elderly Users of Typical vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database\",\"status\":\"Results Available\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"December 29, 2018\",\"endDate\":\"July 31, 2019\",\"protocol\":\"[Protocol](https://github.com/ohdsi-studies/StrokeRiskInElderlyApUsers/tree/master/documents)\",\"publications\":\"-\",\"results\":\"[EvidenceExplorer](https://data.ohdsi.org/StrokeRiskInElderlyApUsers/)\",\"studyLead\":[\"Dan Fife\",\"Clair Blacketer\",\"Karl Knight\",\"James Weaver\"]}},\"scanId\":30,\"id\":1246}",
      "1247": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c1385a3130dcb46595be0df4cb5adaab9735c2e6\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-02-19T14:54:26Z\"},\"repoName\":\"StrokeRiskInApUsers\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1247}",
      "1248": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e72fea56d38a9cfe1acca47e05f82c1d1e0c5094\",\"author\":{\"name\":\"neal1202\",\"email\":\"47546151+neal1202@users.noreply.github.com\",\"date\":\"2020-03-09T15:09:08Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\",\"Oncology WG\"],\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1248}",
      "1249": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6f511fde5b06d5403cfd83dc0d10d12925b4f5a4\",\"author\":{\"name\":\"neal1202\",\"email\":\"47546151+neal1202@users.noreply.github.com\",\"date\":\"2020-03-09T15:08:31Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\",\"Oncology WG\"],\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1249}",
      "1250": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"03f538809c92e139e2a8fcf72481c3f37afc4153\",\"author\":{\"name\":\"neal1202\",\"email\":\"47546151+neal1202@users.noreply.github.com\",\"date\":\"2020-03-09T14:56:56Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\",\"Oncology WG\"],\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1250}",
      "1251": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"44a40ca7eb4d549b82892dc2c3548350652fc656\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-25T07:07:37Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\",\"Oncology WG\"],\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1251}",
      "1252": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"cc492cfe4c0cbc26f74c657991e57ae3c1e57979\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-25T07:06:52Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"Clinical characterization of cancer treatment using the Oncology CDM\",\"status\":\"Repo Created\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI-Korea\",\"FEEDER-NET\",\"Oncology WG\"],\"studyLeads\":null,\"startDate\":\"Februrary 25, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Hokyun Jeon\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1252}",
      "1253": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4a14da3317f525650a370428d31583ab8860f79e\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-02-25T07:02:22Z\"},\"repoName\":\"CancerTxPathway\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1253}",
      "1254": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"bb735572e0a2f0a2fe7bdd68f8c6eb6a112d0514\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-05-13T03:09:31Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1254}",
      "1255": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fd5f78c23c1e6a6e88e05c1bc1ff22add77a39b3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-05-13T03:09:18Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"[MedRxiv]](https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1)\",\"results\":\"[Shiny app](http://evidence.ohdsi.org:3838/Covid19CharacterizationHospitalization/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1255}",
      "1256": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1dcba242e3898967ef9ff04a9c2f7e774105fc9b\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-05-13T03:07:35Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Results Available\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"\",\"results\":\"[Influenza Cohort Diagnostics](https://data.ohdsi.org/Covid19InfluenzaHospitalizations/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1256}",
      "1257": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"21e7323ff4594c341cedc757af71d2f08983c15a\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-08T01:04:10Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"\",\"results\":\"[Influenza Cohort Diagnostics](https://data.ohdsi.org/Covid19InfluenzaHospitalizations/)\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1257}",
      "1258": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"b6b22a47dcca62e7e2556337eaef3065353fac5d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-08T01:03:51Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19HospitalizationCharacterization/blob/master/documents/Protocol_COVID-19%20Hospitalization%20Characterisation_V1.1.docx)\",\"publications\":\"\",\"results\":\"[Influenza Cohort Diagnostics](https://data.ohdsi.org/Covid19InfluenzaHospitalizations/\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1258}",
      "1259": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"273671d17cad9222aa582693f1f00ba1bea3489d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-08T01:00:19Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1259}",
      "1260": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1084813b756bc42efa30ae6172b47fe8664dcc54\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T23:54:22Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1260}",
      "1261": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a1e9ea255f3b144d2d43228a86c6f56dc4afc8b9\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T23:51:52Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1261}",
      "1262": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"abfeb9d4d164e8ac75b0c374549eb3b1a3014a5a\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T23:38:53Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of Patients Hospitalized with COVID-19 and Influenza\\r\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"April 9, 2020\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Edward Burn\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1262}",
      "1263": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aaf120977f92300b55a331d7589b5b138a1e774c\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-03-19T07:36:13Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of COVID-19\\r\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":30,\"id\":1263}",
      "1264": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7b3926453105308d8febaeb58a42c72d28dbcda3\",\"author\":{\"name\":\"Seng Chan You\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-16T06:34:17Z\"},\"repoName\":\"Covid19HospitalizationCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Clinical Characterization of COVID-19\\r\",\"status\":\"Started\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\"],\"studyLeads\":null,\"startDate\":\"March 16, 2020\",\"endDate\":\"\",\"protocol\":\"\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":30,\"id\":1264}",
      "1265": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"da40825f5f3831ea1603b20f56cf1e5485216422\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-19T08:18:54Z\"},\"repoName\":\"Covid19DrugRepurposing\",\"summary\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Martijn Schuemie\",\"Daniel Prieto-Alhambra\"]}},\"scanId\":30,\"id\":1265}",
      "1266": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9e3607fe75078d861da809d67c91906c0db387cb\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-19T07:32:06Z\"},\"repoName\":\"Covid19DrugRepurposing\",\"summary\":{\"exists\":false,\"title\":\"Evaluation of Existing Drugs for Treatment of COVID-19\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 19, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Martijn Schuemie\"]}},\"scanId\":30,\"id\":1266}",
      "1267": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"31a19598e52da5348a88c5b89b46ec74dfa24724\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-03-19T07:15:35Z\"},\"repoName\":\"Covid19DrugRepurposing\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1267}",
      "1268": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7c926d4116c5ab733758ee75826c32cb4d6c5399\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-19T23:20:02Z\"},\"repoName\":\"CovidSeverityPrediction\",\"summary\":{\"exists\":false,\"title\":\"Prediction of clinical outcome in patients with COVID-19 based on their past medical history\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 9, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Seng Chan You\"]}},\"scanId\":30,\"id\":1268}",
      "1269": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"081a047766edfb7af6a243b4c4f1e159973ed3ea\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-03-19T23:14:57Z\"},\"repoName\":\"CovidSeverityPrediction\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1269}",
      "1270": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"50b3254b856a8e696794f1bcc982d3eddae914c3\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-25T07:47:08Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":30,\"id\":1270}",
      "1271": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7c078e4f6bf9162d36de335ab3a353bb22564cd4\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-25T05:36:05Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":30,\"id\":1271}",
      "1272": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a4eb253774c6c0d4899668a386f6041fa4c81af3\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-24T16:50:32Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":30,\"id\":1272}",
      "1273": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aca774db8c3cd87b36fe8eeea272b7e9f7252c82\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-24T16:09:08Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":30,\"id\":1273}",
      "1274": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7dabe0cf615f8c61c494b16b7805d721bc7a2fdd\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-24T15:38:30Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":30,\"id\":1274}",
      "1275": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"ada984610aed1800ceec11d6202ab36457d39030\",\"author\":{\"name\":\"Schuemie\",\"email\":\"MSCHUEMI@its.jnj.com\",\"date\":\"2020-03-23T16:25:16Z\"},\"repoName\":\"Covid19CohortEvaluation\",\"summary\":{\"exists\":false,\"title\":\"Covid19CohortEvaluation\",\"studyLeads\":null}},\"scanId\":30,\"id\":1275}",
      "1276": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"af65b1fc84c04c14956acbbf5541e6d29e571ec5\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-08-17T01:32:30Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Results Available\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"[Simple Models](https://www.medrxiv.org/content/10.1101/2020.05.26.20112649v4) - [C19 Validation](https://www.medrxiv.org/content/10.1101/2020.06.15.20130328v1)\",\"results\":\"[Simple Models](http://evidence.ohdsi.org:3838/Covid19CoverPrediction/) - [C19 Validation](http://evidence.ohdsi.org:3838/C19validation/)\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1276}",
      "1277": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2ecc070799db12cb811743bb3e32eb8d5b32f366\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-24T14:13:01Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1277}",
      "1278": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f90f5bf727f0f8bfd256d70bbde7ddffb45f4c8d\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-22T12:14:58Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Development and validation of complex and simple patient-level prediction models for predicting various outcomes in COVID patients: a rapid network study to inform the management of COVID-19\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1278}",
      "1279": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"36d56c063ad27321eb2560891af9c84d1583a4f1\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-22T09:52:31Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Validation of simple patient-level prediction models for predicting short-term and long-term survival in patients hospitalized with pneumonia and ARDS and requiring intensive care: a rapid network study to inform the management of COVID-19\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1279}",
      "1280": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"61916c5ee5b142e539cef15686a604ea8875cf4b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-20T19:43:30Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1280}",
      "1281": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e8a8440a5db3bcab0b721531a0262b2cf1c03e02\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-17T16:06:29Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1281}",
      "1282": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e02e1ff68ad47e31f3457a6ab78ed5966e4897e3\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-16T19:40:29Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1282}",
      "1283": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a82dca17db1c37b16c0a8dfa92a52e4699f74f2c\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-16T15:47:52Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1283}",
      "1284": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f02dc12a50a721f36620a6e1b34e01f99966e90e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-06T03:36:45Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word docment](https://github.com/ohdsi-studies/Covid19PredictionStudies/blob/master/HospitalizationInSymptomaticPatients/docs/PLP_protocol_Q1%2BQ2_20200329.docx)\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1284}",
      "1285": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7f1ef8141508c45daf8ef4626376c906892f0355\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-04T04:21:38Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1285}",
      "1286": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"84ae56af21a897fab6ca0baa8e0a8f4147ee0d33\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-04-03T02:54:05Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1286}",
      "1287": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eb300df831fb67b73559640b7710b80e89f3bce8\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T23:13:50Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1287}",
      "1288": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0a5e54d900dd7c72593feedce7ce6289dcec42ae\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T19:37:05Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1288}",
      "1289": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e7bab20bcc920e551162373e0e1c311bb76723ab\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-03-29T19:07:56Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1289}",
      "1290": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"90ccfb77e692def449f0b424ea7d7c8ab8b6001d\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-03-29T19:03:07Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1290}",
      "1291": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0437081bc815fdef85ca8904df07bc4e6257037d\",\"author\":{\"name\":\"cyang-emc\",\"email\":\"c.yang@erasmusmc.nl\",\"date\":\"2020-03-29T18:34:04Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1291}",
      "1292": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4bd9e124269c74acfa67a2dce23a6010ff33818b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T07:42:39Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1292}",
      "1293": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a8fd552ca7a91f855b2667b1672310d6568927e7\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T06:18:55Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1293}",
      "1294": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9798d737ef16d44c63b61fbe497e19d22882009a\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T05:52:49Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1294}",
      "1295": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"baafb0d689e60baafcea2df9d276d8c6f6ec58a1\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T05:47:36Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1295}",
      "1296": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eb1a110aec8e29a3ac3f2ac14148c33bcd7f0b47\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-29T04:19:52Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1296}",
      "1297": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a88b3c6e8ec03dbbdf4f5f2d859052237fd8e64f\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T22:24:47Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1297}",
      "1298": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a121b79c2ef256cd0713fe9e30296807dd0245a4\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T22:24:05Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1298}",
      "1299": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"17cdee6cab09f701014fb2c768010e0de4ae54d5\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T22:20:31Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1299}",
      "1300": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"8f1bd884d676c0fa61bad11433e8e11764905b2b\",\"author\":{\"name\":\"Ross D. Williams\",\"email\":\"34747165+rossdwilliams@users.noreply.github.com\",\"date\":\"2020-03-28T18:34:41Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1300}",
      "1301": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5b4827be873507fb2b0bc53bd62b4ee4349dfa12\",\"author\":{\"name\":\"RossDWilliams\",\"email\":\"r.williams@erasmusmc.nl\",\"date\":\"2020-03-28T18:30:28Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1301}",
      "1302": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1a468d33fb4faca0cb0c8efc80cd23dbac97474d\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-28T17:46:57Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1302}",
      "1303": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6ceaf041f80d9cbe297af11134eccd3d26a66dd5\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-27T04:04:17Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1303}",
      "1304": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"99d3a123bd7391a2375e6f46da76d559e17cffcf\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-27T02:22:49Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"Covid19PredictionStudies\",\"status\":\"Started\",\"useCases\":[\"Patient-Level Prediction\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"Mar 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Jenna Reps\",\"Ross Williams\",\"Peter Rijnbeek\"]}},\"scanId\":30,\"id\":1304}",
      "1305": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3ca0a27f5f8f83ca447260b330f83f4e438ce60b\",\"author\":{\"name\":\"jreps\",\"email\":\"jreps@its.jnj.com\",\"date\":\"2020-03-27T00:03:44Z\"},\"repoName\":\"Covid19PredictionStudies\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1305}",
      "1306": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d010dae8dce9e9530825599d24a00a0c08d6230a\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-06-22T09:43:37Z\"},\"repoName\":\"Covid19EstimationIl6JakInhibitors\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"[Evidence Explorer](https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/)\",\"studyLead\":[\"Daniel Prieto-Alhambra\"]}},\"scanId\":30,\"id\":1306}",
      "1307": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7da682d025eb22eaf00b44be69acfc6e19ca1eba\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-28T16:42:10Z\"},\"repoName\":\"Covid19EstimationIl6JakInhibitors\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Il6 and JAK inhibitors population-level effect estimation\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationIl6JakInhibitors/\",\"studyLead\":[\"Daniel Prieto-Alhambra\"]}},\"scanId\":30,\"id\":1307}",
      "1308": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"a27c5a799ad95f23326fdabb57533c51172cceaa\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2020-03-28T15:15:41Z\"},\"repoName\":\"Covid19EstimationIl6JakInhibitors\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1308}",
      "1309": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"d5ab703f48bec9aede5542f530b34a4260b67abf\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-10-28T18:40:56Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Complete\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1309}",
      "1310": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9ab2e646d4c7138bebb25a770fb7f3e22bbdcc8a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-11T06:20:50Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Results Available\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1310}",
      "1311": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"5a57adb42c28c1ed4300457f61733ebe9a796667\",\"author\":{\"name\":\"schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-07T08:56:38Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1311}",
      "1312": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2b3cd5a2e118a332830599adcb83f5910aecb121\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T22:41:31Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1312}",
      "1313": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"eabb1a91ef2b4b8117bef73168bd00f9f66a7dd8\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T17:27:51Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1313}",
      "1314": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"1e77318c70aefe0f37583e821642b106eee3547b\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-05T08:44:50Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/)\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1314}",
      "1315": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"2a1dbc82fd0535ebef3c345a8bce0f241ae677f3\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-04T20:52:39Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1315}",
      "1316": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"811951eb287c74bd2a6042866b553a4c98778ac9\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-03T23:20:51Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1316}",
      "1317": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"584bb31e643d118125f11ca07cb987588549be5b\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-03T23:20:13Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1317}",
      "1318": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3b350b61765cda0aaf7f043ec879d870d3d22731\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-03T23:19:18Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF (as filed with PASS)](https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf)\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1318}",
      "1319": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"aab35d9876e94aa25f8f0e6ffaaabf5221d32d2d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-02T17:49:40Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1319}",
      "1320": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"3d78be016a56e8c2a2badbc8de64a3a54b7155a5\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-04-01T00:51:30Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1320}",
      "1321": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"268244ae9279ecfb89953c6b00743803f71188fb\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-31T20:36:12Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1321}",
      "1322": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"fc719f1433da9e0bde47d5e34d94e8480db52d37\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-31T17:26:32Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\",\"James Weaver\"]}},\"scanId\":30,\"id\":1322}",
      "1323": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e4b02691a00a2173b3fa8000a954cdeba07f7254\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-29T19:53:55Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\"]}},\"scanId\":30,\"id\":1323}",
      "1324": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4f73a6f95fa27adea563023c8fab179e7df6c20a\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jweave17@its.jnj.com\",\"date\":\"2020-03-29T02:20:24Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Hydroxychloroquine population-level effect estimation\",\"status\":\"Started\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"https://data.ohdsi.org/Covid19EstimationHydroxychloroquine/\",\"studyLead\":[\"Jennifer Lane\"]}},\"scanId\":30,\"id\":1324}",
      "1325": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"dbe2a1c4416f15ab54690f10e3fb536f9dcc7d70\",\"author\":{\"name\":\"Jamie Weaver\",\"email\":\"jamieweaver@gmail.com\",\"date\":\"2020-03-28T17:37:26Z\"},\"repoName\":\"Covid19EstimationHydroxychloroquine\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1325}",
      "1326": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"77e8176adbfa6ba62126ba427afbad780404ff03\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-06-05T13:45:48Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/IcariusSusceptibility/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":30,\"id\":1326}",
      "1327": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7d1a38158624f614a2ce7f0559b9071e14dd70e8\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-06-05T13:42:05Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[PDF](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":30,\"id\":1327}",
      "1328": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6808f3b0835d6ce830b702a76cec0a8fa211e0a1\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-06-04T12:54:43Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: International coronavirus disease (COVID) - angiotensin converting enzyme (ACE) Receptor Inhibition Utilization and Safety (ICARIUS) studies: susceptibility and severity\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":30,\"id\":1328}",
      "1329": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"422de1c8ea30e32c093ada52ab7da934e3dfd3cc\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-05-19T15:37:10Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":30,\"id\":1329}",
      "1330": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"633758e75af5623b58a51b07cba8271299f1f7f1\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T22:42:05Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":30,\"id\":1330}",
      "1331": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"4f925bb70675f35e560c5f604e9bd7f2e7c1a005\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T18:08:19Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":30,\"id\":1331}",
      "1332": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0391de3e4e15d8a18d5c1a58acd68457c7e3f5f5\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T17:59:37Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":\"OHDSI COVID-19 Studyathon: Association of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) on coronavirus disease (COVID-19) incidence and complications\",\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":30,\"id\":1332}",
      "1333": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7f9c6e1c16c7cc188810f936f5f3d7610bf18e30\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-05T17:58:59Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":null,\"status\":\"Design Finalized\",\"useCases\":[\"Population-Level Estimation\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"March 26, 2020\",\"endDate\":\"-\",\"protocol\":\"[Word Doc](https://github.com/ohdsi-studies/Covid19EstimationRasInhibitors/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_0.docx)\",\"publications\":\"-\",\"results\":\"[Shiny app](https://data.ohdsi.org/Covid19EstimationAceInhibitors/)\",\"studyLead\":[\"Marc A. Suchard\",\"Seng Chan You\",\"Mitchell M. Conover\"]}},\"scanId\":30,\"id\":1333}",
      "1334": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f496d0bb02f7da9e88a02b0469259b4411d79dc1\",\"author\":{\"name\":\"Marc Suchard\",\"email\":\"msuchard@ucla.edu\",\"date\":\"2020-04-02T20:20:45Z\"},\"repoName\":\"Covid19Icarius\",\"summary\":{\"exists\":false,\"title\":null,\"studyLeads\":null}},\"scanId\":30,\"id\":1334}",
      "1335": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"c0b95e61d0fce1d3de1a5e7ef87cc79f99784f1e\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-06-22T10:01:35Z\"},\"repoName\":\"Covid19TestCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1335}",
      "1336": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9af773f78cede486f8b18632eb672df71b905d7c\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-04-17T02:34:20Z\"},\"repoName\":\"Covid19TestCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1336}",
      "1337": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"6e593c1e4f1030061f0f7cd34bb0b23f29cc75b2\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-04-17T02:32:30Z\"},\"repoName\":\"Covid19TestCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1337}",
      "1338": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"f8e98a4e0083ff6815274aa45e5b6743fdd7eedc\",\"author\":{\"name\":\"chandryou\",\"email\":\"applegna@gmail.com\",\"date\":\"2020-04-17T02:28:01Z\"},\"repoName\":\"Covid19TestCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Characteristics and outcomes of individuals tested for SARS-CoV-2\",\"status\":\"Design Finalized\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical Application\"],\"tags\":[\"OHDSI\",\"Study-a-thon\",\"COVID-19\"],\"studyLeads\":null,\"startDate\":\"April 4, 2020\",\"endDate\":\"\",\"protocol\":\"[Google Doc](https://drive.google.com/drive/folders/1sSrKmNjLAaStWyfZjUlzY97HxcTqrMNW)\",\"publications\":\"\",\"results\":\"\",\"studyLead\":[\"Asieh Golozar\",\"Seng Chan You\"]}},\"scanId\":30,\"id\":1338}",
      "1339": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"0631e7d767ece6463392e383656e290c77d962f9\",\"author\":{\"name\":\"Martijn Schuemie\",\"email\":\"schuemie@ohdsi.org\",\"date\":\"2020-04-28T03:43:14Z\"},\"repoName\":\"COVID19CancerBaselineCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":[\"Characterization\"],\"studyType\":[\"Clinical application\"],\"tags\":[\"COVID-19\",\"Oncology\"],\"studyLeads\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Talita Duarte-Salles\",\"Shilpa Ratwani\"]}},\"scanId\":30,\"id\":1339}",
      "1340": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"e1b08f5b3626e2adaa391089c266e03efad2ea15\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T20:58:53Z\"},\"repoName\":\"COVID19CancerBaselineCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":[\"Clinical application\"],\"studyType\":[\"Characterization\"],\"tags\":[\"COVID-19\",\"Oncology\"],\"studyLeads\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Talita Duarte-Salles\",\"Shilpa Ratwani\"]}},\"scanId\":30,\"id\":1340}",
      "1341": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"7842ff2b717987e3f4f78be70f8ffbbb984de6dc\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T20:58:40Z\"},\"repoName\":\"COVID19CancerBaselineCharacterization\",\"summary\":{\"exists\":false,\"title\":\"Baseline Characteristics of COVID-19 in Cancer Patients \",\"status\":\"Repo Created\",\"useCases\":[\"Clinical application\"],\"studyType\":[\"Characterization\"],\"tags\":[\"COVID-19\",\"Oncology\"],\"studyLeads\":null,\"startDate\":\"April 7, 2020\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"Talita Duarte-Salles\",\"Shilpa Ratwani\"]}},\"scanId\":30,\"id\":1341}",
      "1342": "{\"status\":\"in progress\",\"readmeCommit\":{\"sha\":\"9767d71459e17a5528ffe070d501ed98b0d3845d\",\"author\":{\"name\":\"Kristin Kostka\",\"email\":\"44622115+kmkostka@users.noreply.github.com\",\"date\":\"2020-04-07T20:53:49Z\"},\"repoName\":\"COVID19CancerBaselineCharacterization\",\"summary\":{\"exists\":false,\"title\":\"[Study title]\",\"status\":\"Repo Created\",\"useCases\":[\"-\"],\"studyType\":[\"-\"],\"tags\":[\"-\"],\"studyLeads\":null,\"startDate\":\"-\",\"endDate\":\"-\",\"protocol\":\"-\",\"publications\":\"-\",\"results\":\"-\",\"studyLead\":[\"-\"]}},\"scanId\":30,\"id\":1342}",
      "1343": "{\"status\":\"complete\",\"scanId\":30,\"id\":1343}"
    }
  }
}